<!DOCTYPE html><html lang="en-us" >

<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 4.8.0">

  

  
  
  
  
  
  

  

  
  
  
    
  
  <meta name="description" content="Table 1. List of all 2393 articles with abstract clustered as Diagnosis in PlatOMICs for mesothelioma. *Curation represents the number of person that analyzed the information   Title  Journal      P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining.">

  
  <link rel="alternate" hreflang="en-us" href="/mesothelioma/tables/abstract/diagnose/">

  


  
  
  
  <meta name="theme-color" content="#2962ff">
  

  
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.0-1/css/all.min.css" integrity="sha256-4w9DunooKSr3MFXHXWyFER38WmPdm361bQS/2KUWZbU=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.css" integrity="sha256-Vzbj7sDDS/woiFS3uNKo8eIuni59rjyNGtXfstRzStA=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/styles/github.min.css" crossorigin="anonymous" title="hl-light">
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" disabled>
        
      
    

    

    

    
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
    
      

      
      

      
        <script src="https://cdnjs.cloudflare.com/ajax/libs/lazysizes/5.1.2/lazysizes.min.js" integrity="sha256-Md1qLToewPeKjfAHU1zyPwOutccPAm5tahnaw7Osw0A=" crossorigin="anonymous" async></script>
      
    
      

      
      

      
    
      

      
      

      
    
      

      
      
        
      

      
    
      

      
      

      
    

  

  
  
  
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Montserrat:400,700%7CRoboto:400,400italic,700%7CRoboto+Mono&display=swap">
  

  
  
  
  
  <link rel="stylesheet" href="/mesothelioma/css/academic.css">

  





<script async src="https://www.googletagmanager.com/gtag/js?id=google_analytics_ID"></script>
<script>
  window.dataLayer = window.dataLayer || [];

  function gtag() {
      dataLayer.push(arguments);
  }

  function trackOutboundLink(url, target) {
    gtag('event', 'click', {
         'event_category': 'outbound',
         'event_label': url,
         'transport_type': 'beacon',
         'event_callback': function () {
           if (target !== '_blank') {
             document.location = url;
           }
         }
    });
    console.debug("Outbound link clicked: " + url);
  }

  function onClickCallback(event) {
    if ((event.target.tagName !== 'A') || (event.target.host === window.location.host)) {
      return;
    }
    trackOutboundLink(event.target, event.target.getAttribute('target'));  
  }

  gtag('js', new Date());
  gtag('config', 'google_analytics_ID', {});

  
  document.addEventListener('click', onClickCallback, false);
</script>


  


  
  

  

  <link rel="manifest" href="/mesothelioma/index.webmanifest">
  <link rel="icon" type="image/png" href="/mesothelioma/images/icon_hu3365e08ad5ef6cb6d886bc511b9ad2b3_313689_32x32_fill_lanczos_center_2.png">
  <link rel="apple-touch-icon" type="image/png" href="/mesothelioma/images/icon_hu3365e08ad5ef6cb6d886bc511b9ad2b3_313689_192x192_fill_lanczos_center_2.png">

  <link rel="canonical" href="/mesothelioma/tables/abstract/diagnose/">

  
  
  
  
  
  
  
    
    
  
  
  <meta property="twitter:card" content="summary">
  
  <meta property="og:site_name" content="mesothelioma">
  <meta property="og:url" content="/mesothelioma/tables/abstract/diagnose/">
  <meta property="og:title" content="Diagnosis Articles | mesothelioma">
  <meta property="og:description" content="Table 1. List of all 2393 articles with abstract clustered as Diagnosis in PlatOMICs for mesothelioma. *Curation represents the number of person that analyzed the information   Title  Journal      P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining."><meta property="og:image" content="/mesothelioma/images/icon_hu3365e08ad5ef6cb6d886bc511b9ad2b3_313689_512x512_fill_lanczos_center_2.png">
  <meta property="twitter:image" content="/mesothelioma/images/icon_hu3365e08ad5ef6cb6d886bc511b9ad2b3_313689_512x512_fill_lanczos_center_2.png"><meta property="og:locale" content="en-us">
  
    
      <meta property="article:published_time" content="2018-09-09T00:00:00&#43;00:00">
    
    <meta property="article:modified_time" content="2018-09-09T00:00:00&#43;00:00">
  

  



  


  


  





  <title>Diagnosis Articles | mesothelioma</title>

</head>

<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" >

  <aside class="search-results" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search">
        
      </div>

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>


  







<nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
  <div class="container">

    
    <div class="d-none d-lg-inline-flex">
      <a class="navbar-brand" href="/mesothelioma/">mesothelioma</a>
    </div>
    

    
    <button type="button" class="navbar-toggler" data-toggle="collapse"
            data-target="#navbar-content" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
    <span><i class="fas fa-bars"></i></span>
    </button>
    

    
    <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
      <a class="navbar-brand" href="/mesothelioma/">mesothelioma</a>
    </div>
    

    
    
    <div class="navbar-collapse main-menu-item collapse justify-content-start" id="navbar-content">

      
      <ul class="navbar-nav d-md-inline-flex">
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/mesothelioma/syntax/"><span>Syntax</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/mesothelioma/genepanel/"><span>Gene Panel</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/mesothelioma/drugpanel/"><span>Drug Panel</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/mesothelioma/tissuepanel/"><span>Tissue Panel</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/mesothelioma/syntax_summary/"><span>Literature Consensus</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/mesothelioma/#about"><span>Contact</span></a>
        </li>

        
        

      

        
      </ul>
    </div>

    <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">
      
      <li class="nav-item">
        <a class="nav-link js-search" href="#"><i class="fas fa-search" aria-hidden="true"></i></a>
      </li>
      

      

      

    </ul>

  </div>
</nav>


  

<div class="container-fluid docs">
  <div class="row flex-xl-nowrap">
    <div class="col-12 col-md-3 col-xl-2 docs-sidebar">
      





  
    
  




<form class="docs-search d-flex align-items-center">
  <button class="btn docs-toggle d-md-none p-0 mr-3" type="button" data-toggle="collapse" data-target="#docs-nav" aria-controls="docs-nav" aria-expanded="false" aria-label="Toggle section navigation">
    <span><i class="fas fa-bars"></i></span>
  </button>

  
  <input name="q" type="search" class="form-control" placeholder="Search..." autocomplete="off">
  
</form>

<nav class="collapse docs-links" id="docs-nav">
  

  
  
  
  
  <div class="docs-toc-item">
    <a class="docs-toc-link" href="/mesothelioma/tables/abstract/">Table List</a>
    <ul class="nav docs-sidenav">
      
      <li class="active">
        <a href="/mesothelioma/tables/abstract/diagnose/">Diagnosis</a>
      </li>
      
      <li >
        <a href="/mesothelioma/tables/abstract/treatment/">Treatment</a>
      </li>
      
      <li >
        <a href="/mesothelioma/tables/abstract/epidemiology/">Epidemiology</a>
      </li>
      
      <li >
        <a href="/mesothelioma/tables/abstract/transmission/">Transmission</a>
      </li>
      
      <li >
        <a href="/mesothelioma/tables/abstract/signs/">Clinical, signs &amp; Symptoms</a>
      </li>
      
      <li >
        <a href="/mesothelioma/tables/abstract/no_category/">No Category</a>
      </li>
      
      <li >
        <a href="/mesothelioma/tables/abstract/no_abstract/">No Abstract</a>
      </li>
      
    </ul>
    

  </div>
  
  
</nav>

    </div>

    

    <main class="col-12 col-md-9 col-xl-8 py-md-3 pl-md-5 docs-content" role="main">

      <article class="article">

        <div class="docs-article-container">
          <h1>Diagnosis Articles</h1>

          <div class="article-style">
            
<script src="/mesotheliomarmarkdown-libs/kePrint/kePrint.js"></script>


<br>
<br>
<p style="font-size:12px" align="center">
<strong>Table 1.</strong> List of all 2393 articles with abstract clustered as Diagnosis in PlatOMICs for mesothelioma. <br>*Curation represents the number of person that analyzed the information
</p>
<hr />
<table class="table table-striped" style="width: auto !important; margin-left: auto; margin-right: auto;">
<thead>
<tr>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Title
</th>
<th style="text-align:left;position: sticky; top:0; background-color: #FFFFFF;">
Journal
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining.
</td>
<td style="text-align:left;">
Oncol. Rep.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diagnostic examination for causes of exudative pleurisy].
</td>
<td style="text-align:left;">
Ned Tijdschr Geneeskd
</td>
</tr>
<tr>
<td style="text-align:left;">
[Primary malignant tumors of the pleura. Pleural Mesothelioma (P.M.)].
</td>
<td style="text-align:left;">
Minerva Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
The clinical importance of magnetic resonance imaging versus computed tomography in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Pelvic and lumbar metastasis detected by bone scintigraphy in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Nuklearmedizin
</td>
</tr>
<tr>
<td style="text-align:left;">
[Primary pericardial mesothelioma: report of a case (author’s transl)].
</td>
<td style="text-align:left;">
G Ital Cardiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Ga-67 tumor scan in malignant diffuse mesothelioma–comparison with CT and pathological findings.
</td>
<td style="text-align:left;">
Ann Nucl Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Magnetic resonance appearance of asbestos-related benign and malignant pleural diseases.
</td>
<td style="text-align:left;">
Scand J Work Environ Health
</td>
</tr>
<tr>
<td style="text-align:left;">
Health effects of asbestos exposure in humans: a quantitative assessment.
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
[Video thoracoscopy in the diagnosis of pleural effusions].
</td>
<td style="text-align:left;">
Minerva Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish emigrant cohort.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Case series of mesotheliomas from hospital archives as contribution to preventive intervention].
</td>
<td style="text-align:left;">
Ann. Ist. Super. Sanita
</td>
</tr>
<tr>
<td style="text-align:left;">
[MRT, CT and sonography in the preoperative assessment of the primary tumor spread in malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Rofo
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesotheliomas].
</td>
<td style="text-align:left;">
Medicina (B Aires)
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: US-guided histologic core-needle biopsy.
</td>
<td style="text-align:left;">
Radiology
</td>
</tr>
<tr>
<td style="text-align:left;">
[CA 125 in the department of internal medicine–a marker of ovarian tumor, thoracic fluid or ascites?].
</td>
<td style="text-align:left;">
Vnitr Lek
</td>
</tr>
<tr>
<td style="text-align:left;">
Pseudomesotheliomatous carcinoma involving pleura and peritoneum: A clinicopathologic and immunohistochemical study of three cases.
</td>
<td style="text-align:left;">
Ann Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Horner’s syndrome in a patient with diffuse malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of diffuse pleural mesothelioma disclosed by a 7 mm tumor shadow on chest X-ray film during a regular physical checkup].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
[Chronic pleuropathy due to asbestos and malignant mesothelioma of the pleura: a differential diagnosis not always easy. A case report].
</td>
<td style="text-align:left;">
Recenti Prog Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[Peritoneal mesothelioma–incidence and etiology].
</td>
<td style="text-align:left;">
Pathologe
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: a problematic review.
</td>
<td style="text-align:left;">
Surg Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural malignant mesothelioma complicated by multiple myeloma].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: the spectrum of manifestations on CT in 70 cases.
</td>
<td style="text-align:left;">
Clin Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
How should we treat malignant pleural mesothelioma (MPM)?
</td>
<td style="text-align:left;">
Acta Chir Hung
</td>
</tr>
<tr>
<td style="text-align:left;">
Preoperative work-up of a solitary diaphragmatic mass in a patient with right shoulder pain: a case for diagnosis.
</td>
<td style="text-align:left;">
Monaldi Arch Chest Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the pleural space.
</td>
<td style="text-align:left;">
Oncology (Williston Park, N.Y.)
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic value of FDG PET imaging in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Nucl. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Advances in the treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Cerebral metastases in malignant mesothelioma: a case report.
</td>
<td style="text-align:left;">
Eur J Cancer Care (Engl)
</td>
</tr>
<tr>
<td style="text-align:left;">
[Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma with an unusual radiologic manifestation].
</td>
<td style="text-align:left;">
An Med Interna
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytopathology of malignant mesothelioma of the pleura in fine-needle aspiration biopsy.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro.
</td>
<td style="text-align:left;">
Mol. Cell. Biochem.
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized benign fibrous mesothelioma mimicking a malignant tumor of the pleura.
</td>
<td style="text-align:left;">
JBR-BTR
</td>
</tr>
<tr>
<td style="text-align:left;">
The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
</td>
<td style="text-align:left;">
J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Bull Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.
</td>
<td style="text-align:left;">
AJR Am J Roentgenol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diagnosis of malignant pleural mesothelioma and asbestosis].
</td>
<td style="text-align:left;">
Ned Tijdschr Geneeskd
</td>
</tr>
<tr>
<td style="text-align:left;">
Palliative treatment of malignant pleural effusions by video-assisted thoracoscopic surgery.
</td>
<td style="text-align:left;">
Acta Chir Hung
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma eight years after a diagnosis of atypical mesothelial hyperplasia.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].
</td>
<td style="text-align:left;">
Nuklearmedizin
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgical treatment of mesothelioma: pleurectomy.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleuropneumonectomy in the treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Emerging translational therapies for mesothelioma.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Glycogen-rich mesothelioma.
</td>
<td style="text-align:left;">
Ultrastruct Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Kaposi’s sarcoma following malignant mesothelioma.
</td>
<td style="text-align:left;">
Virchows Arch.
</td>
</tr>
<tr>
<td style="text-align:left;">
Value of morphometry, texture analysis, densitometry, and histometry in the differential diagnosis and prognosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Contemporary management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Oncologist
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology I. Prevalence of markers in tumour cell positive and negative smears.
</td>
<td style="text-align:left;">
Anal Cell Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant epithelioid vascular tumors of the pleura: report of a series and literature review.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis of malignant mesothelioma by fine needle aspiration of a cervical lymph node. A case report.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21-1) in the differentiation of malignant and benign pleural effusions.
</td>
<td style="text-align:left;">
Aust N Z J Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[VATS in malignant pleural effusions].
</td>
<td style="text-align:left;">
Zhonghua Wai Ke Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
[Endoscopic approach to pulmonary diseases: Clinical utility of medical thoracoscopy in diagnosis of pleural diseases].
</td>
<td style="text-align:left;">
Kekkaku
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma: utility of combined E-cadherin and calretinin immunostaining.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Long term survival of a patient with malignant pleural mesothelioma as a late complication of radiotherapy for Hodgkin’s disease treated with 90yttrium-silicate.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[The incidence of malignant mesothelioma (1977-1996) and asbestos exposure in the population of an area neighboring Lake Iseo, northern Italy].
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis.
</td>
<td style="text-align:left;">
Cytopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant Mesothelioma Registry from Piedmont. Incidence in 1990-1995].
</td>
<td style="text-align:left;">
Epidemiol Prev
</td>
</tr>
<tr>
<td style="text-align:left;">
Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma: new concepts in diagnosis and management.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
[Cell-block immunocytochemical characterization of effusions. Use of antibody panel: calretinin, Ber-EP4, keratin and CD68].
</td>
<td style="text-align:left;">
Pathologica
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
</td>
<td style="text-align:left;">
Singapore Med J
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural diseases.
</td>
<td style="text-align:left;">
Monaldi Arch Chest Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Simian virus 40: the link with human malignant mesothelioma is well established.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Adenovirus-mediated wild-type p53 overexpression reverts tumourigenicity of human mesothelioma cells.
</td>
<td style="text-align:left;">
Int. J. Mol. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Relation between natural killer cells and neoplastic cells in serous fluids.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Computed tomography-guided fine needle aspiration of peripheral lung opacities. An initial diagnostic procedure?
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
[Primary biphasic synovial sarcoma of the pleura].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma with CD30-positivity. A case report and review of the literature.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma–a feasibility study.
</td>
<td style="text-align:left;">
Anticancer Drugs
</td>
</tr>
<tr>
<td style="text-align:left;">
[Clinical analysis of 19 patients with pleural mesothelioma].
</td>
<td style="text-align:left;">
Zhonghua Zhong Liu Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary malignant gonadal mesotheliomas and asbestos.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin.
</td>
<td style="text-align:left;">
Clin. Chim. Acta
</td>
</tr>
<tr>
<td style="text-align:left;">
Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Genes Chromosomes Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
The separation of benign and malignant mesothelial proliferations.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the pleura, pericardium and peritoneum. 1: Etiology, pathogenesis, pathology].
</td>
<td style="text-align:left;">
Chirurg
</td>
</tr>
<tr>
<td style="text-align:left;">
Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies.
</td>
<td style="text-align:left;">
Clin. Biochem.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Metastasis of pleural malignant mesothelioma to the brain and upper maxilla: description of 2 cases].
</td>
<td style="text-align:left;">
Pathologica
</td>
</tr>
<tr>
<td style="text-align:left;">
Differential gene expression in mesothelioma.
</td>
<td style="text-align:left;">
FEBS Lett.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant peritoneal mesothelioma associated with deep vein thrombosis following radiotherapy for seminoma of the testis.
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
The difficult diagnostic approach of the intraperitoneal mesothelioma.
</td>
<td style="text-align:left;">
Neth J Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Role of occupational asbestos exposure in Hungarian lung cancer patients.
</td>
<td style="text-align:left;">
Int Arch Occup Environ Health
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma caused by environmental exposure to asbestos in the Southeast of Turkey: CT findings in 117 patients.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
[Surgical treatment for malignant pleural mesothelioma in eight cases].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of panpleuropneumonectomy for diffuse pleural mesothelioma].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Huge malignant localized fibrous tumor of the pleura.
</td>
<td style="text-align:left;">
J Cardiovasc Surg (Torino)
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural and parenchymal lung diseases from asbestos exposure. CT diagnosis].
</td>
<td style="text-align:left;">
Radiol Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Radicular involvement and medullary invasion from a malignant mesothelioma.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Treat. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
SV40 and the pathogenesis of mesothelioma.
</td>
<td style="text-align:left;">
Semin. Cancer Biol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Strategies to circumvent SV40 oncoprotein expression in malignant pleural mesotheliomas.
</td>
<td style="text-align:left;">
Semin. Cancer Biol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Thoracoscopic pleural biopsy under local anesthesia using a 2 mm laparoscope].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunotherapy-based treatment strategies for malignant mesothelioma.
</td>
<td style="text-align:left;">
Curr. Opin. Mol. Ther.
</td>
</tr>
<tr>
<td style="text-align:left;">
Trimodality management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression and prognostic significance of catalase in malignant mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis.
</td>
<td style="text-align:left;">
Int. J. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Nodular thickening of interlobar fissures: an early manifestation of malignant mesothelioma: a case report.
</td>
<td style="text-align:left;">
Jpn. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Gene expression profiling in human mesothelioma cells using DNA microarray and high-density filter array technologies].
</td>
<td style="text-align:left;">
Bull Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Combination chemotherapy with mitoxantrone, methotrexate, and mitomycin (MMM regimen) in malignant pleural mesothelioma: a phase II study.
</td>
<td style="text-align:left;">
Am. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Percutaneous image-guided cutting-needle biopsy of the pleura in the presence of a suspected malignant effusion.
</td>
<td style="text-align:left;">
Radiology
</td>
</tr>
<tr>
<td style="text-align:left;">
Early diagnosis of mesothelioma in serous effusions using AgNOR analysis.
</td>
<td style="text-align:left;">
Anal. Quant. Cytol. Histol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Treatment of malignant mesothelioma.
</td>
<td style="text-align:left;">
World J Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathology of human malignant mesothelioma–preliminary analysis of 1,517 mesothelioma cases.
</td>
<td style="text-align:left;">
Ind Health
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemical MIB-1 and p27kip1 as prognostic factors in pleural mesothelioma.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
Synovial sarcoma and malignant mesothelioma of the pleura: review, differential diagnosis and possible role of apoptosis.
</td>
<td style="text-align:left;">
Pathology
</td>
</tr>
<tr>
<td style="text-align:left;">
[Occupational exposure to asbestos and recognition of pleural mesothelioma as occupational disease in the province of Genoa].
</td>
<td style="text-align:left;">
Epidemiol Prev
</td>
</tr>
<tr>
<td style="text-align:left;">
Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemical differential diagnosis of pleural effusions, with emphasis on malignant mesothelioma.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP).
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural amyloidosis mimicking mesothelioma: a clinicopathologic study of two cases.
</td>
<td style="text-align:left;">
Ann Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of desmoplastic malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Information about occupational exposure to asbestos given to cases in an etiological study: ethical aspects.
</td>
<td style="text-align:left;">
Eur. J. Epidemiol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of antibodies to HBME-1 and calretinin for the detection of mesothelial cells in effusion cytology.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Acta Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma–German mesothelioma register 1987-1999.
</td>
<td style="text-align:left;">
Int Arch Occup Environ Health
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Absence of SV-40 large T antigen (Tag) in malignant mesothelioma effusions: an immunocytochemical study.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
K-ras and rho A mutations in malignant pleural effusion.
</td>
<td style="text-align:left;">
Int. J. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytochemistry in effusion cytology: a contemporary review.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Incidence of malignant mesothelioma (1980-1999) and asbestos exposure in 190 cases diagnosed among residents of the province of Brescia].
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Minerva Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
Unusual clear cell variant of epithelioid mesothelioma.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Survival after conservative (palliative) management of pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
J Surg Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Numerical alteration of chromosome 8 in pleural effusions].
</td>
<td style="text-align:left;">
Zhonghua Zhong Liu Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Pseudomesotheliomatous adenocarcinoma of the lung with rhabdoid features.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Induction of apoptosis in malignant pleural mesothelioma cells by activation of the Fas (Apo-1/CD95) death-signal pathway.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Chylothorax as the initial manifestation of malignant pleural mesothelioma–a case report].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of imaging in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Semin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Multimodality treatment of diffuse malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Semin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival].
</td>
<td style="text-align:left;">
Rev Epidemiol Sante Publique
</td>
</tr>
<tr>
<td style="text-align:left;">
[Current insights in malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Bull Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma with osteoblastic heterologous elements].
</td>
<td style="text-align:left;">
Ann Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients.
</td>
<td style="text-align:left;">
Cancer Immunol. Immunother.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Clinical utility and safety of diagnostic thoracoscopy].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant epithelioid mesothelioma: anti-mesothelial marker expression correlates with histological pattern.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Meningeal metastasis of pleural mesothelioma].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
The value of Wilms tumor susceptibility gene 1 in cytologic preparations as a marker for malignant mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Solitary fibrous thoracic tumor: a rare tumor with unpredictable course].
</td>
<td style="text-align:left;">
Rev Pneumol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytopathology of pleural mesotheliomas.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Flow cytometric analysis of a localized malignant mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of medical thoracoscopy in pleural disease: a 6-year retrospective study.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary thoracic sarcomas.
</td>
<td style="text-align:left;">
Radiographics
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival.
</td>
<td style="text-align:left;">
J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pericardial mesothelioma.
</td>
<td style="text-align:left;">
Curr Treat Options Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diagnosis and staging of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Pneumologie
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic DNA-flow- vs. -image-cytometry in effusion cytology.
</td>
<td style="text-align:left;">
Anal Cell Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Pitfalls in diagnosis of early stage malignant peritoneal mesothelioma: a case report.
</td>
<td style="text-align:left;">
Clin Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant mesothelioma of the pleural space and its management.
</td>
<td style="text-align:left;">
Oncology (Williston Park, N.Y.)
</td>
</tr>
<tr>
<td style="text-align:left;">
The potential value of comparative genomic hybridization analysis in effusion-and fine needle aspiration cytology.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Incidence of malignant pleural mesothelioma in coastal and continental Croatia: epidemiological study.
</td>
<td style="text-align:left;">
Croat. Med. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant gonadal mesothelioma.
</td>
<td style="text-align:left;">
Curr Treat Options Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: PAS-diastase positivity and inversion of polarity in intravascular tumour.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.
</td>
<td style="text-align:left;">
Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Synergistic effect of the anti-HER-2/neu antibody and cisplatin in immortalized and primary mesothelioma cell lines.
</td>
<td style="text-align:left;">
J. Cell. Physiol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology.
</td>
<td style="text-align:left;">
J. Nucl. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Additional techniques in serous effusions.
</td>
<td style="text-align:left;">
Anal Cell Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Report on the study of hyaluronic acid in the diagnosis of pleural mesotheliomas: study of 100 hyaluronic acid rich effusions].
</td>
<td style="text-align:left;">
Biomedicine
</td>
</tr>
<tr>
<td style="text-align:left;">
[Prognosis, staging and therapy of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Med. Klin. (Munich)
</td>
</tr>
<tr>
<td style="text-align:left;">
[Etiology and clinical diagnosis of diffuse pleural mesothelioma (author’s transl)].
</td>
<td style="text-align:left;">
Z Erkr Atmungsorgane
</td>
</tr>
<tr>
<td style="text-align:left;">
Synovial sarcoma of the pleura: a clinical and pathologic study of three cases.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Survival after pleural malignant mesothelioma: a population-based study in Italy.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma in a child: long-term survival with ICE-WAC chemotherapy regimen.
</td>
<td style="text-align:left;">
Turk. J. Pediatr.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Small-cell mesothelioma of the pleura: description of a case].
</td>
<td style="text-align:left;">
Pathologica
</td>
</tr>
<tr>
<td style="text-align:left;">
Closed pleural needle biopsy: predicting diagnostic yield by examining pleural fluid parameters.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the pericardium: case reports and immunohistochemical studies including Ki-67 expression.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: options for management.
</td>
<td style="text-align:left;">
Surg. Clin. North Am.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Leptomeningeal infiltration of malignant mesothelioma.
</td>
<td style="text-align:left;">
Med. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Concurrent malignant mesothelioma of the pleura and hepatocellular carcinoma in the same patient: a report of five cases.
</td>
<td style="text-align:left;">
Ind Health
</td>
</tr>
<tr>
<td style="text-align:left;">
Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Unusual intraparenchymal growth patterns of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diagnosis and treatment of pleural mesothelioma].
</td>
<td style="text-align:left;">
Medicina (Kaunas)
</td>
</tr>
<tr>
<td style="text-align:left;">
Emerging insights into the biology and therapy of malignant mesothelioma.
</td>
<td style="text-align:left;">
Semin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions.
</td>
<td style="text-align:left;">
Int. J. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Localized malignant mesethelioma of the peritoneum revealed by a parietal mass].
</td>
<td style="text-align:left;">
Schweiz Med Wochenschr
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops.
</td>
<td style="text-align:left;">
Int. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of new imaging techniques in diagnosis and staging of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Curr Opin Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of surgery in diagnosis and treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Curr Opin Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Chemotherapy of malignant diffuse mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleuro-pneumonectomy, RT and CT for pleural mesothelioma. Prospective study].
</td>
<td style="text-align:left;">
Chir Ital
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma. Report of 19 cases.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Cardiac tamponade due to pericardial mesothelioma in an 11-year-old dog: diagnosis, medical and interventional treatments].
</td>
<td style="text-align:left;">
Schweiz. Arch. Tierheilkd.
</td>
</tr>
<tr>
<td style="text-align:left;">
Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[VEGF (vascular endothelial growth factor) concentration in serum and pleural fluid of patients with pleural malignancy and pleural tuberculosis].
</td>
<td style="text-align:left;">
Pneumonol Alergol Pol
</td>
</tr>
<tr>
<td style="text-align:left;">
Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial.
</td>
<td style="text-align:left;">
Lancet
</td>
</tr>
<tr>
<td style="text-align:left;">
Assessment of cell cycle state may facilitate the histopathological diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
[Gemcitabine improved QOL and survival in a case of diffuse malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Gan To Kagaku Ryoho
</td>
</tr>
<tr>
<td style="text-align:left;">
[Mesothelioma–asbestos in Lebanon: a problem to be considered].
</td>
<td style="text-align:left;">
J Med Liban
</td>
</tr>
<tr>
<td style="text-align:left;">
Analysis of survival of mesothelioma cases in the Italian register (ReNaM).
</td>
<td style="text-align:left;">
Eur. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Gan To Kagaku Ryoho
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of triple malignancies (gastric cancer, lung cancer and malignant pleural mesothelioma) after asbestos exposure].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic criteria for human diffuse malignant mesothelioma.
</td>
<td style="text-align:left;">
Acta Pathol. Jpn.
</td>
</tr>
<tr>
<td style="text-align:left;">
The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of benign asbestos pleural effusion suspected on thoracoscopic examination under local anesthesia].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma.
</td>
<td style="text-align:left;">
Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Cutaneous metastasis of pleural mesothelioma: two cases].
</td>
<td style="text-align:left;">
Ann Dermatol Venereol
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma: Drug treatment and other interventions.
</td>
<td style="text-align:left;">
Drugs Today
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgical experience of 15 solitary benign fibrous tumor of the pleura.
</td>
<td style="text-align:left;">
Crit. Rev. Oncol. Hematol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: experience at the Singapore General Hospital.
</td>
<td style="text-align:left;">
Ann. Acad. Med. Singap.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Isolated pleural metastases from an atypical meningioma].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
Gene expression profiling of malignant mesothelioma.
</td>
<td style="text-align:left;">
Clin. Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Miliary pulmonary metastases from a clinically occult pleural mesothelioma.
</td>
<td style="text-align:left;">
Ann Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant pleural mesothelioma: Part I. An overview of diagnosis, staging, and treatment options.
</td>
<td style="text-align:left;">
Clin J Oncol Nurs
</td>
</tr>
<tr>
<td style="text-align:left;">
[Surveillance of malignant mesothelioma cases and definition of asbestos exposure: 1997 ReNaM data].
</td>
<td style="text-align:left;">
Epidemiol Prev
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey. Analysis of 135 cases.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant peritoneal mesothelioma: its evolution and outlook].
</td>
<td style="text-align:left;">
Chir Ital
</td>
</tr>
<tr>
<td style="text-align:left;">
Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma.
</td>
<td style="text-align:left;">
Am. J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The differential diagnosis of primary peritoneal papillary tumors.
</td>
<td style="text-align:left;">
Arch. Gynecol. Obstet.
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelial and related neoplasms in children and adolescents: a clinicopathologic and immunohistochemical analysis of eight cases.
</td>
<td style="text-align:left;">
Pediatr Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma producing human chorionic gonadotropin. Report of two cases.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of closed pleural needle biopsy in the diagnosis of malignant mesothelioma of the pleura.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
p53 expression is common in malignant mesothelioma.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic importance of the DNA ploidy pattern in malignant mesothelioma of the pleura.
</td>
<td style="text-align:left;">
Anal. Quant. Cytol. Histol.
</td>
</tr>
<tr>
<td style="text-align:left;">
DNA analysis of malignant effusions. Comparison with cytologic diagnosis and carcinoembryonic antigen content.
</td>
<td style="text-align:left;">
Anal. Quant. Cytol. Histol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Survival of asbestos insulation workers with mesothelioma.
</td>
<td style="text-align:left;">
Br J Ind Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Imaging manifestations of pleural tumors.
</td>
<td style="text-align:left;">
Radiographics
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis and prognostic factors in malignant pleural mesothelioma: a retrospective analysis of sixty-five patients.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the vulva. About one case].
</td>
<td style="text-align:left;">
Gynecol Obstet Fertil
</td>
</tr>
<tr>
<td style="text-align:left;">
Desmoplastic malignant mesothelioma: two cases and a literature review.
</td>
<td style="text-align:left;">
Med Electron Microsc
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Widespread cutaneous and perioral metastases of mesothelioma.
</td>
<td style="text-align:left;">
J. Cutan. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Stereotactic intensity-modulated radiation therapy (IMRT) and inverse treatment planning for advanced pleural mesothelioma. Feasibility and initial results.
</td>
<td style="text-align:left;">
Strahlenther Onkol
</td>
</tr>
<tr>
<td style="text-align:left;">
New strategies are needed in diffuse malignant mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Evaluation of Rare Tumors with [F-18]Fluorodeoxyglucose Positron Emission Tomography.
</td>
<td style="text-align:left;">
Clin. Positron Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
Benign pleural lesion and malignant mesothelioma.
</td>
<td style="text-align:left;">
Virchows Arch A Pathol Anat Histol
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural effusions: is thoracoscopy a reliable investigation? A retrospective review.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[Primary malignant pleural neoplasms. Diagnostic code 163.09].
</td>
<td style="text-align:left;">
Ugeskr. Laeg.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diagnostic difficulties in pleural mesothelioma].
</td>
<td style="text-align:left;">
Wiad. Lek.
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelin-family proteins and diagnosis of mesothelioma.
</td>
<td style="text-align:left;">
Lancet
</td>
</tr>
<tr>
<td style="text-align:left;">
CT findings and serum ca 125 levels in malignant peritoneal mesothelioma: report of 11 new cases and review of the literature.
</td>
<td style="text-align:left;">
Eur Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized benign pleural mesothelioma: a case report.
</td>
<td style="text-align:left;">
Monaldi Arch Chest Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
‘Pseudomesotheliomatous’ carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Implementation of a molecular epidemiology approach to human pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
Mutat. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinoma.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[“Disappearance” of retroperitoneal vessels - a case report].
</td>
<td style="text-align:left;">
Ultraschall Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Bronchial cytology in pleural mesothelioma. A report of 3 positive cases, including 1 diagnosed initially on bronchial brushings.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma in Italy, 1997.
</td>
<td style="text-align:left;">
Am. J. Ind. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Disseminated malignant solitary fibrous tumor of the pleura.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Peritoneal mesothelioma after environmental asbestos exposure.
</td>
<td style="text-align:left;">
Swiss Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.
</td>
<td style="text-align:left;">
Radiographics
</td>
</tr>
<tr>
<td style="text-align:left;">
Cell protection, resistance and invasiveness of two malignant mesotheliomas as assessed by 10K-microarray.
</td>
<td style="text-align:left;">
Biochim. Biophys. Acta
</td>
</tr>
<tr>
<td style="text-align:left;">
[Localized pleural mesotheliomas. Clinicopathological considerations on a case report].
</td>
<td style="text-align:left;">
Minerva Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections.
</td>
<td style="text-align:left;">
J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Distant cutaneous metastasis of pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
J. Cutan. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Localized fibrous mesothelioma with bloody pleural effusion; report of a case].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells.
</td>
<td style="text-align:left;">
Biochimie
</td>
</tr>
<tr>
<td style="text-align:left;">
Abrogation of p21 expression by flavopiridol enhances depsipeptide-mediated apoptosis in malignant pleural mesothelioma cells.
</td>
<td style="text-align:left;">
Clin. Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Recurrent solitary fibrous tumor of the pleura with malignant transformation.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma–an update.
</td>
<td style="text-align:left;">
Int J Occup Environ Health
</td>
</tr>
<tr>
<td style="text-align:left;">
[Possibilities of diagnosis and treatment of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Medicina (Kaunas)
</td>
</tr>
<tr>
<td style="text-align:left;">
High-grade neuroendocrine carcinoma of the lung presenting an unusual spread mimicking pleural mesothelioma associated with dermatomyositis.
</td>
<td style="text-align:left;">
Am. J. Med. Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Integration of multimodality approaches in the management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Clin Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[The computed tomographic diagnosis of malignant pleural mesothelioma. A multicenter study].
</td>
<td style="text-align:left;">
Radiol Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: diagnostic and management strategies for 1992.
</td>
<td style="text-align:left;">
Semin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Estimates of pleural mesothelioma incidence in the Lazio region (Italy), 1997-2000].
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathogenesis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Clin Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Gene therapy in malignant mesothelioma].
</td>
<td style="text-align:left;">
Tuberk Toraks
</td>
</tr>
<tr>
<td style="text-align:left;">
Use of immunohistochemical marker calretinin in the diagnosis of a diffuse malignant metastatic mesothelioma in an equine.
</td>
<td style="text-align:left;">
J. Vet. Diagn. Invest.
</td>
</tr>
<tr>
<td style="text-align:left;">
Role of 18F-FDG PET for evaluating malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Biother. Radiopharm.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma–a diagnostic challenge].
</td>
<td style="text-align:left;">
Rev Port Pneumol
</td>
</tr>
<tr>
<td style="text-align:left;">
Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques.
</td>
<td style="text-align:left;">
Med Phys
</td>
</tr>
<tr>
<td style="text-align:left;">
[Mesotheliomas with leucocytic infiltration].
</td>
<td style="text-align:left;">
Pathologe
</td>
</tr>
<tr>
<td style="text-align:left;">
Localised pleural malignant mesothelioma. Report of two cases simulating pulmonary carcinoma and review of the literature.
</td>
<td style="text-align:left;">
Virchows Arch.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathology of malignant mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Positron emission tomography in the diagnosis of mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracic actinomycosis with mainly pleural involvement.
</td>
<td style="text-align:left;">
J. Infect. Chemother.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleuromesothelioma – psychology and pathogenesis].
</td>
<td style="text-align:left;">
Pneumologie
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic and prognostic value of Ki67 proliferation fraction in serous effusions.
</td>
<td style="text-align:left;">
Cell. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis.
</td>
<td style="text-align:left;">
Histochem. Cell Biol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma: little evidence, still time to do trials.
</td>
<td style="text-align:left;">
Lancet
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant effusions: from diagnosis to biology.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
</td>
<td style="text-align:left;">
Ai Zheng
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
A cytokeratin- and calretinin-negative staining sarcomatoid malignant mesothelioma.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diaphragm reconstruction after extrapleural pneumonectomy].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the pleura in a worker with brief atypical exposure to chrysotile asbestos].
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Extraskeletal myxoid chondrosarcoma of the pleura. Report of a case clinically simulating mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Spontaneous pneumothorax revealing malignant pleural mesothelioma. Three case reports].
</td>
<td style="text-align:left;">
Rev Pneumol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
[Small bowel metastases from lung cancer].
</td>
<td style="text-align:left;">
Chir Ital
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: overview of the North American and European experience.
</td>
<td style="text-align:left;">
Thorac Surg Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Genetics of malignant pleural mesothelioma: molecular markers and biologic targets.
</td>
<td style="text-align:left;">
Thorac Surg Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Preoperative assessment and therapeutic options for patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Thorac Surg Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications.
</td>
<td style="text-align:left;">
Thorac Surg Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary synovial sarcoma of the pleura: beware of misdiagnosis.
</td>
<td style="text-align:left;">
Eur. J. Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the pleura among women].
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Role of biochemical tests in the diagnosis of exudative pleural effusions.
</td>
<td style="text-align:left;">
Clin. Biochem.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Carcinoembryonic antigen in pleural effusion. Adenocarcinoma versus mesothelioma].
</td>
<td style="text-align:left;">
Rev Clin Esp
</td>
</tr>
<tr>
<td style="text-align:left;">
TTF-1 and surfactant-B as co-adjuvants in the diagnosis of lung adenocarcinoma and pleural mesothelioma.
</td>
<td style="text-align:left;">
Ann Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case report of disseminated malignant mesothelioma of peritoneum responding remarkably to thalidomide, celecoxib, vinorelbine and CDDP].
</td>
<td style="text-align:left;">
Gan To Kagaku Ryoho
</td>
</tr>
<tr>
<td style="text-align:left;">
Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Asbestosis accompanied by primary peritoneal mesothelioma].
</td>
<td style="text-align:left;">
Radiologe
</td>
</tr>
<tr>
<td style="text-align:left;">
The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Image cytometry: an aid for cytological diagnosis of pleural effusions.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the pleura–diagnostic difficulties].
</td>
<td style="text-align:left;">
Pol. Merkur. Lekarski
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathogenesis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
Podoplanin as a marker for mesothelioma.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of monoclonal versus polyclonal calretinin antibodies for immunohistochemical diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Appl. Immunohistochem. Mol. Morphol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Management of malignant pleural effusions].
</td>
<td style="text-align:left;">
Pneumologie
</td>
</tr>
<tr>
<td style="text-align:left;">
Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma with the expression of other cytokines.
</td>
<td style="text-align:left;">
Int. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant deciduoid mesothelioma: a diagnostic challenge.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Analysis of chromosomes 9 and 11 aneuploidy frequency in pleural effusion of patients with and without malignancy: interphase FISH technique.
</td>
<td style="text-align:left;">
Cancer Biol. Ther.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural mesothelioma–case with effusion in both pleural cavities].
</td>
<td style="text-align:left;">
Pol. Merkur. Lekarski
</td>
</tr>
<tr>
<td style="text-align:left;">
Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
[Lung cancer and peritoneal mesothelioma: two complications of asbestos exposure in the same patient].
</td>
<td style="text-align:left;">
Rev Pneumol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Desmoplastic malignant mesothelioma: a review of 17 cases.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural malignant mesothelioma in Tuscany, Italy (1970-1988): I. Anatomo-pathologic aspects.
</td>
<td style="text-align:left;">
Am. J. Ind. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Thalidomide in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Problematic cases of mesothelioma reported to the Dutch Institute for Asbestos Victims: evaluation by the Mesothelioma Working Group of the Netherlands Association of Pulmonologists and Specialists in Tuberculosis].
</td>
<td style="text-align:left;">
Ned Tijdschr Geneeskd
</td>
</tr>
<tr>
<td style="text-align:left;">
Survival of malignant pleural mesothelioma cases in the Tuscan Mesothelioma Register, 1988-2000: a population-based study.
</td>
<td style="text-align:left;">
Eur. J. Cancer Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma.
</td>
<td style="text-align:left;">
Curr Opin Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Palliative intracavitary carboplatin therapy in a cat with suspected pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Feline Med. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.
</td>
<td style="text-align:left;">
Am. J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma in Hong Kong.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical trials in malignant pleural mesothelioma in Australasia.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Implications of P16/CDKN2A deletion in pleural mesotheliomas.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized malignant mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Residential proximity to naturally occurring asbestos and mesothelioma risk in California.
</td>
<td style="text-align:left;">
Am. J. Respir. Crit. Care Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
New agents in the management of advanced mesothelioma.
</td>
<td style="text-align:left;">
Semin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure.
</td>
<td style="text-align:left;">
Mutat. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary diagnosis of malignant mesothelioma by fine-needle aspiration of a supraclavicular lymph node.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Spinal cord compression from a malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Rev Pneumol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.
</td>
<td style="text-align:left;">
Oncol. Rep.
</td>
</tr>
<tr>
<td style="text-align:left;">
Chromosomal alterations in early stages of malignant mesotheliomas.
</td>
<td style="text-align:left;">
Virchows Arch.
</td>
</tr>
<tr>
<td style="text-align:left;">
CT in differential diagnosis of benign and malignant pleural disease.
</td>
<td style="text-align:left;">
Monaldi Arch Chest Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of malignant mesothelioma showing rapid progression during one month].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma.
</td>
<td style="text-align:left;">
Lancet
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma: prognostic factors in a series of 125 patients studied from 1973 to 1987].
</td>
<td style="text-align:left;">
Bull. Acad. Natl. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
PET in lung cancer.
</td>
<td style="text-align:left;">
Chang Gung Med J
</td>
</tr>
<tr>
<td style="text-align:left;">
Differential diagnosis between mesothelioma and adenocarcinoma: a multimodal approach based on ultrastructure and immunocytochemistry.
</td>
<td style="text-align:left;">
Semin Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation.
</td>
<td style="text-align:left;">
Semin Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Quantitative and analytical studies in the diagnosis of mesothelioma.
</td>
<td style="text-align:left;">
Semin Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
The spectrum of histologic growth patterns in benign and malignant fibrous tumors of the pleura.
</td>
<td style="text-align:left;">
Semin Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Serum PDGF-AB in pleural mesothelioma.
</td>
<td style="text-align:left;">
Tumour Biol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[The problems of early diagnosis of diffuse malignant mesothelioma from the pathologo-anatomic view].
</td>
<td style="text-align:left;">
Zentralbl. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pseudomesothelioma resulting from metastatic malignant melanoma.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
A case of diffuse pleural mesothelioma in which contralateral exploratory thoracoscopy assisted the selection of therapy.
</td>
<td style="text-align:left;">
Ann Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: current status of histopathologic diagnosis and molecular profile.
</td>
<td style="text-align:left;">
Expert Rev. Mol. Diagn.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4.
</td>
<td style="text-align:left;">
Cytopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
</td>
<td style="text-align:left;">
J. Natl. Cancer Inst.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Recent progress in treatment of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Cancer Radiother
</td>
</tr>
<tr>
<td style="text-align:left;">
The expression pattern of beta-catenin in mesothelial proliferative lesions and its diagnostic utilities.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Recognition of histopathologic patterns of diffuse malignant mesothelioma in differential diagnosis of pleural biopsies.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Review and update of uncommon primary pleural tumors: a practical approach to diagnosis.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Needle-track metastases and prophylactic radiotherapy for mesothelioma.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
Use of imaging in the management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Clin Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
[Asbestos and malignant pleural mesothelioma: molecular, cellular and physiopathological aspects].
</td>
<td style="text-align:left;">
Bull Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Autofluorescence videothoracoscopy in exudative pleural effusions: preliminary results.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: a case report.
</td>
<td style="text-align:left;">
J Manipulative Physiol Ther
</td>
</tr>
<tr>
<td style="text-align:left;">
The immunohistochemical profile of malignant mesotheliomas of the tunica vaginalis: a study of 20 cases.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma: early diagnosis and multimodality management].
</td>
<td style="text-align:left;">
G Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
Multimodality approach in management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant biphasic pleural mesothelioma metastatic to the liver diagnosed by fine-needle aspiration.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Subcutaneous metastases of sarcomatoid mesothelioma with its differential diagnosis on fine needle aspiration–a case report.
</td>
<td style="text-align:left;">
Indian J Pathol Microbiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytopathology of malignant mesothelioma: a stepwise logistic regression analysis.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytologic diagnosis of malignant mesothelioma in serous effusions using an antimesothelial-cell antibody.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Magnetic resonance imaging in the evaluation of pneumonia].
</td>
<td style="text-align:left;">
Radiologe
</td>
</tr>
<tr>
<td style="text-align:left;">
Chemotherapy for intrathoracic cancer in dogs and cats.
</td>
<td style="text-align:left;">
Probl Vet Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Differential diagnosis of preneoplastic lesions of the pleura and of early mesothelioma: immunohistochemical and morphological findings].
</td>
<td style="text-align:left;">
Pathologe
</td>
</tr>
<tr>
<td style="text-align:left;">
[Adenosine deaminase 2 in the diagnosis of tuberculous pleuritis].
</td>
<td style="text-align:left;">
Kekkaku
</td>
</tr>
<tr>
<td style="text-align:left;">
Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Respir. Crit. Care Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma and the working environment: the viewpoint of the occupational physician.
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Peculiar features of mesothelioma occurrence as related to exposure patterns and circumstances in the Lombard Region, Italy.
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma in 2004: How advanced technology and new drugs are changing the perspectives of mesothelioma patients. Highlights from the VIIth Meeting of the International Mesothelioma Interest Group.
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Computed tomographic characterization of malignant peritoneal mesothelioma.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
Lung asbestos fiber content and mesothelioma cell type, site, and survival.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
The French National Mesothelioma Surveillance Program.
</td>
<td style="text-align:left;">
Occup Environ Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Occupational asbestos exposure: how to deal with suspected mesothelioma cases–the Dutch approach.
</td>
<td style="text-align:left;">
Ann. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Confronting cisternae and ciliated cells in malignant pleural mesothelioma: an ultrastructural study.
</td>
<td style="text-align:left;">
Ultrastruct Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
[Thoracoscopic pleurodesis in malignant pleural effusions].
</td>
<td style="text-align:left;">
Rev Med Chir Soc Med Nat Iasi
</td>
</tr>
<tr>
<td style="text-align:left;">
h-Caldesmon, a useful positive marker in the diagnosis of pleural malignant mesothelioma, epithelioid type.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Computed tomography findings in 66 patients with malignant pleural mesothelioma due to environmental exposure to asbestos.
</td>
<td style="text-align:left;">
Clin Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
[18-Fluoro-deoxy-glucose (15FDG) positon emission tomography (PET) for the evaluation of malignant pleural disease].
</td>
<td style="text-align:left;">
Rev Pneumol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic value of pleural fluid pH in malignant epithelial mesothelioma after talc poudrage.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
Imaging before and after multimodal treatment for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Radiol Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Synchronous pulmonary carcinoma and pleural diffuse malignant mesothelioma.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
A novel radiation therapy technique for malignant pleural mesothelioma combining electrons with intensity-modulated photons.
</td>
<td style="text-align:left;">
Radiother Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Imaging of pleural disease.
</td>
<td style="text-align:left;">
Clin. Chest Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Clin. Chest Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Activity of intrapleural recombinant gamma-interferon in malignant mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
My approach to the diagnosis of mesothelial lesions.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Nodular glomeruloid pleuroblastoma: a biphasic pleural-based malignant tumor with immature elements.
</td>
<td style="text-align:left;">
Virchows Arch.
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging.
</td>
<td style="text-align:left;">
J Thorac Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
Subarachnoid-pleural fistula as a complication of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of Abrams percutaneous pleural biopsy in the investigation of exudative pleural effusions.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
D2-40: a reliable marker in the diagnosis of pleural mesothelioma.
</td>
<td style="text-align:left;">
Pathobiology
</td>
</tr>
<tr>
<td style="text-align:left;">
Cellular and molecular parameters of mesothelioma.
</td>
<td style="text-align:left;">
J. Cell. Biochem.
</td>
</tr>
<tr>
<td style="text-align:left;">
Epithelioid and sarcomatoid malignant pleural mesothelioma in endoscopic gastric biopsies: a diagnostic pitfall.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of radiation therapy in malignant pleural mesothelioma: a systematic review.
</td>
<td style="text-align:left;">
Radiother Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnosis of malignancy in effusion cytology: a pattern recognition approach.
</td>
<td style="text-align:left;">
Adv Anat Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy.
</td>
<td style="text-align:left;">
Am. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: some aspects of epidemiology, differential diagnosis and prognosis. Histological and immunohistochemical evaluation and follow-up of mesotheliomas diagnosed from 1964 to January 1985.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of thoracoscopic pleural biopsy for pleurisy under local anaesthesia.
</td>
<td style="text-align:left;">
ANZ J Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey.
</td>
<td style="text-align:left;">
J Carcinog
</td>
</tr>
<tr>
<td style="text-align:left;">
Exclusive intrapulmonary lepidic growth of a malignant pleural mesothelioma presenting with pneumothorax and involving the peritoneum.
</td>
<td style="text-align:left;">
Int. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
An atypical presentation of thymoma with diffuse pleural dissemination mimicking mesothelioma.
</td>
<td style="text-align:left;">
Cancer Invest.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the pleura among seafarers.
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
[New challenges in thoracic surgery as exemplified in asbestos exposure and mesothelioma treatment].
</td>
<td style="text-align:left;">
Offentl Gesundheitswes
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy.
</td>
<td style="text-align:left;">
Radiology
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis of asbestos-related pleuropolmonary diseases.
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura.
</td>
<td style="text-align:left;">
Clin. Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions.
</td>
<td style="text-align:left;">
Int. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
5-year prospective results of trimodality treatment for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Cardiovasc Surg (Torino)
</td>
</tr>
<tr>
<td style="text-align:left;">
Distinguishing benign mesothelial hyperplasia from neoplasia: a practical approach.
</td>
<td style="text-align:left;">
Semin Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Spindle cell tumors of the pleura: differential diagnosis.
</td>
<td style="text-align:left;">
Semin Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
The use of monoclonal antibody 44-3A6 in cell blocks in the diagnosis of lung carcinoma, carcinomas metastatic to lung and pleura, and pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Can pemetrexed help in malignant mesothelioma?
</td>
<td style="text-align:left;">
Drug Ther Bull
</td>
</tr>
<tr>
<td style="text-align:left;">
Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Adv Anat Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: a comprehensive review.
</td>
<td style="text-align:left;">
Cancer Control
</td>
</tr>
<tr>
<td style="text-align:left;">
Solitary fibrous tumor of the pleura.
</td>
<td style="text-align:left;">
Cancer Control
</td>
</tr>
<tr>
<td style="text-align:left;">
[Video-assisted diagnostic thoracoscopy].
</td>
<td style="text-align:left;">
Chirurg
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma with non-pleural malignancy: a red herring or just an uncommon pairing?
</td>
<td style="text-align:left;">
J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma in a 14-year-old boy with right aortic arch.
</td>
<td style="text-align:left;">
Jpn. J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Autopsy case of sarcomatoid malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
The Portsmouth thoracoscopy experience, an evaluation of service by retrospective case note analysis.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Intracranial metastases from malignant pleural mesothelioma. Report of three autopsy cases and review of the literature.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytochemical panel for the identification of malignant cells in serous effusions.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
CT-guided percutaneous transthoracic biopsy in the evaluation of undetermined pulmonary lesions.
</td>
<td style="text-align:left;">
Rev Port Pneumol
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytochemical differential diagnosis of diffuse malignant pleural mesotheliomas–a clinicomorphological study of 158 cases.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
</td>
<td style="text-align:left;">
In Vivo
</td>
</tr>
<tr>
<td style="text-align:left;">
Metastatic malignant pleural mesothelioma to the breast.
</td>
<td style="text-align:left;">
South. Med. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Immunotherapy and malignant mesothelioma: clinical perspectives].
</td>
<td style="text-align:left;">
Bull Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: a case presentation and review.
</td>
<td style="text-align:left;">
J Am Osteopath Assoc
</td>
</tr>
<tr>
<td style="text-align:left;">
[Histopathologic diagnosis of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
[Clinical diagnosis of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
[Current problems in the diagnosis of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diffuse malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
[Extrapleural pneumonectomy for malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
Morphological aspects as prognostic factors in malignant mesothelioma: a study of 58 cases.
</td>
<td style="text-align:left;">
J Bras Pneumol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma with scalp, cerebellar, and finger metastases: a rare case.
</td>
<td style="text-align:left;">
South. Med. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant peritoneal mesothelioma].
</td>
<td style="text-align:left;">
Chirurgia (Bucur)
</td>
</tr>
<tr>
<td style="text-align:left;">
Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Palliative intravenous cisplatin treatment for concurrent peritoneal and pleural mesothelioma in a dog.
</td>
<td style="text-align:left;">
J. Vet. Med. Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Immunohistochemistry and surgical approaches in solitary fibrous tumor of the pleura].
</td>
<td style="text-align:left;">
Cir Esp
</td>
</tr>
<tr>
<td style="text-align:left;">
[Clinico-pathological prognostic factors in malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Thorax
</td>
</tr>
<tr>
<td style="text-align:left;">
D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos-related lung disease.
</td>
<td style="text-align:left;">
Am Fam Physician
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytological diagnosis of malignant mesothelioma–improvement by additional analysis of hyaluronic acid in pleural effusions.
</td>
<td style="text-align:left;">
Virchows Arch.
</td>
</tr>
<tr>
<td style="text-align:left;">
Retroperitoneal malignant schwannoma and peritoneal malignant mesothelioma: a case report.
</td>
<td style="text-align:left;">
J BUON
</td>
</tr>
<tr>
<td style="text-align:left;">
Medical thoracoscopy in an Australian regional hospital.
</td>
<td style="text-align:left;">
Intern Med J
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature.
</td>
<td style="text-align:left;">
Am. J. Ind. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic procedures of pleural malignant mesothelioma: our experience.
</td>
<td style="text-align:left;">
J BUON
</td>
</tr>
<tr>
<td style="text-align:left;">
Fine-needle aspiration of malignant mesothelioma with unusual morphologic features: a case report.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of malignant pleural mesothelioma with elevation of G-CSF and CYFRA in the serum and pleural fluid].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
A large abdominal wall mass as an initial manifestation of malignant mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Med. Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Late-onset chylothorax following extrapleural pneumonectomy for mesothelioma.
</td>
<td style="text-align:left;">
Gen Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Superior vena cava syndrome associated with malignant mesothelioma.
</td>
<td style="text-align:left;">
J La State Med Soc
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma.
</td>
<td style="text-align:left;">
J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma with intracytoplasmic crystalline inclusions.
</td>
<td style="text-align:left;">
Ultrastruct Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma following thoracic radiotherapy for lung cancer.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results.
</td>
<td style="text-align:left;">
Clin. Chem. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Computer-assisted diagnosis for early stage pleural mesothelioma: towards automated detection and quantitative assessment of pleural thickening from thoracic CT images.
</td>
<td style="text-align:left;">
Methods Inf Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic utility of D2-40 and podoplanin in effusion cell blocks.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.
</td>
<td style="text-align:left;">
Clin. Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnostic role of claudins in serous effusions.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Management options for malignant pleural mesothelioma: clinical and cost considerations.
</td>
<td style="text-align:left;">
Drugs
</td>
</tr>
<tr>
<td style="text-align:left;">
Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma.
</td>
<td style="text-align:left;">
Appl. Immunohistochem. Mol. Morphol.
</td>
</tr>
<tr>
<td style="text-align:left;">
MN/CA9: a potential gene marker for detection of malignant cells in effusions.
</td>
<td style="text-align:left;">
Biomarkers
</td>
</tr>
<tr>
<td style="text-align:left;">
Recent discovery of an old disease: malignant pleural mesothelioma in a village in south-east Turkey.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
[A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
</td>
<td style="text-align:left;">
Pneumonol Alergol Pol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Management of malignant pleural effusion].
</td>
<td style="text-align:left;">
Rev Prat
</td>
</tr>
<tr>
<td style="text-align:left;">
A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Radiother Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Peritoneal mesothelioma: an inusual clinical presentation in a patient without exposure to asbestos].
</td>
<td style="text-align:left;">
An Med Interna
</td>
</tr>
<tr>
<td style="text-align:left;">
Constrictive pericarditis after left extrapleural pneumonectomy and radiotherapy for malignant mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pseudomesotheliomatous carcinoma of the lung].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
DNA methylation profile of 28 potential marker loci in malignant mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Case of asbestosis with massive benign pleural involvement].
</td>
<td style="text-align:left;">
Med Tr Prom Ekol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: outcome of limited surgical management.
</td>
<td style="text-align:left;">
Interact Cardiovasc Thorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Multidisciplinary treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Oncologist
</td>
</tr>
<tr>
<td style="text-align:left;">
D2-40-positive solitary fibrous tumors of the pleura: diagnostic pitfall of biopsy specimen.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Optimising survival in malignant mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Accuracy and reproducibility of pleural effusion cytology.
</td>
<td style="text-align:left;">
Leg Med (Tokyo)
</td>
</tr>
<tr>
<td style="text-align:left;">
[Family mesotheliomas: genetic interaction with environmental carcinogenic exposure?].
</td>
<td style="text-align:left;">
Bull Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Clinical utility of thoracoscopy under local anesthesia].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
Assessment of tumor response in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Treat. Rev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Correlations between findings at computed tomography (CT) and at thoracoscopy/thoracotomy/autopsy in pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Differential diagnosis of pleurisy of tuberculous etiology].
</td>
<td style="text-align:left;">
Probl Tuberk
</td>
</tr>
<tr>
<td style="text-align:left;">
Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Role of DNA microarrays in the diagnosis of pleural exudates: a feasibility study].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
</td>
<td style="text-align:left;">
Int. J. Radiat. Oncol. Biol. Phys.
</td>
</tr>
<tr>
<td style="text-align:left;">
Phase II study of vinflunine in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemical detection of XIAP in mesothelium and mesothelial lesions.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial–an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
</td>
<td style="text-align:left;">
Oncologist
</td>
</tr>
<tr>
<td style="text-align:left;">
Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register.
</td>
<td style="text-align:left;">
Eur. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Dedifferentiated liposarcoma of the pleura mimicking a malignant solitary fibrous tumor and associated with dedifferentiated liposarcoma of the mediastinum: usefulness of cytogenetic and molecular genetic analyses.
</td>
<td style="text-align:left;">
Cancer Genet. Cytogenet.
</td>
</tr>
<tr>
<td style="text-align:left;">
Role of fragile histidine triad protein expression in pathogenesis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Pathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Solitary fibrous tumor of the anterior mediastinum: a rare extrapleural neoplasm.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
[Renal cell carcinoma with malignant pleural mesothelioma after asbestos exposure: a case report].
</td>
<td style="text-align:left;">
Hinyokika Kiyo
</td>
</tr>
<tr>
<td style="text-align:left;">
Endoscopic ultrasound-guided fine needle aspiration is useful for nodal staging in patients with pleural mesothelioma.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Fine needle aspiration of follicular variant of papillary thyroid carcinoma presenting with pleural effusion: a case report.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Nuklearmedizin
</td>
</tr>
<tr>
<td style="text-align:left;">
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Absence of evidence for a significant background incidence of diffuse malignant mesothelioma apart from asbestos exposure.
</td>
<td style="text-align:left;">
Ann. N. Y. Acad. Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma: interrogations and hopes concerning the expected epidemic].
</td>
<td style="text-align:left;">
Rev Pneumol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Aberrant splicing and protease involvement in mesothelin release from epithelioid mesothelioma cells.
</td>
<td style="text-align:left;">
Cancer Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Presence of malignant mesothelial cells in the sputum.
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytologic malignancy versus benignancy: how useful are the “newer” markers in body fluid cytology?
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Population based epidemiology and prognosis of mesothelioma in Leeds, UK.
</td>
<td style="text-align:left;">
Thorax
</td>
</tr>
<tr>
<td style="text-align:left;">
Tissue inhibitor of metalloproteinase 2 (TIMP-2) expression in adenocarcinoma pleural effusions.
</td>
<td style="text-align:left;">
Oncol. Rep.
</td>
</tr>
<tr>
<td style="text-align:left;">
Xanthomatous pleuritis mimicking mesothelioma.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
[Environmental cancer: malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Bull Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural mesothelioma: impact of the staging for the therapeutic strategy].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
[Epidemiology, molecular biology, diagnostic and therapeutic strategy of malignant pleural mesothelioma in 2007 - an update].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
[The Lombardy Mesothelioma Register, Regional Operating Centre (ROC) of National Mesothelioma Register: organizational aspects].
</td>
<td style="text-align:left;">
Epidemiol Prev
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma: multidisciplinary experience in a public tertiary hospital].
</td>
<td style="text-align:left;">
J Bras Pneumol
</td>
</tr>
<tr>
<td style="text-align:left;">
Current concepts in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Expert Rev Anticancer Ther
</td>
</tr>
<tr>
<td style="text-align:left;">
Pericardial malignant mesothelioma: a latent complication of radiotherapy?
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Establishment of a novel specific ELISA system for rat N- and C-ERC/mesothelin. Rat ERC/mesothelin in the body fluids of mice bearing mesothelioma.
</td>
<td style="text-align:left;">
Cancer Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Biological characteristics of cancers involving the serosal cavities.
</td>
<td style="text-align:left;">
Crit Rev Oncog
</td>
</tr>
<tr>
<td style="text-align:left;">
Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
</td>
<td style="text-align:left;">
Appl. Immunohistochem. Mol. Morphol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma: diagnostic problems and evaluation of prognostic factors.
</td>
<td style="text-align:left;">
J Egypt Natl Canc Inst
</td>
</tr>
<tr>
<td style="text-align:left;">
Local recurrence of tumor at sites of intervention in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[New diagnostic markers for malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Bull Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Improved identification of malignant cells in serous effusions using a small, robust panel of antibodies on paraffin-embedded cell suspensions.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Advances in the molecular biology of malignant mesothelioma.
</td>
<td style="text-align:left;">
Acta Med. Okayama
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized malignant mesenteric mesothelioma causing small bowel obstruction.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma in the Veneto Region (north-east of Italy), 1988-2002: incidence, geographical analysis, trends and comparison with mortality].
</td>
<td style="text-align:left;">
Epidemiol Prev
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural effusion].
</td>
<td style="text-align:left;">
Ann Ital Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: utility of 18 F-FDG PET.
</td>
<td style="text-align:left;">
Ann Ital Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: computed tomography and correlation with histology.
</td>
<td style="text-align:left;">
Eur J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT.
</td>
<td style="text-align:left;">
Eur Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of muscle flap in preventing bronchus stump insufficiency after pneumonectomy for malignant pleural mesothelioma in high-risk patients.
</td>
<td style="text-align:left;">
Interact Cardiovasc Thorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Management of malignant pleural effusion associated with trapped lung syndrome.
</td>
<td style="text-align:left;">
Asian Cardiovasc Thorac Ann
</td>
</tr>
<tr>
<td style="text-align:left;">
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Work related mesothelioma: analysis of cases discovered at the Section for Occupational Medicine and Toxicology of Siena University during the years 2000-2007].
</td>
<td style="text-align:left;">
G Ital Med Lav Ergon
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma (MM) in women: findings of the Mesothelioma Register of the Friuli Venezia Giulia Region].
</td>
<td style="text-align:left;">
G Ital Med Lav Ergon
</td>
</tr>
<tr>
<td style="text-align:left;">
[Biomarkers for prevention and early diagnosis of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
G Ital Med Lav Ergon
</td>
</tr>
<tr>
<td style="text-align:left;">
[Evaluation of a series of serum mesothelin in patients with pleural malignant mesothelioma].
</td>
<td style="text-align:left;">
G Ital Med Lav Ergon
</td>
</tr>
<tr>
<td style="text-align:left;">
[Serum mesothelin dosages in follow-up of previously exposed workers].
</td>
<td style="text-align:left;">
G Ital Med Lav Ergon
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural mesothelioma in barman with probable occupational exposure to asbestos].
</td>
<td style="text-align:left;">
G Ital Med Lav Ergon
</td>
</tr>
<tr>
<td style="text-align:left;">
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases.
</td>
<td style="text-align:left;">
Mutat. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patients.
</td>
<td style="text-align:left;">
Jpn. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Incidence of pleural mesotheliomas in Poland (preliminary report)].
</td>
<td style="text-align:left;">
Pneumonol Alergol Pol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant peritoneal mesothelioma as a rare cause of ascites: a case report.
</td>
<td style="text-align:left;">
J Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
[Video-assisted thoracoscopic surgery in diagnostic and treatment of non-operable malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Khirurgiia (Sofiia)
</td>
</tr>
<tr>
<td style="text-align:left;">
Trimodality treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[The contribution of positron emission tomography in pleural disease].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
Video-assisted cervical thoracoscopy: a novel approach for diagnosis, staging and pleurodesis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Overexpression and altered glycosylation of MUC1 in malignant mesothelioma.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
MR imaging of benign and malignant pleural disease.
</td>
<td style="text-align:left;">
Magn Reson Imaging Clin N Am
</td>
</tr>
<tr>
<td style="text-align:left;">
Neoplastic and nonneoplastic conditions of serosal membrane origin: CT findings.
</td>
<td style="text-align:left;">
Radiographics
</td>
</tr>
<tr>
<td style="text-align:left;">
CT findings in malignant pleural mesothelioma related to nonoccupational exposure to asbestos and fibrous zeolite (erionite).
</td>
<td style="text-align:left;">
J Comput Assist Tomogr
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracoscopy in pleural malignant mesothelioma diagnosis.
</td>
<td style="text-align:left;">
Diagn Ther Endosc
</td>
</tr>
<tr>
<td style="text-align:left;">
[Erionite-induced pleural plaques. Exposition to urban pollution in a female Turkish migrant in Germany].
</td>
<td style="text-align:left;">
Chirurg
</td>
</tr>
<tr>
<td style="text-align:left;">
Two cases of asbestosis and one case of rounded atelectasis due to non-occupational asbestos exposure.
</td>
<td style="text-align:left;">
Monaldi Arch Chest Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
[Autopsy case of diffuse pleural thickening presenting respiratory impairment and benign asbestos pleurisy].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Image-guided pleural biopsy.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Response of a patient with pleural and peritoneal mesothelioma after second-line chemotherapy with lipoplatin and gemcitabine.
</td>
<td style="text-align:left;">
Oncology
</td>
</tr>
<tr>
<td style="text-align:left;">
Uroplakin is not a reliable immunohistochemical marker for malignant mesothelioma of the pleura.
</td>
<td style="text-align:left;">
Appl. Immunohistochem. Mol. Morphol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic significance of pleural fluid data in patients with malignant effusion.
</td>
<td style="text-align:left;">
Eur. J. Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos burden predicts survival in pleural mesothelioma.
</td>
<td style="text-align:left;">
Environ. Health Perspect.
</td>
</tr>
<tr>
<td style="text-align:left;">
Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations.
</td>
<td style="text-align:left;">
J. Exp. Clin. Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT.
</td>
<td style="text-align:left;">
Clin Nucl Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma and asbestos-related pleural diseases.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Int J Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary pleural neoplasia: entities other than diffuse malignant mesothelioma.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: current status and perspective in Japan and the world.
</td>
<td style="text-align:left;">
Gen Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Use of monoclonal antibody B72.3 as a marker of metastatic carcinoma cells in neoplastic effusions.
</td>
<td style="text-align:left;">
Pathologica
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.
</td>
<td style="text-align:left;">
J Carcinog
</td>
</tr>
<tr>
<td style="text-align:left;">
Establishment of a human malignant fibrous mesothelioma cell line and the biological characteristics compared with malignant epithelial mesothelioma cell line.
</td>
<td style="text-align:left;">
Hum. Cell
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Use of hospital discharge records to estimate the incidence of malignant mesotheliomas].
</td>
<td style="text-align:left;">
Epidemiol Prev
</td>
</tr>
<tr>
<td style="text-align:left;">
[Incidence of malignant mesothelioma in Piedmont, 1990-2001].
</td>
<td style="text-align:left;">
Epidemiol Prev
</td>
</tr>
<tr>
<td style="text-align:left;">
[Full-thickness pleural biopsy using an Insulation-tipped Diathermic Knife in a patient with malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
Effusion cytology.
</td>
<td style="text-align:left;">
Clin. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis, staging, and surgical treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Curr Treat Options Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diagnosis of diffuse pleural mesotheliomas].
</td>
<td style="text-align:left;">
Pneumologie
</td>
</tr>
<tr>
<td style="text-align:left;">
[Therapy of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Pneumologie
</td>
</tr>
<tr>
<td style="text-align:left;">
Prevention of malignant seeding at drain sites after invasive procedures (surgery and/or thoracoscopy) by hypofractionated radiotherapy in patients with pleural mesothelioma.
</td>
<td style="text-align:left;">
Acta Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical consequences of asbestos-related diffuse pleural thickening: A review.
</td>
<td style="text-align:left;">
J Occup Med Toxicol
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.
</td>
<td style="text-align:left;">
J. Cancer Res. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
</td>
<td style="text-align:left;">
Invest Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Survival of pleural malignant mesothelioma in Italy: a population-based study.
</td>
<td style="text-align:left;">
Int. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Survival of peritoneal malignant mesothelioma in Italy: a population-based study.
</td>
<td style="text-align:left;">
Int. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Pulmonary epithelioid hemangioendothelioma mimicking mesothelioma.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cardiac tamponade as primary manifestation of angioimmunoblastic T-cell lymphoma (AILT). Coexistence with malignant mesothelioma.
</td>
<td style="text-align:left;">
Onkologie
</td>
</tr>
<tr>
<td style="text-align:left;">
A case of solid pseudopapillary tumour of the pancreas and malignant mesothelioma.
</td>
<td style="text-align:left;">
J Gastrointest Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas.
</td>
<td style="text-align:left;">
Virchows Arch.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant pleural mesothelioma: a multi-institutional clinicopathological study.
</td>
<td style="text-align:left;">
Surg. Today
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural mesothelioma in data from the Surgical Clinic in Hradec Králové 1971-1987].
</td>
<td style="text-align:left;">
Rozhl Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
[Other thoracic cancers. Malignant pleural mesothelioma: biology and diagnosis].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Polyneuropathy in a patient with malignant pleural mesothelioma: a paraneoplastic syndrome.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the tunica vaginalis of the testis without exposure to asbestos.
</td>
<td style="text-align:left;">
Cases J
</td>
</tr>
<tr>
<td style="text-align:left;">
Compensator-based intensity-modulated radiation therapy for malignant pleural mesothelioma post extrapleural pneumonectomy.
</td>
<td style="text-align:left;">
J Appl Clin Med Phys
</td>
</tr>
<tr>
<td style="text-align:left;">
Biomarkers for malignant pleural mesothelioma: current status.
</td>
<td style="text-align:left;">
Mol Diagn Ther
</td>
</tr>
<tr>
<td style="text-align:left;">
Problems in mesothelioma diagnosis.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Telomerase activity in effusions: a comparison between telomere repeat amplification protocol in situ and conventional telomere repeat amplification protocol assay.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos-related occupational lung diseases in NSW, Australia and potential exposure of the general population.
</td>
<td style="text-align:left;">
Ind Health
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma.
</td>
<td style="text-align:left;">
Orphanet J Rare Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural effusion as the presenting site of cancer: comparison with metastatic pleural effusions from known cancers].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
A new electrocautery pleural biopsy technique using an insulated-tip diathermic knife during semirigid pleuroscopy.
</td>
<td style="text-align:left;">
Surg Endosc
</td>
</tr>
<tr>
<td style="text-align:left;">
Duodenal metastasis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Formos. Med. Assoc.
</td>
</tr>
<tr>
<td style="text-align:left;">
Does video-assisted thoracoscopic decortication in advanced malignant mesothelioma improve prognosis?
</td>
<td style="text-align:left;">
Interact Cardiovasc Thorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural diseases: diagnosis and treatment].
</td>
<td style="text-align:left;">
Medicina (Kaunas)
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis of epithelial mesothelioma using tree-based regression analysis and a minimal panel of antibodies.
</td>
<td style="text-align:left;">
Pathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Texture- and object-related automated information analysis in histological still images of various organs.
</td>
<td style="text-align:left;">
Anal. Quant. Cytol. Histol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Osteopontin levels in an asbestos-exposed population.
</td>
<td style="text-align:left;">
Clin. Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure.
</td>
<td style="text-align:left;">
Cancer Epidemiol. Biomarkers Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Death certificate categorization of malignant pleural and peritoneal mesothelioma in a cohort of asbestos insulation workers.
</td>
<td style="text-align:left;">
J Soc Occup Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracoscopy in the diagnosis of pleural effusion of ambiguous etiology.
</td>
<td style="text-align:left;">
J Surg Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant sarcomatoid mesothelioma of the pleura: a histological and immunohistological study of a case.
</td>
<td style="text-align:left;">
Pathologica
</td>
</tr>
<tr>
<td style="text-align:left;">
Pneumothorax and malignant mesothelioma in patients over the age of 40.
</td>
<td style="text-align:left;">
Thorax
</td>
</tr>
<tr>
<td style="text-align:left;">
Establishment of novel mAb to human ERC/mesothelin useful for study and diagnosis of ERC/mesothelin-expressing cancers.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Is FDG-PET/CT useful for managing malignant pleural mesothelioma?
</td>
<td style="text-align:left;">
J. Med. Invest.
</td>
</tr>
<tr>
<td style="text-align:left;">
Tumorigenic properties of alternative osteopontin isoforms in mesothelioma.
</td>
<td style="text-align:left;">
Biochem. Biophys. Res. Commun.
</td>
</tr>
<tr>
<td style="text-align:left;">
Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions.
</td>
<td style="text-align:left;">
Am. J. Respir. Crit. Care Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma: an unusual case diagnosed on pleural fluid cytology and immunocytochemistry.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma.
</td>
<td style="text-align:left;">
Clin. Biochem.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Update in respiratory disease and environmental exposure: an invisible relationship].
</td>
<td style="text-align:left;">
Arch. Bronconeumol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Dual time point FDG PET for evaluation of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Nucl Med Commun
</td>
</tr>
<tr>
<td style="text-align:left;">
Recurrent malignant peritoneal mesothelioma: radiological manifestations.
</td>
<td style="text-align:left;">
Abdom Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Fine-needle aspiration of a well-differentiated papillary mesothelioma in the inguinal hernia sac: A case report and review of literature.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Fine-needle aspiration biopsy of pleural metastases from a carcinosarcoma or true malignant mixed tumor of the parotid gland mimicking a mesothelioma.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Future Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Future developments in the management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Expert Rev Anticancer Ther
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural malignant mesothelioma causing cord infiltration through the nerve root. Case report.
</td>
<td style="text-align:left;">
Neurol. Med. Chir. (Tokyo)
</td>
</tr>
<tr>
<td style="text-align:left;">
Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma.
</td>
<td style="text-align:left;">
J. Natl. Cancer Inst.
</td>
</tr>
<tr>
<td style="text-align:left;">
Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Serum and pleural fluid biomarkers for mesothelioma.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos–a legacy and a persistent problem.
</td>
<td style="text-align:left;">
J R Nav Med Serv
</td>
</tr>
<tr>
<td style="text-align:left;">
Expanded applications of diagnostic and therapeutic thoracoscopy.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B cells and the clinical significance of the antibody titers.
</td>
<td style="text-align:left;">
Cancer Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Benign cystic mesothelioma in a child.
</td>
<td style="text-align:left;">
J. Pediatr. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Stage Ia malignant pleural mesothelioma: clinical course and appropriate diagnostic process.
</td>
<td style="text-align:left;">
Gen Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Spontaneous pneumothorax and lung carcinoma: should one consider synchronous malignant pleural mesothelioma?
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease.
</td>
<td style="text-align:left;">
Mol Imaging Biol
</td>
</tr>
<tr>
<td style="text-align:left;">
Estrogen receptor-beta affects the prognosis of human malignant mesothelioma.
</td>
<td style="text-align:left;">
Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant peritoneal mesothelioma].
</td>
<td style="text-align:left;">
Chirurgia (Bucur)
</td>
</tr>
<tr>
<td style="text-align:left;">
[Twenty-one patients of malignant pleural mesothelioma in the Senshu district].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
[Case of malignant pleural mesothelioma with long-term disease control after 4 different lines of systemic chemotherapy and pleurodesis].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
[Case of pemetrexed-induced acute lung injury].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of different clones (WT49 versus 6F-H2) of WT-1 antibodies for immunohistochemical diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Appl. Immunohistochem. Mol. Morphol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical utility of diagnostic markers for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Monaldi Arch Chest Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Closed pleural biopsy to diagnose mesothelioma: dead or alive?
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Med Imaging Radiat Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach?
</td>
<td style="text-align:left;">
Curr Opin Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Impact of malignant mesothelioma in Taiwan: a 27-year review of population-based cancer registry data.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytogenetics and fluorescence in situ hybridization as adjuncts to cytology in the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural well-differentiated papillary mesothelioma: a case report.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005.
</td>
<td style="text-align:left;">
Int. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Scoring system for differential diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology specimens.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations?
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
Interobserver variations in diagnosing asbestosis according to the ILO classification.
</td>
<td style="text-align:left;">
Arh Hig Rada Toksikol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Early malignant pleural mesothelioma; report of a case].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
Isolated pancreatic metastasis of a malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Kaohsiung J. Med. Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Lung cancer gene expression database analysis incorporating prior knowledge with support vector machine-based classification method.
</td>
<td style="text-align:left;">
J. Exp. Clin. Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Lymphangiomatoid pattern in diffuse malignant mesothelioma of the pleura: a report of six cases.
</td>
<td style="text-align:left;">
Virchows Arch.
</td>
</tr>
<tr>
<td style="text-align:left;">
Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma initially diagnosed on cervical lymph node biopsy.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Clin Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Osteopontin is not a specific marker in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Int. J. Biol. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma].
</td>
<td style="text-align:left;">
Rev Prat
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of surgery in the management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J BUON
</td>
</tr>
<tr>
<td style="text-align:left;">
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases.
</td>
<td style="text-align:left;">
Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Epidermal growth factor receptor aberrations in malignant mesotheliomas].
</td>
<td style="text-align:left;">
Rinsho Byori
</td>
</tr>
<tr>
<td style="text-align:left;">
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Update on pleural diseases–2007.
</td>
<td style="text-align:left;">
Ann Thorac Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: an update on biomarkers and treatment.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Tenascin-X is a novel diagnostic marker of malignant mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS.
</td>
<td style="text-align:left;">
Technol. Cancer Res. Treat.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Immunocytochemical identification of carcinomas of unknown primaries on fine-needle-aspiration-biopsies].
</td>
<td style="text-align:left;">
Pathologe
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Radiat Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
</td>
<td style="text-align:left;">
Med Clin (Barc)
</td>
</tr>
<tr>
<td style="text-align:left;">
Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: can we differentiate reactive mesothelial cells from malignant cells?
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Current status of screening for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Semin. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Current trends in radiologic management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Semin. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathologic evaluation of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Semin. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication.
</td>
<td style="text-align:left;">
Semin. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Radiation therapy options for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Semin. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Multimodality strategies in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Semin. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the greater omentum mimicking omental infarction: a case report.
</td>
<td style="text-align:left;">
World J. Gastroenterol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos exposure and malignant mesothelioma in Korea.
</td>
<td style="text-align:left;">
Asian Pac. J. Cancer Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Treatment of pleural metastases in an interdisciplinary concept].
</td>
<td style="text-align:left;">
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
[Medical insurance aspects of peritoneal tumors with particular attention to peritoneal mesotheliomas].
</td>
<td style="text-align:left;">
Med. Klin. (Munich)
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary small cell carcinoma of the pleura: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes.
</td>
<td style="text-align:left;">
Med. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Porcelain factory worker with asbestos-related mesothelioma.
</td>
<td style="text-align:left;">
J. Formos. Med. Assoc.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Estimation of pulmonary motion in healthy subjects and patients with intrathoracic tumors using 3D-dynamic MRI: initial results.
</td>
<td style="text-align:left;">
Korean J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
</td>
<td style="text-align:left;">
Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma presenting as low back pain: diagnosed by bone scan coordinating with F-18 FDG PET/CT.
</td>
<td style="text-align:left;">
Spine
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: a meta-analysis.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant peritoneal mesothelioma: contribution and limitation of imaging for its diagnosis.
</td>
<td style="text-align:left;">
JBR-BTR
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diagnosis of malignant pleural mesothelioma–thoracoscopic biopsy and tumor marker].
</td>
<td style="text-align:left;">
Nihon Geka Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: biology, diagnosis and therapeutic approaches.
</td>
<td style="text-align:left;">
Curr Mol Pharmacol
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of diagnostic quality and accuracy in color-coded versus gray-scale DCE-MR imaging display.
</td>
<td style="text-align:left;">
Int J Comput Assist Radiol Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Chest CT combined with artificial pneumothorax: value in determining origin and extent of tumor.
</td>
<td style="text-align:left;">
AJR Am J Roentgenol
</td>
</tr>
<tr>
<td style="text-align:left;">
Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.
</td>
<td style="text-align:left;">
BMC Med. Genet.
</td>
</tr>
<tr>
<td style="text-align:left;">
The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Respir. Crit. Care Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary pleural epithelioid angiosarcoma. A case report and review of the literature.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
Computed tomography of asbestos-related pulmonary parenchymal and pleural diseases.
</td>
<td style="text-align:left;">
Clin. Chest Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.
</td>
<td style="text-align:left;">
Int. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Management of pleural disease].
</td>
<td style="text-align:left;">
Arch. Bronconeumol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary malignant mesothelioma of the pericardium.
</td>
<td style="text-align:left;">
Cardiovasc. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Podoplanin is a useful marker for identifying mesothelioma in malignant effusions.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized intrapancreatic malignant mesothelioma: a rare entity that may be confused with other pancreatic neoplasms.
</td>
<td style="text-align:left;">
Virchows Arch.
</td>
</tr>
<tr>
<td style="text-align:left;">
Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model.
</td>
<td style="text-align:left;">
Genomics
</td>
</tr>
<tr>
<td style="text-align:left;">
Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Minute localized malignant pleural mesothelioma coexisting with multiple adenocarcinomas.
</td>
<td style="text-align:left;">
Gen Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
25-year old male with pleural thickening.
</td>
<td style="text-align:left;">
Lung India
</td>
</tr>
<tr>
<td style="text-align:left;">
In vitro and in vivo characterization of highly purified human mesothelioma derived cells.
</td>
<td style="text-align:left;">
BMC Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma presenting as an acute surgical abdomen due to metastatic jejunal perforation.
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
The influence of the diagnostic technique on the histopathological diagnosis in malignant mesothelioma.
</td>
<td style="text-align:left;">
Virchows Arch A Pathol Anat Histopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma.
</td>
<td style="text-align:left;">
Intern Med J
</td>
</tr>
<tr>
<td style="text-align:left;">
The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation.
</td>
<td style="text-align:left;">
J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma risk associated with asbestos production in Slovenia.
</td>
<td style="text-align:left;">
Arh Hig Rada Toksikol
</td>
</tr>
<tr>
<td style="text-align:left;">
Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population.
</td>
<td style="text-align:left;">
Clin. Chem. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Obtaining an upper estimate of the survival benefit associated with surgery for mesothelioma.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized malignant pleural mesothelioma showing a thoracic mass and metastasizing to the stomach.
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Volumetric modulation arc radiotherapy compared with static gantry intensity-modulated radiotherapy for malignant pleural mesothelioma tumor: a feasibility study.
</td>
<td style="text-align:left;">
Int. J. Radiat. Oncol. Biol. Phys.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma in Italy.
</td>
<td style="text-align:left;">
Indian J Occup Environ Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases.
</td>
<td style="text-align:left;">
J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Expert opinions of the first italian consensus conference on the management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Radiologic manifestation of primary pleural tumors].
</td>
<td style="text-align:left;">
Acta Chir Iugosl
</td>
</tr>
<tr>
<td style="text-align:left;">
Soluble mesothelin-related protein in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Egypt Natl Canc Inst
</td>
</tr>
<tr>
<td style="text-align:left;">
Value of D2-40 in the differential diagnosis of pleural neoplasms with emphasis on its positivity in solitary fibrous tumor.
</td>
<td style="text-align:left;">
Appl. Immunohistochem. Mol. Morphol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic factors for 100 patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Arch Environ Occup Health
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant peritoneal mesothelioma].
</td>
<td style="text-align:left;">
Rev Gastroenterol Peru
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of malignant pericardial mesothelioma detected by gallium-67 scintigraphy].
</td>
<td style="text-align:left;">
Kaku Igaku
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: the standard of care and challenges for future management.
</td>
<td style="text-align:left;">
Crit. Rev. Oncol. Hematol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Thoracic pain, dyspnea].
</td>
<td style="text-align:left;">
Schweiz. Rundsch. Med. Prax.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin.
</td>
<td style="text-align:left;">
Diagn. Mol. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgery for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Expert Rev Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer.
</td>
<td style="text-align:left;">
Cancer Immunol. Immunother.
</td>
</tr>
<tr>
<td style="text-align:left;">
Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of pulmonary epithelioid hemangioendothelioma that required differentiation from malignant mesothelioma].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
[Osteoarthropathy].
</td>
<td style="text-align:left;">
Gan To Kagaku Ryoho
</td>
</tr>
<tr>
<td style="text-align:left;">
Pearls and myths in pleural fluid analysis.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Multimodality approach to malignant pleural mesothelioma. A case report.
</td>
<td style="text-align:left;">
Ann Ital Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
Predominantly fibrous malignant mesothelioma in a cat.
</td>
<td style="text-align:left;">
Vet Med Int
</td>
</tr>
<tr>
<td style="text-align:left;">
Molecular imaging of mesothelioma by detection of manganese-superoxide dismutase activity using manganese-enhanced magnetic resonance imaging.
</td>
<td style="text-align:left;">
Int. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes.
</td>
<td style="text-align:left;">
AJR Am J Roentgenol
</td>
</tr>
<tr>
<td style="text-align:left;">
Usefulness of the nude mouse model in mesothelioma based on a direct patient-xenograft comparison.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis of diffuse malignant mesothelioma: experience of a US/Canadian Mesothelioma Panel.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of localized malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pulmonary concentration of asbestos fibers in steel workers with pleural mesothelioma].
</td>
<td style="text-align:left;">
G Ital Med Lav Ergon
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural liposarcoma mimicking carcinoma in pleural effusion cytology: a case report.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma with associated minimal change disease and acute renal failure.
</td>
<td style="text-align:left;">
Ren Fail
</td>
</tr>
<tr>
<td style="text-align:left;">
Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos.
</td>
<td style="text-align:left;">
Arch. Toxicol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary Pericardial Mesothelioma: Report of a Patient and Literature Review.
</td>
<td style="text-align:left;">
Case Rep Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Incidence of extrapleural malignant mesothelioma and asbestos exposure, from the Italian national register.
</td>
<td style="text-align:left;">
Occup Environ Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan.
</td>
<td style="text-align:left;">
Jpn. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Sensitivity of urinary mesothelin in patients with malignant mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnostic utility of maspin in the distinction between malignant mesothelioma and pulmonary adenocarcinoma.
</td>
<td style="text-align:left;">
J. Int. Med. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma in a female lion (Panthera leo).
</td>
<td style="text-align:left;">
Res. Vet. Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Expectations after ban on asbestos].
</td>
<td style="text-align:left;">
Arh Hig Rada Toksikol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma in patients hospitalised at the Clinical Hospital Centre Rijeka between 1989 and 2008].
</td>
<td style="text-align:left;">
Arh Hig Rada Toksikol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Immunological aspects of asbestos-related diseases].
</td>
<td style="text-align:left;">
Arh Hig Rada Toksikol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Croatian and international regulations on the protection and rights of workers exposed to asbestos at work].
</td>
<td style="text-align:left;">
Arh Hig Rada Toksikol
</td>
</tr>
<tr>
<td style="text-align:left;">
A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Mol Diagn
</td>
</tr>
<tr>
<td style="text-align:left;">
A rare cause of dysphagia: malignant pleural mesothelioma in the posterior mediastinum.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Int. J. Biol. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
Prevention of malignant seeding at drain sites by hypofractionated radiotherapy in patients with pleural mesothelioma.
</td>
<td style="text-align:left;">
Asia Pac J Clin Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Sarcomatoid mesothelioma–a diagnostic challenge].
</td>
<td style="text-align:left;">
Ugeskr. Laeg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure.
</td>
<td style="text-align:left;">
Anal Bioanal Chem
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of diffuse peritoneal malignant mesothelioma–intraabdominal administration of cisplatin is useful for diminishing ascites].
</td>
<td style="text-align:left;">
Gan To Kagaku Ryoho
</td>
</tr>
<tr>
<td style="text-align:left;">
Contribution of positron emission tomography in pleural disease.
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
Intensity-modulated radiation therapy with simultaneous integrated boost in unresected left-sided pleural mesothelioma: a case report.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
The use of insulin like-growth factor II messenger RNA binding protein-3 in diagnostic pathology.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytopathology of malignant mesothelioma. Reappraisal of the diagnostic value of collagen cores.
</td>
<td style="text-align:left;">
Cytopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Sarcomatoid neoplasms of the lung and pleura.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
What is the best way to diagnose and stage malignant pleural mesothelioma?
</td>
<td style="text-align:left;">
Interact Cardiovasc Thorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Cutaneous needle track seeding of mesothelioma diagnosed by fine needle aspiration cytology: a case report.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
CT in differential diagnosis of diffuse pleural disease.
</td>
<td style="text-align:left;">
AJR Am J Roentgenol
</td>
</tr>
<tr>
<td style="text-align:left;">
The use of pleural fluid sCD44v6/std ratio for distinguishing mesothelioma from other pleural malignancies.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant peritoneal mesothelioma: a case report].
</td>
<td style="text-align:left;">
Rev Med Liege
</td>
</tr>
<tr>
<td style="text-align:left;">
Fine-needle aspiration biopsies for gene expression ratio-based diagnostic and prognostic tests in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Clin. Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma with prominent adenomatoid features: a clinicopathologic and immunohistochemical study of 10 cases.
</td>
<td style="text-align:left;">
Ann Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Delayed bronchial stump dehiscence following trimodality treatment for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Egypt Natl Canc Inst
</td>
</tr>
<tr>
<td style="text-align:left;">
Pericardial mesothelioma and asbestos exposure.
</td>
<td style="text-align:left;">
Int J Hyg Environ Health
</td>
</tr>
<tr>
<td style="text-align:left;">
Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
</td>
<td style="text-align:left;">
Interact Cardiovasc Thorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: a clinical study of 238 cases.
</td>
<td style="text-align:left;">
Ind Health
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of peritoneal mesothelioma with direct invasion to gastric mucosa].
</td>
<td style="text-align:left;">
Korean J Gastroenterol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Treatment of malignant mesothelioma using intrapleural gamma interferon].
</td>
<td style="text-align:left;">
Bull. Acad. Natl. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cervical endometriosis associated with malignant pleural mesothelioma mimicking cervical cancer–Occam’s razor or the “third man”.
</td>
<td style="text-align:left;">
Fertil. Steril.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma in paraoccupational, environmental and occupational patients exposed to asbestos.
</td>
<td style="text-align:left;">
Rev Med Inst Mex Seguro Soc
</td>
</tr>
<tr>
<td style="text-align:left;">
Establishment of a cell line from a Japanese patient useful for generating an in vivo model of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival.
</td>
<td style="text-align:left;">
Eur. J. Nucl. Med. Mol. Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
The pleura in health and disease.
</td>
<td style="text-align:left;">
Semin Respir Crit Care Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical-therapeutic management of thoracoscopy in pleural effusion: a groundbreaking technique in the twenty-first century.
</td>
<td style="text-align:left;">
Clin Transl Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
</td>
<td style="text-align:left;">
Interact Cardiovasc Thorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Advances in the biology of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Treat. Rev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos-related disease.
</td>
<td style="text-align:left;">
Intern Med J
</td>
</tr>
<tr>
<td style="text-align:left;">
Peritoneal mesothelioma: description of a case and review of literature.
</td>
<td style="text-align:left;">
Int J Immunopathol Pharmacol
</td>
</tr>
<tr>
<td style="text-align:left;">
Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Int. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
5-Aminolevulinic acid-induced fluorescence diagnosis of pleural malignant tumor.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Identification of novel markers for the diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathology of the pleura: what the pulmonologists need to know.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
Tumor extension along chest wall tract after diagnostic intervention in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Interact Cardiovasc Thorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of coexisting malignant mesothelioma and squamous cell carcinoma of the lung].
</td>
<td style="text-align:left;">
Gan To Kagaku Ryoho
</td>
</tr>
<tr>
<td style="text-align:left;">
Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma–which is best?
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Molecular biomarkers in malignant mesothelioma: state of the art.
</td>
<td style="text-align:left;">
Pathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Markers for the non-invasive diagnosis of mesothelioma: a systematic review.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the spermatic cord.
</td>
<td style="text-align:left;">
Korean J Urol
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgical treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Curr Treat Options Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytopathologic diagnosis in pleural effusion and cyto-histopathologic correlation.
</td>
<td style="text-align:left;">
Turk Patoloji Derg
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Soluble markers for diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Biomark Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Imaging of mesothelioma.
</td>
<td style="text-align:left;">
Recent Results Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgical therapy of mesothelioma.
</td>
<td style="text-align:left;">
Recent Results Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma.
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Multicystic mesothelioma of the pericardium.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
A case report of metastasis of malignant mesothelioma to the oral gingiva.
</td>
<td style="text-align:left;">
Head Neck Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Outcome of patients with nonspecific pleuritis at thoracoscopy.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Pathology
</td>
</tr>
<tr>
<td style="text-align:left;">
The diminishing role of surgery in pleural disease.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Curr Oncol Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Detection of integrin-linked kinase in the serum of patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Combined chemotherapy with cytotoxic and targeted compounds for the management of human malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Trends Pharmacol. Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Usefulness of 18F-FDG PET-CT in the presurgical assessment of malignant pleural mesothelioma treated with neoadjuvant chemotherapy].
</td>
<td style="text-align:left;">
Rev Esp Med Nucl
</td>
</tr>
<tr>
<td style="text-align:left;">
Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Value of tomotherapy in malignant pleural mesothelioma: first clinical results].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
Outcomes and complications following medical thoracoscopy.
</td>
<td style="text-align:left;">
Clin Respir J
</td>
</tr>
<tr>
<td style="text-align:left;">
Re-evaluating the role of palliative radiotherapy in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural effusion: what lies underneath?
</td>
<td style="text-align:left;">
BMJ Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Clin. Chem. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation.
</td>
<td style="text-align:left;">
J Med Imaging Radiat Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
A case of diffused malignant pleural mesothelioma forming small multiple disseminations with intraoperatively suspicious carcinoid tumors.
</td>
<td style="text-align:left;">
Ann Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Predicting survival in malignant mesothelioma.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients.
</td>
<td style="text-align:left;">
Ann Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.
</td>
<td style="text-align:left;">
Clin. Lab.
</td>
</tr>
<tr>
<td style="text-align:left;">
Missed opportunities to counsel patients with malignant pleural mesothelioma about causation and potential compensation.
</td>
<td style="text-align:left;">
Am. J. Med. Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Proteomic surfaceome analysis of mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?
</td>
<td style="text-align:left;">
Acta Med. Okayama
</td>
</tr>
<tr>
<td style="text-align:left;">
BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.
</td>
<td style="text-align:left;">
J. Cancer Res. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Desmoplastic malignant mesothelioma of the pericardium: Description of a case and review of the literature.
</td>
<td style="text-align:left;">
Lung India
</td>
</tr>
<tr>
<td style="text-align:left;">
Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation.
</td>
<td style="text-align:left;">
Med. J. Aust.
</td>
</tr>
<tr>
<td style="text-align:left;">
Miliary mesothelioma: a new clinical and radiological presentation in mesothelioma patients with prolonged survival after trimodality therapy.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Biomarkers in malignant mesothelioma: diagnostic and prognostic role of soluble mesothelin-related peptide.
</td>
<td style="text-align:left;">
Int. J. Biol. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Benign pulmonary lesions that may be misdiagnosed as malignant.
</td>
<td style="text-align:left;">
Semin Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Metastatic proximal epithelioid sarcoma in pleural effusion: cytopathologic findings and differential diagnosis.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Leu-M1, CEA and intermediate filament proteins in histochemical differential diagnosis of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Pneumologie
</td>
</tr>
<tr>
<td style="text-align:left;">
Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10.
</td>
<td style="text-align:left;">
J Clin Bioinforma
</td>
</tr>
<tr>
<td style="text-align:left;">
The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura.
</td>
<td style="text-align:left;">
Am J Cancer Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary pleural epithelioid mesothelioma of clear cell type: a case report and review of current literature.
</td>
<td style="text-align:left;">
Ultrastruct Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Prophylactic irradiation of intervention sites in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Radiother Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Sustained expression of steroid receptor coactivator SRC-2/TIF-2 is associated with better prognosis in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Aquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Lymphohistiocytoid mesothelioma of the pleura: a case report with cytological findings.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Oncol. Rep.
</td>
</tr>
<tr>
<td style="text-align:left;">
Polycomb repressor complex-2 is a novel target for mesothelioma therapy.
</td>
<td style="text-align:left;">
Clin. Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
PET-CT in the diagnosis of localized malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Clin Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma presenting as a giant chest, abdominal and pelvic wall mass.
</td>
<td style="text-align:left;">
Korean J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Metastasis of pleural mesothelioma presenting as bleeding colonic polyp.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Mortality and cancer morbidity in cohorts of asbestos cement workers and referents.
</td>
<td style="text-align:left;">
Br J Ind Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant peritoneal mesothelioma–an update on treatment.
</td>
<td style="text-align:left;">
Cancer Treat. Rev.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleuro-pulmonary metastases from a malignant mesothelioma of the tunica vaginalis].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
National survey of malignant mesothelioma and asbestos exposure in Japan.
</td>
<td style="text-align:left;">
Cancer Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
β-catenin expression in benign and malignant pleural disorders.
</td>
<td style="text-align:left;">
Int J Clin Exp Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Anti-angiogenic factors in thoracic oncology: successes, failures and prospects].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
[Follow-up of subjects occupationally exposed to asbestos, what are the objectives, the benefits, and the possible risks?].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
[Tumoral markers and monoclonal antibodies].
</td>
<td style="text-align:left;">
Rev Prat
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diagnosis and prognosis of malignant mesothelioma].
</td>
<td style="text-align:left;">
Rev Prat
</td>
</tr>
<tr>
<td style="text-align:left;">
Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy.
</td>
<td style="text-align:left;">
Int. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathological and molecular biological approaches to early mesothelioma.
</td>
<td style="text-align:left;">
Int. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH Group.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
The new case for cervical mediastinoscopy in selection for radical surgery for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
[Desmoplastic mesothelioma with bony metastases. A case report].
</td>
<td style="text-align:left;">
Rev Pneumol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment.
</td>
<td style="text-align:left;">
Strahlenther Onkol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Clinical analysis of 45 patients with malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Zhongguo Fei Ai Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Fluorescence thoracoscopy in the detection of pleural malignancy.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Am J Health Syst Pharm
</td>
</tr>
<tr>
<td style="text-align:left;">
[An autopsied case of primary malignant pericardial mesothelioma diagnosed antemortally].
</td>
<td style="text-align:left;">
Nihon Kokyuki Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Epithelioid lesions of the serosa.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemistry and molecular diagnostics of pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Lymphoproliferative conditions of the serosa.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Molecular changes in mesothelioma with an impact on prognosis and treatment.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Dtsch. Med. Wochenschr.
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Advances in malignant pleural mesothelioma therapy: targeting EphA2 a novel approach.
</td>
<td style="text-align:left;">
Am J Cancer Res
</td>
</tr>
<tr>
<td style="text-align:left;">
[microRNAs as biological indicators of environmental and occupational exposure to asbestos].
</td>
<td style="text-align:left;">
G Ital Med Lav Ergon
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of cytological evaluation of pleural fluid in diagnosing malignant mesothelioma.
</td>
<td style="text-align:left;">
Med. Pregl.
</td>
</tr>
<tr>
<td style="text-align:left;">
Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy’s and St Thomas’ hospitals.
</td>
<td style="text-align:left;">
Gen Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Treat. Rev.
</td>
</tr>
<tr>
<td style="text-align:left;">
18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma.
</td>
<td style="text-align:left;">
Clin Nucl Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[Bilateral pleural mesothelioma–case report].
</td>
<td style="text-align:left;">
Z Gesamte Inn Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Complete response and long-term survival in malignant pleural mesothelioma: case report.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
[‘Malignant peritoneal mesothelioma’: a condition difficult to diagnose].
</td>
<td style="text-align:left;">
Ned Tijdschr Geneeskd
</td>
</tr>
<tr>
<td style="text-align:left;">
Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients.
</td>
<td style="text-align:left;">
Exp. Mol. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma in a child with ataxia-telangiectasia.
</td>
<td style="text-align:left;">
Pediatr. Pulmonol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
The application of immunocytochemistry to direct smears in the diagnosis of effusions.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytologic re-evaluation of negative effusions from patients with malignant mesothelioma.
</td>
<td style="text-align:left;">
Pathologica
</td>
</tr>
<tr>
<td style="text-align:left;">
Huge malignant solitary fibrous tumor of the pleura.
</td>
<td style="text-align:left;">
Gen Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Outcome of patients diagnosed with fibrinous pleuritis after medical thoracoscopy.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos-related pleural disease.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Bilateral pleural effusion due to malignant mesothelioma, diagnosed by means of immunostaining.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognosis and prognostic factors of patients with mesothelioma: a population-based study.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.
</td>
<td style="text-align:left;">
Clin Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
PET scan contribution in chest tumor management: a systematic review for thoracic surgeons.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
Effects of combined therapies on the survival of pleural mesothelioma patients treated in Brescia, 1982-2006.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
[Radiologic aspect of benign pleural fibrous mesothelioma. Reports of 4 cases].
</td>
<td style="text-align:left;">
Ann Radiol (Paris)
</td>
</tr>
<tr>
<td style="text-align:left;">
[Mesothelioma and mesothelial hyperplasia].
</td>
<td style="text-align:left;">
Zhonghua Nei Ke Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: from the bench to the bedside.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Distribution and trends in mesothelioma mortality in Italy from 1974 to 2006.
</td>
<td style="text-align:left;">
Int Arch Occup Environ Health
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Oncol Lett
</td>
</tr>
<tr>
<td style="text-align:left;">
Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Chemotherapy for malignant tumors of lung and pleura].
</td>
<td style="text-align:left;">
Ther Umsch
</td>
</tr>
<tr>
<td style="text-align:left;">
Specific expression of human intelectin-1 in malignant pleural mesothelioma and gastrointestinal goblet cells.
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma in a patient with systemic sclerosis: the first report.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Meningeal and brainstem infiltration by a malignant mesothelioma.
</td>
<td style="text-align:left;">
BMJ Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Circulating endothelial cell (CEC) as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM).
</td>
<td style="text-align:left;">
Ann. Surg. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
A case report of an extremely rare and aggressive tumor: primary malignant pericardial mesothelioma.
</td>
<td style="text-align:left;">
Rare Tumors
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytomorphologic features of metastatic urothelial carcinoma in serous effusions.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunoperoxidase staining of malignant cells in pleural effusions.
</td>
<td style="text-align:left;">
Pathologica
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diffuse malignant mesothelioma. Presentation of 10 cases and review of the literature].
</td>
<td style="text-align:left;">
Rev Med Panama
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant mesothelioma.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Cisplatin and cytosine arabinoside (ARA-C) for the therapy of primary and secondary pleural neoplasms].
</td>
<td style="text-align:left;">
G Ital Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos-related disease: screening and diagnosis.
</td>
<td style="text-align:left;">
Adv Clin Chem
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic factors in malignant pleural mesothelioma: role of talc pleurodesis.
</td>
<td style="text-align:left;">
Asian Cardiovasc Thorac Ann
</td>
</tr>
<tr>
<td style="text-align:left;">
‘It’s all bad news’: the first 3 months following a diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Psychooncology
</td>
</tr>
<tr>
<td style="text-align:left;">
Patterns of care for malignant pleural mesothelioma patients compensated by the Dust Diseases Board in New South Wales, Australia.
</td>
<td style="text-align:left;">
Intern Med J
</td>
</tr>
<tr>
<td style="text-align:left;">
Parakeratotic-like cells in effusions - A clue to diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Cytojournal
</td>
</tr>
<tr>
<td style="text-align:left;">
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
3T MRI in evaluation of asbestos-related thoracic diseases - preliminary results.
</td>
<td style="text-align:left;">
Radiol Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Paraneoplastic leukocytoclastic vasculitis as an initial presentation of malignant pleural mesothelioma: a case report.
</td>
<td style="text-align:left;">
J Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Development of a guideline on reading CT images of malignant pleural mesothelioma and selection of the reference CT films.
</td>
<td style="text-align:left;">
Eur J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Soluble mesothelin-related protein in pleural effusion from patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Exp Ther Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Distinguishing benign from malignant mesothelial cells in effusions by Glut-1, EMA, and Desmin expression: an evidence-based approach.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Case reports of primary pulmonary adenocarcinoma with pleural spread: so-called pseudomesotheliomatous adenocarcinoma.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.
</td>
<td style="text-align:left;">
BMC Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Evaluation of the efficacy of the guideline on reading CT images of malignant pleural mesothelioma with reference CT films for improving the proficiency of radiologists.
</td>
<td style="text-align:left;">
Eur J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
The separation of benign and malignant mesothelial proliferations.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Analysis of “dry” mesothelioma with ultrasound guided biopsies.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos exposure and survival in malignant mesothelioma: a description of 122 consecutive cases at an occupational clinic.
</td>
<td style="text-align:left;">
Int J Occup Environ Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Carbonic anhydrase IX in malignant pleural mesotheliomas: a potential target for anti-cancer therapy.
</td>
<td style="text-align:left;">
Bioorg. Med. Chem.
</td>
</tr>
<tr>
<td style="text-align:left;">
Heterozygous loss of NF2 is an early molecular alteration in well-differentiated papillary mesothelioma of the peritoneum.
</td>
<td style="text-align:left;">
Cancer Genet
</td>
</tr>
<tr>
<td style="text-align:left;">
Toxic epidermal necrolysis related to Cisplatin and pemetrexed for metastatic non-small cell lung cancer.
</td>
<td style="text-align:left;">
Onkologie
</td>
</tr>
<tr>
<td style="text-align:left;">
Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Spinal cord compression: an unusual presentation of malignant pleural mesothelioma. A case report and review of the literature.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
Pegylated liposomal doxorubicin in malignant pleural mesothelioma: a possible guardian for long-term survival.
</td>
<td style="text-align:left;">
Onco Targets Ther
</td>
</tr>
<tr>
<td style="text-align:left;">
Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool.
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.
</td>
<td style="text-align:left;">
Am. J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[One case of malignant mesothelioma that developed right pneumothorax after a diagnosis with left pneumothorax].
</td>
<td style="text-align:left;">
Gan To Kagaku Ryoho
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of FDG PET-CT in differential diagnosis of pleural pathologies.
</td>
<td style="text-align:left;">
Rev Esp Med Nucl Imagen Mol
</td>
</tr>
<tr>
<td style="text-align:left;">
Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients.
</td>
<td style="text-align:left;">
Radiol Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Excision repair cross complementation group 1 and thymidylate synthase expression in patients with mesothelioma.
</td>
<td style="text-align:left;">
Clin Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
A predictive equation to adjust for clinical variables in soluble mesothelin-related protein (SMRP) levels.
</td>
<td style="text-align:left;">
Clin. Chem. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
The recurrence of malignant pleural mesothelioma 14 years after extrapleural pneumonectomy: possible histological transformation.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural mesothelioma–case report].
</td>
<td style="text-align:left;">
Acta Med Croatica
</td>
</tr>
<tr>
<td style="text-align:left;">
Long term survival after trimodal therapy in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Swiss Med Wkly
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Ann. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical utility of 18-fluorodeoxyglucose positron emission tomography/computed tomography in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Exp Ther Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Incidence and survival of malignant pleural mesothelioma in norway: a population-based study of 1686 cases.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Adenomatoid mesothelioma with intranuclear inclusion bodies: a case report with cytological and histological findings.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: trends in Australia and a literature review.
</td>
<td style="text-align:left;">
Asia Pac J Clin Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis of Mesothelioma Using Flexible Bronchoscopy With Endobronchial Ultrasound-guided Biopsy of Mediastinal Lymph Nodes.
</td>
<td style="text-align:left;">
J Bronchology Interv Pulmonol
</td>
</tr>
<tr>
<td style="text-align:left;">
Performance characteristics of semirigid thoracoscopy in pleural effusions of undetermined etiology.
</td>
<td style="text-align:left;">
J Bronchology Interv Pulmonol
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis of malignant pericarditis: a single centre experience.
</td>
<td style="text-align:left;">
Kardiol Pol
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of immunohistochemistry in the diagnosis of neoplastic pleural effusions.
</td>
<td style="text-align:left;">
Rom J Morphol Embryol
</td>
</tr>
<tr>
<td style="text-align:left;">
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma: a soon to be forgotten disease in the United States?
</td>
<td style="text-align:left;">
J Bronchology Interv Pulmonol
</td>
</tr>
<tr>
<td style="text-align:left;">
A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit.
</td>
<td style="text-align:left;">
Pathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Extraskeletal osteosarcoma of the pleura:report of a case.
</td>
<td style="text-align:left;">
Ann Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
“Thick” cell membranes revealed by immunocytochemical staining: a clue to the diagnosis of mesothelioma.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Second Italian consensus conference on malignant pleural mesothelioma: state of the art and recommendations.
</td>
<td style="text-align:left;">
Cancer Treat. Rev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology.
</td>
<td style="text-align:left;">
Cancer Invest.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
A seven-year disease-free survivor of malignant pleural mesothelioma treated with hyperthermia and chemotherapy: a case report.
</td>
<td style="text-align:left;">
J Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the pleura. Analysis of its immunohistochemical aspects].
</td>
<td style="text-align:left;">
Ann Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma - Update on Diagnostic Strategies.
</td>
<td style="text-align:left;">
Clin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical characteristics, treatment and survival outcomes in malignant mesothelioma: eighteen years’ experience in Turkey.
</td>
<td style="text-align:left;">
Asian Pac. J. Cancer Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma: diagnosis and treatment].
</td>
<td style="text-align:left;">
Rev Pneumol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Metachronous malignant mesothelioma and pulmonary adenocarcinoma.
</td>
<td style="text-align:left;">
Turk Patoloji Derg
</td>
</tr>
<tr>
<td style="text-align:left;">
Morphologic and immunocytochemical performances of effusion cell blocks prepared using 3 different methods.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The malignancy grading method is not a reliable assessment of malignancy in mesothelioma.
</td>
<td style="text-align:left;">
J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
A case of malignant peritoneal mesothelioma revealed with limitation of PET-CT in the diagnosis of thoracic metastasis.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case report: an university professor suffering from malignant mesothelioma].
</td>
<td style="text-align:left;">
G Ital Med Lav Ergon
</td>
</tr>
<tr>
<td style="text-align:left;">
[Identification and characterization of microRNA involving in malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
G Ital Med Lav Ergon
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma: analysis of a hospital case series].
</td>
<td style="text-align:left;">
G Ital Med Lav Ergon
</td>
</tr>
<tr>
<td style="text-align:left;">
[Preliminary study to evaluate the meaning of GGT fractions analysis in a population of workers previously exposed to asbestos].
</td>
<td style="text-align:left;">
G Ital Med Lav Ergon
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgery in mesothelioma–where do we go after MARS?
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Rare pleural tumors.
</td>
<td style="text-align:left;">
Clin. Chest Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Laparoscopic repair of secondary parahiatal hernia with incarceration of the stomach: a case report.
</td>
<td style="text-align:left;">
J Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers.
</td>
<td style="text-align:left;">
Int Arch Occup Environ Health
</td>
</tr>
<tr>
<td style="text-align:left;">
Value of autofluorescence in video-assisted thoracoscopic surgery in pleural diseases.
</td>
<td style="text-align:left;">
Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Hypoxia affects in vitro growth of newly established cell lines from patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Biomed. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pneumoconiosis and malignant mesothelioma in a family operated metal casting business that used industrial talc from New York state.
</td>
<td style="text-align:left;">
Am. J. Ind. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology.
</td>
<td style="text-align:left;">
Cancer Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Multimodality treatment of pleural mesothelioma.
</td>
<td style="text-align:left;">
Surg. Oncol. Clin. N. Am.
</td>
</tr>
<tr>
<td style="text-align:left;">
Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
Jpn. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Circulating tumor cells as a diagnostic test for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Expert Opin Med Diagn
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.
</td>
<td style="text-align:left;">
Tuberc Respir Dis (Seoul)
</td>
</tr>
<tr>
<td style="text-align:left;">
Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Clin. Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Autopsy findings and pleural plaques in the Malignant Mesothelioma (MM) Regional Register of Friuli-Venezia-Giulia].
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA.
</td>
<td style="text-align:left;">
Med. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Is galectin-3 antibody a useful marker in the diagnosis of malignant pleural mesothelioma?
</td>
<td style="text-align:left;">
J Immunoassay Immunochem
</td>
</tr>
<tr>
<td style="text-align:left;">
Current and future options for the diagnosis of malignant pleural effusion.
</td>
<td style="text-align:left;">
Expert Opin Med Diagn
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic delay in malignant pleural mesothelioma due to physicians fixation on history with non-exposure to asbestos.
</td>
<td style="text-align:left;">
BMJ Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
[Epidemiologic surveillance of mesothelioma for the prevention of asbestos exposure also in non-traditional settings].
</td>
<td style="text-align:left;">
Epidemiol Prev
</td>
</tr>
<tr>
<td style="text-align:left;">
[Considerations about the epidemiologic surveillance system on mesothelioma in Tuscany (Italy) after 25 years of activity].
</td>
<td style="text-align:left;">
Epidemiol Prev
</td>
</tr>
<tr>
<td style="text-align:left;">
The N-ERC index is a novel monitoring and prognostic marker for advanced malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
[Cytological exam of the pleural fluid in the diagnosis of neoplastic pleuritis. Cases contribution].
</td>
<td style="text-align:left;">
Minerva Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy?
</td>
<td style="text-align:left;">
Int. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Intraoperative chemotherapy after radical pleurectomy or extrapleural pneumonectomy].
</td>
<td style="text-align:left;">
Chirurg
</td>
</tr>
<tr>
<td style="text-align:left;">
Desmoplastic malignant mesothelioma.
</td>
<td style="text-align:left;">
J Bronchology Interv Pulmonol
</td>
</tr>
<tr>
<td style="text-align:left;">
Pseudomesotheliomatous lung cancer mimicking mesothelioma on ¹⁸F-FDG PET/CT images: report of 2 cases.
</td>
<td style="text-align:left;">
Jpn J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
p16 Deletion in sarcomatoid tumors of the lung and pleura.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic surgical pathology in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma.
</td>
<td style="text-align:left;">
Turk Patoloji Derg
</td>
</tr>
<tr>
<td style="text-align:left;">
PET/CT versus body coil PET/MRI: how low can you go?
</td>
<td style="text-align:left;">
Insights Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
Management of malignant pleural mesothelioma: have we made any progress?
</td>
<td style="text-align:left;">
Panminerva Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Molecular pathogenesis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Carcinogenesis
</td>
</tr>
<tr>
<td style="text-align:left;">
Secondary malignant peritoneal mesothelioma of the greater omentum after therapy for primary pleural mesothelioma.
</td>
<td style="text-align:left;">
Case Rep Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Relationship between 18 FDG PET-CT findings and the survival of 177 patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur Rev Med Pharmacol Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos and the lung in the 21st century: an update.
</td>
<td style="text-align:left;">
Clin Respir J
</td>
</tr>
<tr>
<td style="text-align:left;">
Investigation of pleural effusion: comparison between fibreoptic thoracoscopy, needle biopsy and cytology.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health.
</td>
<td style="text-align:left;">
Dtsch Arztebl Int
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pulmonary disease due to asbestos in steel industry workers].
</td>
<td style="text-align:left;">
Medicina (B Aires)
</td>
</tr>
<tr>
<td style="text-align:left;">
[Regional treatment of malignant pleural mesothelioma: results from the tumor centre Regensburg].
</td>
<td style="text-align:left;">
Chirurg
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelin is more useful in pleural effusion than in serum in the diagnosis of pleural mesothelioma.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Surgical aspects of malignant pleural mesothelioma: from the perspective of pathology].
</td>
<td style="text-align:left;">
Chirurg
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position.
</td>
<td style="text-align:left;">
Thorax
</td>
</tr>
<tr>
<td style="text-align:left;">
Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Combination of mesothelin and CEA significantly improves the differentiation between malignant pleural mesothelioma, benign asbestos disease, and lung cancer.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Occupational exposure to asbestos and incidence of malignant mesothelioma in the Lazio region, years 2001-2009: results of the activities of the regional register].
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respir Investig
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma after radiation treatment for Hodgkin lymphoma].
</td>
<td style="text-align:left;">
Rev Pneumol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse intrapulmonary malignant mesothelioma masquerading as interstitial lung disease: a distinctive variant of mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
MUC1 has prognostic significance in malignant peritoneal mesothelioma.
</td>
<td style="text-align:left;">
Int. J. Biol. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary pericardial mesothelioma: a rare entity.
</td>
<td style="text-align:left;">
Case Rep Oncol Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Differential diagnosis of reactive mesothelial cells and malignant mesothelioma cells using the cell proliferation markers minichromosome maintenance protein 7, geminin, topoisomerase II alpha and Ki-67.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Metastatic carcinoma to the thyroid gland: a single institution 20-year experience and review of the literature.
</td>
<td style="text-align:left;">
Endocr. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical value of mesothelin in pleural effusions versus histology by medical thoracoscopy: brief report.
</td>
<td style="text-align:left;">
Med. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
FDG PET/CT in the management of primary pleural tumors and pleural metastases.
</td>
<td style="text-align:left;">
AJR Am J Roentgenol
</td>
</tr>
<tr>
<td style="text-align:left;">
Lymph node metastasis as the initial manifestation of malignant mesothelioma. Report of six cases.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
18F-FDG PET/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up).
</td>
<td style="text-align:left;">
Clin Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma in a clerk working in an asbestos factory.
</td>
<td style="text-align:left;">
Ann. Acad. Med. Singap.
</td>
</tr>
<tr>
<td style="text-align:left;">
Giant malignant mesothelioma in the upper mediastinum: A case report.
</td>
<td style="text-align:left;">
Oncol Lett
</td>
</tr>
<tr>
<td style="text-align:left;">
Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM).
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
Do we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC database.
</td>
<td style="text-align:left;">
Ann Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: an epidemiological perspective.
</td>
<td style="text-align:left;">
Ann Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
</td>
<td style="text-align:left;">
Cancer Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
Which type of surgery should become the preferred procedure for malignant pleural mesothelioma: extrapleural pneumonectomy or extended pleurectomy?
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey.
</td>
<td style="text-align:left;">
Cancer Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
CD90 is a diagnostic marker to differentiate between malignant pleural mesothelioma and lung carcinoma with immunohistochemistry.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[The diagnostic value of medical thoracoscopy for unexplained pleural effusion].
</td>
<td style="text-align:left;">
Zhonghua Jie He He Hu Xi Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized Intrasplenic Mesothelioma: A Case Report.
</td>
<td style="text-align:left;">
Int. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pulmonary mucinous cystadenocarcinoma presenting as a pleural mesothelioma.
</td>
<td style="text-align:left;">
Int J Surg Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma: a clinicopathologic study of 12 cases.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma presenting with symptomatic brain metastases: report of a case.
</td>
<td style="text-align:left;">
Rom J Morphol Embryol
</td>
</tr>
<tr>
<td style="text-align:left;">
Pulmonary alveolar microlithiasis with concurrent pleural mesothelioma in a dog.
</td>
<td style="text-align:left;">
J. Vet. Diagn. Invest.
</td>
</tr>
<tr>
<td style="text-align:left;">
Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: current and future perspectives.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant transformation of well-differentiated papillary mesothelioma 13 years after the diagnosis: a case report.
</td>
<td style="text-align:left;">
Clin Respir J
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleuroscopic punch biopsy using insulated-tip diathermic knife-2 for the diagnosis of desmoplastic malignant mesothelioma.
</td>
<td style="text-align:left;">
J Bronchology Interv Pulmonol
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of the diagnostic accuracy of the MSLN gene products, mesothelin and megakaryocyte potentiating factor, as biomarkers for mesothelioma in pleural effusions and serum.
</td>
<td style="text-align:left;">
Dis. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant peritoneal mesothelioma.
</td>
<td style="text-align:left;">
Kaohsiung J. Med. Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).
</td>
<td style="text-align:left;">
Am. J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemical staining for vimentin and keratin in malignant mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring.
</td>
<td style="text-align:left;">
Clin Proteomics
</td>
</tr>
<tr>
<td style="text-align:left;">
Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: implications for the diagnosis of desmoplastic mesothelioma.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma: 2013 state of the art].
</td>
<td style="text-align:left;">
Bull Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.
</td>
<td style="text-align:left;">
Am. J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Extrapleural and cardiophrenic lymph nodes: prevalence, clinical significance and diagnostic value.
</td>
<td style="text-align:left;">
Radiol Med
</td>
</tr>
<tr>
<td style="text-align:left;">
AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma.
</td>
<td style="text-align:left;">
Int. J. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis.
</td>
<td style="text-align:left;">
Redox Rep.
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgical pathology of lung cancer.
</td>
<td style="text-align:left;">
Semin Respir Crit Care Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[Helical tomotherapy in the treatment of malignant pleural mesothelioma: The impact of low doses on pulmonary and oesophageal toxicity].
</td>
<td style="text-align:left;">
Cancer Radiother
</td>
</tr>
<tr>
<td style="text-align:left;">
Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM).
</td>
<td style="text-align:left;">
Ann. Surg. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Radiotherapy for the treatment of pain in malignant pleural mesothelioma: a systematic review.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression of Wilms’ tumor gene (WT1) is associated with survival in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Clin Transl Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Solitary fibrous tumors of the pleura: a case report and review of the literature.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
Tissue polypeptide antigen (TPA) in pleural effusions.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma in a young male patient.
</td>
<td style="text-align:left;">
Monaldi Arch Chest Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.
</td>
<td style="text-align:left;">
Mol. Cell Proteomics
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic histochemical and immunohistochemical studies in malignant mesothelioma.
</td>
<td style="text-align:left;">
J Surg Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis and treatment of malignant pleural effusion.
</td>
<td style="text-align:left;">
Cancer Metastasis Rev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
</td>
<td style="text-align:left;">
Cancer Epidemiol
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of immunohistochemical evaluation in the diagnosis of malignant mesothelioma of the pleura.
</td>
<td style="text-align:left;">
Vojnosanit Pregl
</td>
</tr>
<tr>
<td style="text-align:left;">
Is soluble mesothelin-related protein an upfront predictive marker of pleural mesothelioma? A prospective study on Italian workers exposed to asbestos.
</td>
<td style="text-align:left;">
Oncology
</td>
</tr>
<tr>
<td style="text-align:left;">
Distinction between cells in serous effusions using a panel of antibodies.
</td>
<td style="text-align:left;">
Virchows Arch A Pathol Anat Histopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparative proteomic analysis of malignant pleural mesothelioma evidences an altered expression of nuclear lamin and filament-related proteins.
</td>
<td style="text-align:left;">
Proteomics Clin Appl
</td>
</tr>
<tr>
<td style="text-align:left;">
Radiotherapy applications of patients with malignant mesothelioma: A single center experience.
</td>
<td style="text-align:left;">
Rep Pract Oncol Radiother
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemistry in the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Virchows Arch A Pathol Anat Histopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition.
</td>
<td style="text-align:left;">
Clin. Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnosis of thoracic malignant mesothelioma: practical considerations and recent developments.
</td>
<td style="text-align:left;">
Turk Patoloji Derg
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical outcome of postoperative highly conformal versus 3D conformal radiotherapy in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Radiat Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic factors in patients presenting with pleural effusion revealing malignancy.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
</td>
<td style="text-align:left;">
Neoplasma
</td>
</tr>
<tr>
<td style="text-align:left;">
New applications of magnetic resonance imaging for thoracic oncology.
</td>
<td style="text-align:left;">
Semin Respir Crit Care Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Predictors of long-term survival following radical surgery for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung.
</td>
<td style="text-align:left;">
Am. J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
An autopsy case of malignant pleural mesothelioma associated with nephrotic syndrome.
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Clinicopathological characteristics and prognosis of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Zhonghua Jie He He Hu Xi Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
The journey of mesothelioma: from postmortem to FNA.
</td>
<td style="text-align:left;">
BMJ Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
</td>
<td style="text-align:left;">
Asian Pac. J. Cancer Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma.
</td>
<td style="text-align:left;">
Pak J Med Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
Role of microRNAs in malignant mesothelioma.
</td>
<td style="text-align:left;">
Cell. Mol. Life Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis.
</td>
<td style="text-align:left;">
BMJ Open
</td>
</tr>
<tr>
<td style="text-align:left;">
“Dry” pleural mesothelioma successfully diagnosed on endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA).
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pericardiectomy for treatment of neoplastic constrictive pericarditis.
</td>
<td style="text-align:left;">
Asian Cardiovasc Thorac Ann
</td>
</tr>
<tr>
<td style="text-align:left;">
Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma.
</td>
<td style="text-align:left;">
Ultrastruct Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Semirigid thoracoscopy: an effective method for diagnosing pleural malignancies.
</td>
<td style="text-align:left;">
Radiol Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant intraperitoneal mesothelioma-Başkent University experience.
</td>
<td style="text-align:left;">
J Turk Ger Gynecol Assoc
</td>
</tr>
<tr>
<td style="text-align:left;">
Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins αvβ3 and αvβ5.
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgery for malignant pleural mesothelioma: why, when and what?
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Radiological review of pleural tumors.
</td>
<td style="text-align:left;">
Indian J Radiol Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic accuracy of osteopontin for malignant pleural mesothelioma: a systematic review and meta-analysis.
</td>
<td style="text-align:left;">
Clin. Chim. Acta
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural effusion cytology of asbestos-associated malignant mesothelioma and lung carcinoma in the diagnosis of occupational diseases by the statutory accident insurance funds].
</td>
<td style="text-align:left;">
Pneumologie
</td>
</tr>
<tr>
<td style="text-align:left;">
Differentiation of malignant from normal and reactive mesothelial cells by the argyrophil technique for nucleolar organiser region associated proteins.
</td>
<td style="text-align:left;">
Thorax
</td>
</tr>
<tr>
<td style="text-align:left;">
Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
[Peritoneal malignant mesothelioma: review and recent data].
</td>
<td style="text-align:left;">
Ann Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Small cell carcinoma presenting with massive pleural spread mimicking malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma.
</td>
<td style="text-align:left;">
Neoplasma
</td>
</tr>
<tr>
<td style="text-align:left;">
Telomerase activity analyzed with TRAP in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma-a hypothesis.
</td>
<td style="text-align:left;">
Cancer Epidemiol. Biomarkers Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
A biphasic tumor of the mediastinum with features of synovial sarcoma. A report of four cases.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant peritoneal mesothelioma: clinicopathological characteristics of two cases.
</td>
<td style="text-align:left;">
Case Rep Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Relationship between prognosis and neutrophil: lymphocyte and platelet:lymphocyte ratios in patients with malignant pleural mesotheliomas.
</td>
<td style="text-align:left;">
Asian Pac. J. Cancer Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Synchronous occurrence of pulmonary adenocarcinoma and pleural diffuse malignant mesothelioma.
</td>
<td style="text-align:left;">
Pathologica
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma metastatic to the submandibular salivary gland, simulating glandular hypertrophy, diagnosed by fine-needle aspiration biopsy: a case report and literature review.
</td>
<td style="text-align:left;">
World J Surg Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Desmoplastic small round cell tumor with sphere-like clusters mimicking adenocarcinoma.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Physician-based ultrasound-guided biopsy for diagnosing pleural disease.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Autofluorescence thoracoscopy in pleural disease: does it have clinical relevance?
</td>
<td style="text-align:left;">
Expert Rev Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
EUS-guided fine needle tissue acquisition for the diagnosis of pleural metastases from endometrial cancer.
</td>
<td style="text-align:left;">
Eur Rev Med Pharmacol Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma: an institutional experience of 66 cases.
</td>
<td style="text-align:left;">
Korean J Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Flex-rigid pleuroscopy under local anesthesia in patients with dry pleural dissemination on radiography.
</td>
<td style="text-align:left;">
Jpn. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Mol Diagn
</td>
</tr>
<tr>
<td style="text-align:left;">
[Intrathoracic schwannoma].
</td>
<td style="text-align:left;">
Medicina (B Aires)
</td>
</tr>
<tr>
<td style="text-align:left;">
Women with malignant pleural mesothelioma have a threefold better survival rate than men.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial.
</td>
<td style="text-align:left;">
Lancet
</td>
</tr>
<tr>
<td style="text-align:left;">
Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study.
</td>
<td style="text-align:left;">
Med. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Synchronous pleural and peritoneal malignant mesothelioma: a case report and review of literature.
</td>
<td style="text-align:left;">
Int J Clin Exp Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Epithelioid malignant mesothelioma presenting with features of gastric tumor in a child.
</td>
<td style="text-align:left;">
Int J Clin Exp Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Performance of osteopontin in the diagnosis of malignant pleural mesothelioma: a meta-analysis.
</td>
<td style="text-align:left;">
Int J Clin Exp Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Local recurrence of lung adenocarcinoma 10 years after left upper lobectomy resembling pseudomesotheliomatous adenocarcinoma: a case report.
</td>
<td style="text-align:left;">
J Nippon Med Sch
</td>
</tr>
<tr>
<td style="text-align:left;">
p53 Expression in a Malignant Mesothelioma Patient during Seven-Year Follow-up.
</td>
<td style="text-align:left;">
Tuberc Respir Dis (Seoul)
</td>
</tr>
<tr>
<td style="text-align:left;">
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma.
</td>
<td style="text-align:left;">
Thorax
</td>
</tr>
<tr>
<td style="text-align:left;">
Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
</td>
<td style="text-align:left;">
Cancer Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Newly established ELISA for N-ERC/mesothelin improves diagnostic accuracy in patients with suspected pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Med
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of microRNAs in the diagnosis and treatment of malignant pleural mesothelioma–a short review.
</td>
<td style="text-align:left;">
Microrna
</td>
</tr>
<tr>
<td style="text-align:left;">
Sarcomatoid malignant mesothelioma presenting with intramedullary spinal cord metastasis: a case report and literature review.
</td>
<td style="text-align:left;">
Global Spine J
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis and treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Arch. Bronconeumol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural mesothelioma. Cytology and molecular diagnostics].
</td>
<td style="text-align:left;">
Pathologe
</td>
</tr>
<tr>
<td style="text-align:left;">
Microcystic variant malignant mesothelioma presenting as a localized paraspinal mass.
</td>
<td style="text-align:left;">
Cytojournal
</td>
</tr>
<tr>
<td style="text-align:left;">
Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Int. J. Radiat. Oncol. Biol. Phys.
</td>
</tr>
<tr>
<td style="text-align:left;">
Phrenic nerve paralysis as the initial presentation in pleural sarcomatoid mesothelioma.
</td>
<td style="text-align:left;">
Case Rep Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Role of CT in assessing pleural malignancy prior to thoracoscopy.
</td>
<td style="text-align:left;">
Thorax
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma and central nervous system metastases. Report of two cases, pooled analysis, and systematic review.
</td>
<td style="text-align:left;">
Ann Am Thorac Soc
</td>
</tr>
<tr>
<td style="text-align:left;">
Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.
</td>
<td style="text-align:left;">
Thorax
</td>
</tr>
<tr>
<td style="text-align:left;">
Metastasis of mesothelioma to the maxillary gingiva.
</td>
<td style="text-align:left;">
Oncol Lett
</td>
</tr>
<tr>
<td style="text-align:left;">
Gamma knife radiosurgery of brain metastasis from malignant pleural mesothelioma–report of three cases with autopsy study in a case.
</td>
<td style="text-align:left;">
Nagoya J Med Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
Photodynamic diagnoses of malignant pleural diseases using the autofluorescence imaging system.
</td>
<td style="text-align:left;">
Ann Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic and prognostic value of soluble syndecan-1 in pleural malignancies.
</td>
<td style="text-align:left;">
Biomed Res Int
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural and peritoneal mesothelioma consequential to brief indirect asbestos exposure.
</td>
<td style="text-align:left;">
J Clin Imaging Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
Non-asbestos-related malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Almost half of women with malignant mesothelioma were exposed to asbestos at home through their husbands or sons.
</td>
<td style="text-align:left;">
Dan Med J
</td>
</tr>
<tr>
<td style="text-align:left;">
Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Ultrasound-guided medical thoracoscopy in the absence of pleural effusion.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Past trends and future prediction of mesothelioma incidence in an industrialized area of Italy, the Veneto Region.
</td>
<td style="text-align:left;">
Cancer Epidemiol
</td>
</tr>
<tr>
<td style="text-align:left;">
The clinicopathological characteristics with long-term outcomes in malignant mesothelioma.
</td>
<td style="text-align:left;">
Med. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Sarcomatoid malignant mesothelioma: a clinicopathologic and immunohistochemical analysis of 22 cases].
</td>
<td style="text-align:left;">
Zhonghua Bing Li Xue Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
High incidence of lung cancer and malignant mesothelioma linked to erionite fibre exposure in a rural community in Central Mexico.
</td>
<td style="text-align:left;">
Occup Environ Med
</td>
</tr>
<tr>
<td style="text-align:left;">
A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial.
</td>
<td style="text-align:left;">
Trials
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: visual assessment by using pleural pointillism at diffusion-weighted MR imaging.
</td>
<td style="text-align:left;">
Radiology
</td>
</tr>
<tr>
<td style="text-align:left;">
[Correlation of computed tomography imaging and clinical prognosis of pleural mesothelioma].
</td>
<td style="text-align:left;">
Zhonghua Yi Xue Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions.
</td>
<td style="text-align:left;">
BMC Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Local and systemic therapies for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Curr Treat Options Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Electron microscopy remains the gold standard for the diagnosis of epithelial malignant mesothelioma: a case study.
</td>
<td style="text-align:left;">
Ultrastruct Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Reproducibility of histological subtyping of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Virchows Arch.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Morphological diagnostics of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Pathologe
</td>
</tr>
<tr>
<td style="text-align:left;">
Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Radiographics
</td>
</tr>
<tr>
<td style="text-align:left;">
Pseudo-tumor mimicking indwelling pleural catheter tract metastasis in mesothelioma.
</td>
<td style="text-align:left;">
J Bronchology Interv Pulmonol
</td>
</tr>
<tr>
<td style="text-align:left;">
Advances in malignant peritoneal mesothelioma.
</td>
<td style="text-align:left;">
Int J Colorectal Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Use of computed tomography and positron emission tomography/computed tomography for staging of local extent in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Comput Assist Tomogr
</td>
</tr>
<tr>
<td style="text-align:left;">
Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component.
</td>
<td style="text-align:left;">
Med. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinicopathological characteristics of pulmonary epithelioid hemangioendothelioma: A report of four cases and review of the literature.
</td>
<td style="text-align:left;">
Oncol Lett
</td>
</tr>
<tr>
<td style="text-align:left;">
Hyaluronic Acid concentration in pleural fluid: diagnostic aid for tuberculous pleurisy.
</td>
<td style="text-align:left;">
J Clin Med Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Intercellular communication in malignant pleural mesothelioma: properties of tunneling nanotubes.
</td>
<td style="text-align:left;">
Front Physiol
</td>
</tr>
<tr>
<td style="text-align:left;">
FISH analysis of intrapulmonary malignant mesothelioma without a clinically detectable primary pleural lesion: an autopsy case.
</td>
<td style="text-align:left;">
Jpn. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Contribution of pleural fluid analysis to the diagnosis of pleural effusion].
</td>
<td style="text-align:left;">
Med Clin (Barc)
</td>
</tr>
<tr>
<td style="text-align:left;">
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Computed tomography-guided cutting needle pleural biopsy: Accuracy and complications.
</td>
<td style="text-align:left;">
Exp Ther Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Current controversies in the management of malignant pleural effusions.
</td>
<td style="text-align:left;">
Semin Respir Crit Care Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Amosite mesothelioma in a cohort of asbestos workers.
</td>
<td style="text-align:left;">
Scand J Work Environ Health
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
Dis. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Biomark
</td>
</tr>
<tr>
<td style="text-align:left;">
Thromboembolic Events in Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Clin. Appl. Thromb. Hemost.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical significance of soluble CD26 in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
Novel induction therapies for pleural mesothelioma.
</td>
<td style="text-align:left;">
Semin. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pemetrexed-induced scleroderma-like changes in the lower legs].
</td>
<td style="text-align:left;">
Ann Dermatol Venereol
</td>
</tr>
<tr>
<td style="text-align:left;">
Third-line chemotherapy with carboplatin, gemcitabine and liposomised doxorubicin for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Med. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases.
</td>
<td style="text-align:left;">
BMJ Open
</td>
</tr>
<tr>
<td style="text-align:left;">
Detection of malignant mesothelioma using nuclear structure of mesothelial cells in effusion cytology specimens.
</td>
<td style="text-align:left;">
Cytometry A
</td>
</tr>
<tr>
<td style="text-align:left;">
Fast neutron radiotherapy in the treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Is Radiotherapy Useful for Treating Pain in Mesothelioma?: A Phase II Trial.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Epithelioid angiosarcoma at chest wall which needs to be carefully distinguished from malignant mesothelioma: report of a rare case.
</td>
<td style="text-align:left;">
Int J Clin Exp Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Pleural Mesothelioma: Accuracy of CT Against Immunohistochemical Test Among the Mexican Population.
</td>
<td style="text-align:left;">
Arch. Med. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Shoulder ring complaints as a rare first symptom of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Adv. Exp. Med. Biol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic.
</td>
<td style="text-align:left;">
Eur Respir Rev
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of malignant peritoneal mesothelioma without deletion of p16].
</td>
<td style="text-align:left;">
Gan To Kagaku Ryoho
</td>
</tr>
<tr>
<td style="text-align:left;">
Changing pattern in malignant mesothelioma survival.
</td>
<td style="text-align:left;">
Transl Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion.
</td>
<td style="text-align:left;">
Biomed Res Int
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse intrapulmonary malignant mesothelioma presenting with miliary pulmonary nodules: A case report.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Unusual appearance of malignant peritoneal mesothelioma.
</td>
<td style="text-align:left;">
J Comput Assist Tomogr
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic yield of pleural biopsy in exudative pleural effusion.
</td>
<td style="text-align:left;">
Nepal Med Coll J
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma presenting as a spontaneous pneumothorax.
</td>
<td style="text-align:left;">
Respirol Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic accuracy of calretinin for malignant mesothelioma in serous effusions: a meta-analysis.
</td>
<td style="text-align:left;">
Sci Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
</td>
<td style="text-align:left;">
Jpn. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Breast cancer or metastasis? An unusual case of metastatic malignant pleural mesothelioma to the breast.
</td>
<td style="text-align:left;">
World J Surg Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Importance of the cell block technique in diagnosing patients with non-small cell carcinoma accompanied by pleural effusion.
</td>
<td style="text-align:left;">
Asian Pac. J. Cancer Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathologic diagnosis of malignant mesothelioma: chronological prospect and advent of recommendations and guidelines.
</td>
<td style="text-align:left;">
Ann. Ist. Super. Sanita
</td>
</tr>
<tr>
<td style="text-align:left;">
Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Comparing the results of pathologic diagnosis of mesothelioma between Chinese and Japanese experts].
</td>
<td style="text-align:left;">
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic factors in malignant pleural mesothelioma: a retrospective study of 60 Turkish patients.
</td>
<td style="text-align:left;">
J Cancer Res Ther
</td>
</tr>
<tr>
<td style="text-align:left;">
Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Ann Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Randomized Trials of Systemic Medically-treated Malignant Mesothelioma: A Systematic Review.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyperplasia and Epithelial Ovarian Cancer.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Detection of p16 by fluorescence in-situ hybridization and immunohistochemistry in malignant mesothelioma].
</td>
<td style="text-align:left;">
Zhonghua Bing Li Xue Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
The established and future biomarkers of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Treat. Rev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Multiple distant metastases in a case of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respir Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Effectiveness of medical thoracoscopy and thoracoscopic talc poudrage in patients with exudative pleural effusion.
</td>
<td style="text-align:left;">
Singapore Med J
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma due to non-occupational asbestos exposure from the Italian national surveillance system (ReNaM): epidemiology and public health issues.
</td>
<td style="text-align:left;">
Occup Environ Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural neoplastic pathology.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[18F]Fluorodeoxyglucose PET in Thoracic Malignancies.
</td>
<td style="text-align:left;">
PET Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Differential diagnosis of pleural mesothelioma using Logic Learning Machine.
</td>
<td style="text-align:left;">
BMC Bioinformatics
</td>
</tr>
<tr>
<td style="text-align:left;">
Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patients.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma in the southwestern part of The Netherlands.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Dis. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
[Endobronchial ultrasound in the diagnosis of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgical Management of Malignant Pleural Mesothelioma: An Update of Clinical Evidence.
</td>
<td style="text-align:left;">
Semin. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant pleural mesothelioma in an urban hospital: clinical spectrum and trend in incidence over time.
</td>
<td style="text-align:left;">
Am. J. Ind. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Sarcomatoid mesothelioma: future advances in diagnosis, biomolecular assessment, and therapeutic options in a poor-outcome disease.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
Research priorities in mesothelioma: A James Lind Alliance Priority Setting Partnership.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant peritoneal mesothelioma: a series of 19 cases.
</td>
<td style="text-align:left;">
Digestion
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos textile production linked to malignant peritoneal and pleural mesothelioma in women: Analysis of 28 cases in Southeast China.
</td>
<td style="text-align:left;">
Am. J. Ind. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
BMC Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma cells breaking bad: loss of integrin α7 promotes cell motility and poor clinical outcomes in patients.
</td>
<td style="text-align:left;">
J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Survival from malignant mesothelioma: where are we now?
</td>
<td style="text-align:left;">
J R Coll Physicians Edinb
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant spindle cell tumor of the pericardium. Evidence of sarcomatous mesothelioma with aberrant antigen expression.
</td>
<td style="text-align:left;">
Acta Pathol. Jpn.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion.
</td>
<td style="text-align:left;">
Medicine (Baltimore)
</td>
</tr>
<tr>
<td style="text-align:left;">
Long-term Outcome of Patients With Undiagnosed Pleural Effusion.
</td>
<td style="text-align:left;">
Arch. Bronconeumol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary Peritoneal Mesothelioma Resulting in Small Bowel Obstruction: A Case Report and Review of Literature.
</td>
<td style="text-align:left;">
Am J Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Mesothelioma Diagnosis.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleuropulmonary tumors. Presentation of 2 cases with peculiar clinicopathologic traits].
</td>
<td style="text-align:left;">
Rev Clin Esp
</td>
</tr>
<tr>
<td style="text-align:left;">
Computational genomic analysis of PARK7 interactome reveals high BBS1 gene expression as a prognostic factor favoring survival in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Physiol. Lung Cell Mol. Physiol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma and occupational and non-occupational asbestos exposure: a case-control study with quantitative risk assessment.
</td>
<td style="text-align:left;">
Occup Environ Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Granulocyte-colony stimulating factor (G-CSF) producing malignant pleural mesothelioma: Report of a case.
</td>
<td style="text-align:left;">
Thorac Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
The expression and clinical effects of alpha-methylacyl-CoA racemase (AMACR/ P504S) as an immunohistochemical marker in malign pleural mesothelioma.
</td>
<td style="text-align:left;">
Turk J Med Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
</td>
<td style="text-align:left;">
Int. J. Radiat. Oncol. Biol. Phys.
</td>
</tr>
<tr>
<td style="text-align:left;">
An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue.
</td>
<td style="text-align:left;">
Cancer Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Environmental carcinogenesis - 100th anniversary of creating cancer.
</td>
<td style="text-align:left;">
Cancer Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of endobronchial ultrasound-guided fine needle aspiration in the diagnosis of pleural mesothelioma.
</td>
<td style="text-align:left;">
Cytopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
[Radiologic diagnosis of pleural mesothelioma].
</td>
<td style="text-align:left;">
Nihon Igaku Hoshasen Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review.
</td>
<td style="text-align:left;">
Am. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnosis, therapy and prognosis of diffuse malignant mesothelioma.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Tumour Biol.
</td>
</tr>
<tr>
<td style="text-align:left;">
An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.
</td>
<td style="text-align:left;">
Cancer Genet
</td>
</tr>
<tr>
<td style="text-align:left;">
Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Ann Transl Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Epithelioid pleural mesothelioma concurrently associated with miliary pulmonary metastases and minimal change nephrotic syndrome - A hitherto undescribed case.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and Occupational Medicine related issues.
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
[Health expenditures for cases of pleural mesothelioma].
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression Profiles of Cytokine mRNAs in the Pleural Fluid Reveal Differences Among Tuberculosis, Malignancies, and Pneumonia-Exudative Pleural Effusions.
</td>
<td style="text-align:left;">
Lung
</td>
</tr>
<tr>
<td style="text-align:left;">
Identification of circulating miRNAs profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma.
</td>
<td style="text-align:left;">
EXCLI J
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis.
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
Response evaluation in mesothelioma: Beyond RECIST.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Mesothelioma Mimicking Invasive Mammary Carcinoma in a Male Breast.
</td>
<td style="text-align:left;">
Case Rep Oncol Med
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnosis of pleural effusions.
</td>
<td style="text-align:left;">
Expert Rev Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement during Initial Diagnosis.
</td>
<td style="text-align:left;">
Case Rep Pulmonol
</td>
</tr>
<tr>
<td style="text-align:left;">
Paraneoplastic nephritic syndrome and concurrent solitary mediastinal lymph node metastasis from mesothelioma of testis diagnosed by endobronchial ultrasound: Unusual manifestations of an extremely rare tumor.
</td>
<td style="text-align:left;">
J Cancer Res Ther
</td>
</tr>
<tr>
<td style="text-align:left;">
Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.
</td>
<td style="text-align:left;">
Clin. Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Verification of the histologic diagnosis of malignant mesothelioma in relation to the binding of an antimesothelial cell antibody.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytology in malignant pleural mesothelioma. Expression of tumor markers and distribution of lymphocyte subsets.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Imaging characteristics of pleural tumours.
</td>
<td style="text-align:left;">
Insights Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma in infancy.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Rapidly progressive sarcomatoid malignant mesothelioma of the pleura mimicking pulmonary empyema.
</td>
<td style="text-align:left;">
Clin Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study).
</td>
<td style="text-align:left;">
BMC Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
An Autopsy Case Report of Malignant Pleural Mesothelioma with Deciduoid Features.
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
</td>
<td style="text-align:left;">
Int. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Brain metastases in malignant pleural mesothelioma. Case report and review of the literature.
</td>
<td style="text-align:left;">
Am. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
An Autopsied Case of Malignant Sarcomatoid Pleural Mesothelioma in Which Chest Pain Developed Several Months Earlier without Abnormality on Imaging.
</td>
<td style="text-align:left;">
Case Rep Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytomorphometry of serosal effusion in dogs.
</td>
<td style="text-align:left;">
Pol J Vet Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
Cell aggregates in malignant mesothelioma.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.
</td>
<td style="text-align:left;">
Future Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Biomarkers and prognostic factors for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Future Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Analysis of the clinical diagnosis of asbestosis complicated with malignant mesothelioma].
</td>
<td style="text-align:left;">
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients.
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
Unusual lesions of the mediastinum.
</td>
<td style="text-align:left;">
Lung India
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural epitheliod hemangioendothelioma: What started as a liver fluke and ended up being almost mistaken for malignant mesothelioma.
</td>
<td style="text-align:left;">
Ann Thorac Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical Investigation of Benign Asbestos Pleural Effusion.
</td>
<td style="text-align:left;">
Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[Analysis of misdiagnosis of 38 cases of solitary fibrous tumor of the pleura].
</td>
<td style="text-align:left;">
Zhonghua Jie He He Hu Xi Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
</td>
<td style="text-align:left;">
Radiat Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Non-islet Cell Tumour Hypoglycaemia (NICTH) in Malignant Mesothelioma: Case Report.
</td>
<td style="text-align:left;">
Malays J Med Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
Infant pleuropulmonary blastoma: report of a rare case and review of literature.
</td>
<td style="text-align:left;">
Int J Clin Exp Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Foreign body granuloma mimicking recurrence of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respir Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
A rare clinical case - Solitary fibrous tumor of the pleura.
</td>
<td style="text-align:left;">
Respir Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Young investigator challenge: MicroRNA-21/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology.
</td>
<td style="text-align:left;">
Cancer Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Massive localized malignant pleural mesothelioma (LMPM): manifestations on computed tomography in 6 cases.
</td>
<td style="text-align:left;">
Int J Clin Exp Med
</td>
</tr>
<tr>
<td style="text-align:left;">
A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
CT Scan-Guided Abrams’ Needle Pleural Biopsy versus Ultrasound-Assisted Cutting Needle Pleural Biopsy for Diagnosis in Patients with Pleural Effusion: A Randomized, Controlled Trial.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Int. J. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009.
</td>
<td style="text-align:left;">
Occup Environ Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.
</td>
<td style="text-align:left;">
Clin Proteomics
</td>
</tr>
<tr>
<td style="text-align:left;">
The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Retrospective analysis of unknown primary cancers with malignant pleural effusion at initial diagnosis.
</td>
<td style="text-align:left;">
Thorac Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Microrna
</td>
</tr>
<tr>
<td style="text-align:left;">
Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention.
</td>
<td style="text-align:left;">
BMJ Open
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesotheliomas with unknown exposure to asbestos: a re-examination].
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Benign and Malignant Mesothelial Proliferation.
</td>
<td style="text-align:left;">
Surg Pathol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: an update on diagnosis and treatment options.
</td>
<td style="text-align:left;">
Ther Adv Respir Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Anaesthetic management of extra-pleural pneumonectomy and hyperthermic intrathoracic chemotherapy procedure.
</td>
<td style="text-align:left;">
Indian J Anaesth
</td>
</tr>
<tr>
<td style="text-align:left;">
Asymptomatic localized pleural amyloidosis mimicking malignant pleural mesothelioma: report of a case.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesotheliomas show higher hyaluronan positivity around tumor cells than metastatic pulmonary adenocarcinomas.
</td>
<td style="text-align:left;">
Histol. Histopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytomorphology of ovarian clear cell carcinomas in peritoneal effusions.
</td>
<td style="text-align:left;">
Cytopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
[Proposal of an Italian national protocol of health surveillance for former asbestos workers: an ongoing project].
</td>
<td style="text-align:left;">
Epidemiol Prev
</td>
</tr>
<tr>
<td style="text-align:left;">
Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers: A Predictive Multivariate Model.
</td>
<td style="text-align:left;">
Medicine (Baltimore)
</td>
</tr>
<tr>
<td style="text-align:left;">
A simple “expert system” for morphometric evaluation of cells in pleural effusions.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Computed Tomographic Features of Malignant Peritoneal Mesothelioma.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
[BRCA1 associated protein 1 (BAP1) expression in pleural diffuse malignant mesothelioma: A comparative cytological and histological analyses on 50 patients].
</td>
<td style="text-align:left;">
Ann Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Immune response profiling of malignant pleural mesothelioma for diagnostic and prognostic biomarkers.
</td>
<td style="text-align:left;">
Biomarkers
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of thoracic surgery in the management of mesothelioma: an expert opinion on the limited evidence.
</td>
<td style="text-align:left;">
Expert Rev Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytochemical utility of claudin-4 versus those of Ber-EP4 and MOC-31 in effusion cytology.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Fatal pleural mesothelioma in Japan (2003-2008): evaluation of computed tomography findings.
</td>
<td style="text-align:left;">
Jpn J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.
</td>
<td style="text-align:left;">
Lung
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary Malignant Neuroendocrine Tumour of Pleura: First Case Report.
</td>
<td style="text-align:left;">
Case Rep Oncol Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant mesothelioma and synchronous lung cancer: A clinicopathological study of 18 cases.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural mesothelioma–problems in diagnosis and clinical course in 25 patients].
</td>
<td style="text-align:left;">
Langenbecks Arch Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
Deformable medical image registration of pleural cavity for photodynamic therapy by using finite-element based method.
</td>
<td style="text-align:left;">
Proc SPIE Int Soc Opt Eng
</td>
</tr>
<tr>
<td style="text-align:left;">
Advances in treatment of mesothelioma.
</td>
<td style="text-align:left;">
Expert Opin Pharmacother
</td>
</tr>
<tr>
<td style="text-align:left;">
A pilot study of volumetric-modulated arc therapy for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Appl Clin Med Phys
</td>
</tr>
<tr>
<td style="text-align:left;">
[Localized Malignant Mesothelioma of the Pleura with Hemothorax].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis of p16.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge.
</td>
<td style="text-align:left;">
Iran J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Pain in Malignant Pleural Mesothelioma: A Prospective Characterization Study.
</td>
<td style="text-align:left;">
Pain Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Intrathoracic splenosis - lesson learned: a case report.
</td>
<td style="text-align:left;">
J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Genome-based Mutational Analysis by Next Generation Sequencing in Patients with Malignant Pleural and Peritoneal Mesothelioma.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Massive chest wall resection and reconstruction for malignant disease.
</td>
<td style="text-align:left;">
Onco Targets Ther
</td>
</tr>
<tr>
<td style="text-align:left;">
Multimodality Imaging Review of Malignant Pleural Mesothelioma Diagnosis and Staging.
</td>
<td style="text-align:left;">
PET Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
The incidence of malignant mesothelioma in Australia, 1947-1980.
</td>
<td style="text-align:left;">
Med. J. Aust.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Surgical therapy of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Chirurg
</td>
</tr>
<tr>
<td style="text-align:left;">
Conjunctival Metastasis from Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Ocul Oncol Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracoscopy in malignant mesothelioma.
</td>
<td style="text-align:left;">
Pneumologie
</td>
</tr>
<tr>
<td style="text-align:left;">
[Clinical Pathological Diagnosis, and Treatment for Pleural Mesothelioma].
</td>
<td style="text-align:left;">
Gan To Kagaku Ryoho
</td>
</tr>
<tr>
<td style="text-align:left;">
Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?
</td>
<td style="text-align:left;">
Ther Clin Risk Manag
</td>
</tr>
<tr>
<td style="text-align:left;">
Use of p16 FISH for differential diagnosis of mesothelioma in smear preparations.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Jpn J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma in a 17-year old boy: A case report and literature review.
</td>
<td style="text-align:left;">
Respir Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Metastatic malignant pleural mesothelioma masquerading as a case of acute abdomen secondary to small bowel perforation.
</td>
<td style="text-align:left;">
Ann Saudi Med
</td>
</tr>
<tr>
<td style="text-align:left;">
KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Mol. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diagnosis and prognosis of malignant mesothelioma. A description of 8 clinical cases].
</td>
<td style="text-align:left;">
Minerva Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.
</td>
<td style="text-align:left;">
Crit. Rev. Oncol. Hematol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model.
</td>
<td style="text-align:left;">
Int. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
</td>
<td style="text-align:left;">
Eur. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Applications of Magnetic Resonance Imaging of the Thorax in Pleural Diseases: A State-of-the-Art Review.
</td>
<td style="text-align:left;">
Lung
</td>
</tr>
<tr>
<td style="text-align:left;">
Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural fluid infection caused by Dietzia cinnamea.
</td>
<td style="text-align:left;">
Diagn. Microbiol. Infect. Dis.
</td>
</tr>
<tr>
<td style="text-align:left;">
Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial.
</td>
<td style="text-align:left;">
Lancet Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Thoracoscopy using flexible fiberoptic bronchoscopy–a preliminary report of experimental and clinical studies].
</td>
<td style="text-align:left;">
Zhonghua Nei Ke Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
A case of pseudoachalasia hiding a malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
Usefulness of Aquaporin 1 as a Prognostic Marker in a Prospective Cohort of Malignant Mesotheliomas.
</td>
<td style="text-align:left;">
Int J Mol Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
</td>
<td style="text-align:left;">
Ultrastruct Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.
</td>
<td style="text-align:left;">
J Natl Compr Canc Netw
</td>
</tr>
<tr>
<td style="text-align:left;">
MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients.
</td>
<td style="text-align:left;">
Genom Data
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma with lacrimal gland metastasis.
</td>
<td style="text-align:left;">
Acta Ophthalmol
</td>
</tr>
<tr>
<td style="text-align:left;">
BRCA1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: A Large Retrospective Study.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
A case report of metastasis of malignant mesothelioma to the retromolar trigone.
</td>
<td style="text-align:left;">
World J Surg Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database.
</td>
<td style="text-align:left;">
Wien. Klin. Wochenschr.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Not Available].
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathology reporting of malignant pleural mesothelioma first diagnosis: A population-based approach.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
Recurrent hydropneumothorax: An unusual presentation for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respir Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
[Health damage caused by asbestos and other mineral fibers].
</td>
<td style="text-align:left;">
Tidsskr. Nor. Laegeforen.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural irregularities and mediastinal pleural involvement in early stages of malignant pleural mesothelioma and benign asbestos pleural effusion.
</td>
<td style="text-align:left;">
Eur J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Early recognition of lung cancer in workers occupationally exposed to asbestos].
</td>
<td style="text-align:left;">
Radiologe
</td>
</tr>
<tr>
<td style="text-align:left;">
Medical thoracoscopy: Analysis on diagnostic yield through 30 years of experience.
</td>
<td style="text-align:left;">
Ann Thorac Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Alveolar-filling growth pattern of sarcomatoid malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respirol Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Evaluation of predictive value of pleural CEA in patients with pleural effusions and histological findings: A prospective study and literature review.
</td>
<td style="text-align:left;">
Clin. Biochem.
</td>
</tr>
<tr>
<td style="text-align:left;">
Co-existing tuberculosis and malignant mesothelioma with multiple sites venous thrombosis: a case report.
</td>
<td style="text-align:left;">
BMC Res Notes
</td>
</tr>
<tr>
<td style="text-align:left;">
The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
Low homozygous/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review.
</td>
<td style="text-align:left;">
BMC Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant Pleural Mesotheliomas].
</td>
<td style="text-align:left;">
Zentralbl Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
</td>
<td style="text-align:left;">
Wien. Klin. Wochenschr.
</td>
</tr>
<tr>
<td style="text-align:left;">
Validation of EORTC and CALGB prognostic models in surgical patients submitted to diagnostic, palliative or curative surgery for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
The cytology of malignant mesothelioma in Western Australia.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Int. J. Biol. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
Intensity-modulated radiotherapy for relapsed malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Future Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of monoclonal antibody B72.3 in detecting adenocarcinoma cells in serous effusions.
</td>
<td style="text-align:left;">
APMIS
</td>
</tr>
<tr>
<td style="text-align:left;">
Biphasic Malignant Pleural Mesothelioma Masquerading as a Primary Skeletal Tumor.
</td>
<td style="text-align:left;">
Case Rep Pulmonol
</td>
</tr>
<tr>
<td style="text-align:left;">
Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS).
</td>
<td style="text-align:left;">
J Breath Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma in South Africa, 1976-84: incidence and case characteristics.
</td>
<td style="text-align:left;">
Int J Epidemiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Geographical patterns of mesothelioma incidence and asbestos exposure in Lombardy, Italy.
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Rare presentation of a localised malignant pleural mesothelioma with cranial metastasis.
</td>
<td style="text-align:left;">
BMJ Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Pulmonary tumor diagnosed as an undifferentiated sarcoma with epithelioid features: a case report.
</td>
<td style="text-align:left;">
J Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: A retrospective analysis of clinicopathological and survival data.
</td>
<td style="text-align:left;">
Thorac Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
The Role of CD90 in the Differential Diagnosis of Pleural Malignant Mesothelioma, Pulmonary Carcinoma and Comparison with Calretının.
</td>
<td style="text-align:left;">
Pathol. Oncol. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Ultrastructural histochemistry of mesotheliomas and adenocarcinomas in malignant effusions.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Relation between neutrophil/lymphocyte ratio and primary tumor metabolic activity in patients with malign pleural mesothelioma.
</td>
<td style="text-align:left;">
Clin Respir J
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Sarcomatoid Type Primary Pericardial Mesothelioma with a Long-term Survival after the Onset of Cardiac Tamponade.
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Update on epidemiology, pathophysiology, diagnosis and treatment of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Rev Med Inst Mex Seguro Soc
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival.
</td>
<td style="text-align:left;">
Clin Epidemiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic Utility of Pleural Fluid Cell Block versus Pleural Biopsy Collected by Flex-Rigid Pleuroscopy for Malignant Pleural Disease: A Single Center Retrospective Analysis.
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study.
</td>
<td style="text-align:left;">
BMJ Open
</td>
</tr>
<tr>
<td style="text-align:left;">
Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells.
</td>
<td style="text-align:left;">
Oncol Lett
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary malignant pericardial mesothelioma with increased serum mesothelin diagnosed by surgical pericardial resection: A case report.
</td>
<td style="text-align:left;">
Mol Clin Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
</td>
<td style="text-align:left;">
Eur Respir Rev
</td>
</tr>
<tr>
<td style="text-align:left;">
The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Onco Targets Ther
</td>
</tr>
<tr>
<td style="text-align:left;">
Minimal change disease associated with malignant pleural mesothelioma: case report and review of the literature.
</td>
<td style="text-align:left;">
BMJ Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Advances in pleuroscopy.
</td>
<td style="text-align:left;">
Clin Respir J
</td>
</tr>
<tr>
<td style="text-align:left;">
Distinction between mesothelioma and lung adenocarcinoma based on immunohistochemistry in a patient with asbestos bodies in bronchoalveolar fluid - case report.
</td>
<td style="text-align:left;">
Rom J Morphol Embryol
</td>
</tr>
<tr>
<td style="text-align:left;">
Pericardial Effusion due to Primary Malignant Pericardial Mesothelioma: A Common Finding but an Uncommon Cause.
</td>
<td style="text-align:left;">
Case Rep Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Mesothelioma Biomarkers: From Discovery to Use in Clinical Practice for Diagnosis, Monitoring, Screening, and Treatment.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Improving the Accuracy of Mesothelioma Diagnosis in China.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
The importance of EZH2 and MOC-31 expression in the differential diagnosis of benign and malignant effusions.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnostic performance of routinely acquired and reported computed tomography imaging in patients presenting with suspected pleural malignancy.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Deciduoid mesothelioma of the thorax: A comprehensive review of the scientific literature.
</td>
<td style="text-align:left;">
Clin Respir J
</td>
</tr>
<tr>
<td style="text-align:left;">
Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Pemetrexed for epithelioid haemangioendothelioma of the pleura.
</td>
<td style="text-align:left;">
Respirol Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma.
</td>
<td style="text-align:left;">
Ann Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma–analysis of 12 cases in Chang-Gung Memorial Hospital.
</td>
<td style="text-align:left;">
Changgeng Yi Xue Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural Mesothelioma with No Asbestos Exposure: A Case Report.
</td>
<td style="text-align:left;">
J Clin Diagn Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis.
</td>
<td style="text-align:left;">
Pathol. Oncol. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Flex-rigid pleuroscopic biopsy with the SB knife Jr is a novel technique for diagnosis of malignant or benign fibrothorax.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
[Problems of diagnosis and surgical treatment in pleural mesothelioma].
</td>
<td style="text-align:left;">
Nihon Kyobu Geka Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Small bowel metastasis from pancreatic cancer in a long-term survival patient with synchronous advanced malignant pleural mesothelioma: A case report and literature review.
</td>
<td style="text-align:left;">
Oncol Lett
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural fluid cytology samples in cases of suspected lung cancer: An experience from a tertiary care centre.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pericardial mesothelioma : A systematic review of current practice.
</td>
<td style="text-align:left;">
Herz
</td>
</tr>
<tr>
<td style="text-align:left;">
A Single-Institution Experience in Percutaneous Image-Guided Biopsy of Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Cardiovasc Intervent Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause.
</td>
<td style="text-align:left;">
Rofo
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of remission induced in diffuse pleural malignant mesothelioma by the treatment with cisplatin and doxorubicin].
</td>
<td style="text-align:left;">
Gan To Kagaku Ryoho
</td>
</tr>
<tr>
<td style="text-align:left;">
Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation.
</td>
<td style="text-align:left;">
Cancer Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Monosomy 14, monosomy 22 and 13q–three chromosomal abnormalities observed in cells of two malignant mesotheliomas studied by banding techniques.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Unusual pleural effusion from vulvar squamous cell carcinoma: report of a case and review of the literature.
</td>
<td style="text-align:left;">
Pathologica
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Oncoimmunology
</td>
</tr>
<tr>
<td style="text-align:left;">
Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Int. J. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Modern management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer (Auckl)
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Radiation therapy for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Radiother
</td>
</tr>
<tr>
<td style="text-align:left;">
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions.
</td>
<td style="text-align:left;">
Clin Respir J
</td>
</tr>
<tr>
<td style="text-align:left;">
Aberrant Cytokeratin 20 Reactivity in Epithelioid Malignant Mesothelioma: A Case Report.
</td>
<td style="text-align:left;">
Appl. Immunohistochem. Mol. Morphol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioid reaction following talc pleurodesis: a case report.
</td>
<td style="text-align:left;">
Gen Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Non-Hodgkin Lymphoma and Pleural Mesothelioma in a Person Exposed to Asbestos.
</td>
<td style="text-align:left;">
Turk Patoloji Derg
</td>
</tr>
<tr>
<td style="text-align:left;">
Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives.
</td>
<td style="text-align:left;">
Lung Cancer (Auckl)
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin.
</td>
<td style="text-align:left;">
BMC Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals.
</td>
<td style="text-align:left;">
Occup Environ Med
</td>
</tr>
<tr>
<td style="text-align:left;">
A Novel Panel of Serum Biomarkers for MPM Diagnosis.
</td>
<td style="text-align:left;">
Dis. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.
</td>
<td style="text-align:left;">
Dis. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
A second case of pericardial mesothelioma mimicking systemic lupus erythematosus in the literature in over 30 years: a case report.
</td>
<td style="text-align:left;">
J Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Transcriptomic Analysis of the Claudin Interactome in Malignant Pleural Mesothelioma: Evaluation of the Effect of Disease Phenotype, Asbestos Exposure, and CDKN2A Deletion Status.
</td>
<td style="text-align:left;">
Front Physiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year period.
</td>
<td style="text-align:left;">
Acta Chir. Belg.
</td>
</tr>
<tr>
<td style="text-align:left;">
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.
</td>
<td style="text-align:left;">
Respir. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Prophylactic radiotherapy for procedure tract metastases in mesothelioma: a review.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Can CT and MR Shape and Textural Features Differentiate Benign Versus Malignant Pleural Lesions?
</td>
<td style="text-align:left;">
Acad Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma in doll manufacture: possible asbestos exposure.
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology.
</td>
<td style="text-align:left;">
Cancer Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Significant Clinical Benefit of Pemetrexed-based Chemotherapy for Advanced Diffuse Malignant Peritoneal Mesothelioma: A Case Presentation.
</td>
<td style="text-align:left;">
Indian J Med Paediatr Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
</td>
<td style="text-align:left;">
PLoS ONE
</td>
</tr>
<tr>
<td style="text-align:left;">
Spontaneous massive hemopneumothorax: Double trouble with a twist.
</td>
<td style="text-align:left;">
Lung India
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma in household members of asbestos-exposed workers in Friuli Venezia Giulia, Italy.
</td>
<td style="text-align:left;">
Int J Occup Med Environ Health
</td>
</tr>
<tr>
<td style="text-align:left;">
Multiple malignant epithelioid mesotheliomas of the liver and greater omentum: a case report and review of the literature.
</td>
<td style="text-align:left;">
Surg Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
SU-E-T-595: Comparison of Volumetric Modulated Arc Therapy (VMAT) and Static Intensity Modulated Radiotherapy (IMRT) for Malignant Pleural Mesothelioma in Patients with Intact Lungs/Post Pleurectomy.
</td>
<td style="text-align:left;">
Med Phys
</td>
</tr>
<tr>
<td style="text-align:left;">
Diode-Pumped Laser for Lung-Sparing Surgical Treatment of Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Calretinin as a blood-based biomarker for mesothelioma.
</td>
<td style="text-align:left;">
BMC Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Unusual Contiguous Soft Tissue Spread of Advanced Malignant Mesothelioma Detected by FDG PET/CT.
</td>
<td style="text-align:left;">
Nucl Med Mol Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
</td>
<td style="text-align:left;">
Cell Oncol (Dordr)
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgery as part of radical treatment for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism.
</td>
<td style="text-align:left;">
Sci Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Front Genet
</td>
</tr>
<tr>
<td style="text-align:left;">
GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Pleural Mesothelioma with Marked Lymphatic Involvement: A Report of Two Autopsy Cases.
</td>
<td style="text-align:left;">
Case Rep Oncol Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Chest pain and recurrent chylothorax: an unusual presentation of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respirol Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
</td>
<td style="text-align:left;">
Lung
</td>
</tr>
<tr>
<td style="text-align:left;">
Risk Factors of Mortality from All Asbestos-Related Diseases: A Competing Risk Analysis.
</td>
<td style="text-align:left;">
Can. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
The impact of surgical approach on quality of life for pleural malignant mesothelioma.
</td>
<td style="text-align:left;">
Ann Transl Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Extrapleural pneumonectomy (EPP) <i>vs.</i> pleurectomy decortication (P/D).
</td>
<td style="text-align:left;">
Ann Transl Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant peritoneal mesothelioma: a review.
</td>
<td style="text-align:left;">
Ann Transl Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis and prognosis-review of biomarkers for mesothelioma.
</td>
<td style="text-align:left;">
Ann Transl Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Radio-immunotherapy and chemo-immunotherapy as a novel treatment paradigm in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Transl Lung Cancer Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Can malignant and inflammatory pleural effusions in dogs be distinguished using computed tomography?
</td>
<td style="text-align:left;">
Vet Radiol Ultrasound
</td>
</tr>
<tr>
<td style="text-align:left;">
MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study.
</td>
<td style="text-align:left;">
Dis. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of medical thoracoscopy in malignant pleural effusion.
</td>
<td style="text-align:left;">
BMC Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma segmentation for photodynamic therapy planning.
</td>
<td style="text-align:left;">
Comput Med Imaging Graph
</td>
</tr>
<tr>
<td style="text-align:left;">
Epithelioid malignant mesothelioma metastatic to the skin: A case report and review of the literature.
</td>
<td style="text-align:left;">
J. Cutan. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Radiographic features of importance in the National Institute for Occupational Safety and Health-administered Coal Workers’ Health Surveillance Program: characterising the use of the ‘other symbols’.
</td>
<td style="text-align:left;">
BMJ Open
</td>
</tr>
<tr>
<td style="text-align:left;">
[Clinical and pathologic features of extrapleural sarcomatoid mesothelioma].
</td>
<td style="text-align:left;">
Zhonghua Bing Li Xue Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma - Pleural cavity irradiation after decortication with helical tomotherapy.
</td>
<td style="text-align:left;">
Rep Pract Oncol Radiother
</td>
</tr>
<tr>
<td style="text-align:left;">
Chest ultrasonography in health surveillance of asbestos related pleural disease.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
National Cancer Database Report on Pneumonectomy Versus Lung-Sparing Surgery for Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic Imaging and workup of Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Acta Biomed
</td>
</tr>
<tr>
<td style="text-align:left;">
Accumulation of long asbestos fibers in the peripheral upper lobe in cases of malignant mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Ind. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Migrating pleural plaque in a patient with asbestos induced pleural disease: a case report.
</td>
<td style="text-align:left;">
J Occup Med Toxicol
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review.
</td>
<td style="text-align:left;">
Radiother Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical staging of malignant pleural mesothelioma: current perspectives.
</td>
<td style="text-align:left;">
Lung Cancer (Auckl)
</td>
</tr>
<tr>
<td style="text-align:left;">
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
</td>
<td style="text-align:left;">
Lancet Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Radiotherapy for the treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lancet Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Secondary hypertrophic osteoarthropathy caused by non-pleural or pulmonary tumors.
</td>
<td style="text-align:left;">
Medicine (Baltimore)
</td>
</tr>
<tr>
<td style="text-align:left;">
The epithelioid BAP1-negative and p16-positive phenotype predicts prolonged survival in pleural mesothelioma.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion.
</td>
<td style="text-align:left;">
Lung
</td>
</tr>
<tr>
<td style="text-align:left;">
Role of new radiation techniques in the treatment of pleural mesothelioma.
</td>
<td style="text-align:left;">
Thorac Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Determination of PD-L1 expression in effusions from mesothelioma by immuno-cytochemical staining.
</td>
<td style="text-align:left;">
Cancer Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
The value of delayed phase enhanced imaging in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Mesothelioma].
</td>
<td style="text-align:left;">
Pathologe
</td>
</tr>
<tr>
<td style="text-align:left;">
Loss of BRCA1-associated protein 1 (BAP1) expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
New Concepts in the Treatment of Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Annu. Rev. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemistry in Peritoneal Mesothelioma: A Single-Center Experience of 244 Cases.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Extended pleurectomy decortication for malignant pleural mesothelioma in the elderly: the need for an inclusive yet selective approach.
</td>
<td style="text-align:left;">
Interact Cardiovasc Thorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
[Loss of BRCA associated protein 1 expression in malignant mesothelioma and its diagnostic application].
</td>
<td style="text-align:left;">
Zhonghua Bing Li Xue Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.
</td>
<td style="text-align:left;">
Cancer Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Cutaneous Presentation of Mesothelioma With a Sarcomatoid Transformation.
</td>
<td style="text-align:left;">
Am J Dermatopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Role of thoracoscopy, mediastinoscopy and laparoscopy in the diagnosis and staging of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Vis Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
</td>
<td style="text-align:left;">
Dis. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service.
</td>
<td style="text-align:left;">
J Clin Pharm Ther
</td>
</tr>
<tr>
<td style="text-align:left;">
Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgical and non-surgical management of malignant pleural effusions.
</td>
<td style="text-align:left;">
Expert Rev Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a/Arf).
</td>
<td style="text-align:left;">
Curr. Biol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytological Profile of a Case of Malignant Mesothelioma of Pleura with Supraclavicular Lymph Node Metastasis.
</td>
<td style="text-align:left;">
J Cytol
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma in Australia: a review.
</td>
<td style="text-align:left;">
Med. J. Aust.
</td>
</tr>
<tr>
<td style="text-align:left;">
<i>Ex vivo</i> evaluation of tumor cell specific drug responses in malignant pleural effusions.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Pleural Mesothelioma: Diagnosis, Staging, Pitfalls and Follow-up.
</td>
<td style="text-align:left;">
Semin. Ultrasound CT MR
</td>
</tr>
<tr>
<td style="text-align:left;">
The importance of serum and pleural fluid level of vascular endothelial growth factor (VEGF) and VEGF fluid/serum ratio in the differential diagnosis of malignant mesothelioma-related pleural effusion.
</td>
<td style="text-align:left;">
Contemp Oncol (Pozn)
</td>
</tr>
<tr>
<td style="text-align:left;">
Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Sci Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
A Case of the Resected Lymphohistiocytoid Mesothelioma: BAP1 Is a Key of Accurate Diagnosis.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population.
</td>
<td style="text-align:left;">
Dis. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
Sudden death as the initial manifestation of diffuse pleural mesothelioma.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy.
</td>
<td style="text-align:left;">
Ann. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth.
</td>
<td style="text-align:left;">
Front Immunol
</td>
</tr>
<tr>
<td style="text-align:left;">
Recent Advances in the Diagnosis of Malignant Mesothelioma: Focus on Approach in Challenging Cases and in Limited Tissue and Cytologic Samples.
</td>
<td style="text-align:left;">
Adv Anat Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Targeting CXCR4 with [<sup>68</sup>Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos fibre burden in gallbladder: A case study.
</td>
<td style="text-align:left;">
Micron
</td>
</tr>
<tr>
<td style="text-align:left;">
The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure.
</td>
<td style="text-align:left;">
Occup Environ Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[Is malignant mesothelioma of the pleura only an occupational disease?].
</td>
<td style="text-align:left;">
Minerva Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
A Nomogram to Predict Prognosis in Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
World J Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malign pleural mesothelioma - so far an undefeated tumor].
</td>
<td style="text-align:left;">
Vnitr Lek
</td>
</tr>
<tr>
<td style="text-align:left;">
Minor regression and long-time survival (56 months) in a patient with malignant pleural mesothelioma under Viscum album and Helleborus niger extracts-a case report.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients.
</td>
<td style="text-align:left;">
Biomark Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Pseudomesotheliomatous carcinoma of the lung.
</td>
<td style="text-align:left;">
Vojnosanit Pregl
</td>
</tr>
<tr>
<td style="text-align:left;">
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma in situ.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma as a difficult interdisciplinary problem.
</td>
<td style="text-align:left;">
Kardiochir Torakochirurgia Pol
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma With a Large Prevascular Lymph Node: N1 Involvement or Something Different?
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression analysis of HMGB1 in histological samples of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Vascular endothelial growth factor in pleural effusions and correlation with radiologic and biochemical parameters.
</td>
<td style="text-align:left;">
Niger J Clin Pract
</td>
</tr>
<tr>
<td style="text-align:left;">
Progress and challenges in Mesothelioma: From bench to bedside.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma with squamous differentiation.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Int J Mol Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma presenting with remitting-relapsing pleural effusions: report of two cases.
</td>
<td style="text-align:left;">
Respirol Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: A preliminary study.
</td>
<td style="text-align:left;">
Eur J Surg Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Imaging of malignant pleural mesothelioma: it is possible a screening or early diagnosis program?-a systematic review about the use of screening programs in a population of asbestos exposed workers.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Endoscopic diagnosis and management of pleural effusion in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgery for malignant pleural mesothelioma: an international guidelines review.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Diaphragmatic and pericardial reconstruction after surgery for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Serum mesothelin and other biomarkers: what have we learned in the last decade?
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Macroscopic complete resection is not associated with improved survival in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
</td>
<td style="text-align:left;">
Ann. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Progress in the Management of Malignant Pleural Mesothelioma in 2017.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression.
</td>
<td style="text-align:left;">
Front Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion.
</td>
<td style="text-align:left;">
Mol. Ther.
</td>
</tr>
<tr>
<td style="text-align:left;">
Updates in the diagnosis and treatment of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Low-dose chest computed tomography screening of subjects exposed to asbestos.
</td>
<td style="text-align:left;">
Eur J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications.
</td>
<td style="text-align:left;">
J. Natl. Cancer Inst.
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary Spinal Malignant Mesothelioma: A Case Report and Literature Review.
</td>
<td style="text-align:left;">
World Neurosurg
</td>
</tr>
<tr>
<td style="text-align:left;">
SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Clin Transl Radiat Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Utility of Site-Specific Biopsy for Diagnosis of Desmoplastic Malignant Mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis.
</td>
<td style="text-align:left;">
BMC Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Randomised controlled trial to compare the diagnostic yield of positron emission tomography CT (PET-CT) TARGETed pleural biopsy versus CT-guided pleural biopsy in suspected pleural malignancy (TARGET trial).
</td>
<td style="text-align:left;">
BMJ Open Respir Res
</td>
</tr>
<tr>
<td style="text-align:left;">
The current aetiology of malignant pleural effusion in the Western Cape Province, South Africa.
</td>
<td style="text-align:left;">
S. Afr. Med. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Front Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Ugeskr. Laeg.
</td>
</tr>
<tr>
<td style="text-align:left;">
MiR-21 over-expression and Programmed Cell Death 4 down-regulation features malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Increased micronucleus count predicts malignant behavior in pleural effusion fluid
</td>
<td style="text-align:left;">
Turk J Med Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
On the diagnosis of malignant pleural mesothelioma: A necropsy-based study of 171 cases (1997-2016).
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma presenting as recurrent hydro-pneumothorax: An atypical case presentation and literature review.
</td>
<td style="text-align:left;">
Respir Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression of plakophilin 3 in diffuse malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Histol. Histopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
How to assess the best immunohistochemical panel in the diagnosis of malignant pleural mesothelioma in a pathology lab.
</td>
<td style="text-align:left;">
J Immunoassay Immunochem
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnostic role of BAP1 in serous effusions.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States.
</td>
<td style="text-align:left;">
Clin Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
<sup>18</sup>F-fluorodeoxyglucose imaging of primary malignant pericardial mesothelioma with concurrent pericardial and pleural effusions and bone metastasis: A case report.
</td>
<td style="text-align:left;">
Mol Clin Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience.
</td>
<td style="text-align:left;">
Intern Med J
</td>
</tr>
<tr>
<td style="text-align:left;">
Aquaporin-1 expression in fluoro-edenite-induced mesothelioma effusions: An approach by cell-block procedure.
</td>
<td style="text-align:left;">
Cytopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Proton beam therapy for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Transl Lung Cancer Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Air in the Pleural Cavity Enhances Detection of Pleural Abnormalities by CT Scan.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Integrated Histogenetic Analysis Reveals <i>BAP1</i>-Mutated Epithelioid Mesothelioma in a Patient With Cancer of Unknown Primary.
</td>
<td style="text-align:left;">
J Natl Compr Canc Netw
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype.
</td>
<td style="text-align:left;">
EuPA Open Proteom
</td>
</tr>
<tr>
<td style="text-align:left;">
Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on.
</td>
<td style="text-align:left;">
Cancers (Basel)
</td>
</tr>
<tr>
<td style="text-align:left;">
[Computed tomographic findings in diffuse malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Rofo
</td>
</tr>
<tr>
<td style="text-align:left;">
Multisensor Imaging-From Sample Preparation to Integrated Multimodal Interpretation of LA-ICPMS and MALDI MS Imaging Data.
</td>
<td style="text-align:left;">
Anal. Chem.
</td>
</tr>
<tr>
<td style="text-align:left;">
Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population.
</td>
<td style="text-align:left;">
Int J Med Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
The Diagnosis of Pleural Tumors Other Than Mesothelioma.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: Ten Years of Clinical Experience in Relation to International Guidelines.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
ERS/EACTS statement on the management of malignant pleural effusions.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
ERS/EACTS statement on the management of malignant pleural effusions.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Genomics and Epigenetics of Malignant Mesothelioma.
</td>
<td style="text-align:left;">
High Throughput
</td>
</tr>
<tr>
<td style="text-align:left;">
Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.
</td>
<td style="text-align:left;">
J. Formos. Med. Assoc.
</td>
</tr>
<tr>
<td style="text-align:left;">
The Economic Impact of Clinical Research in an Italian Public Hospital: The Malignant Pleural Mesothelioma Case Study.
</td>
<td style="text-align:left;">
Int J Health Policy Manag
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Pleural Mesothelioma, Biphasic Type: An Unusual and Insidious Case of Rapidly Progressive Small Blue Cell Tumor.
</td>
<td style="text-align:left;">
Cureus
</td>
</tr>
<tr>
<td style="text-align:left;">
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgery in Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin.
</td>
<td style="text-align:left;">
Multidiscip Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications.
</td>
<td style="text-align:left;">
Pathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
In Vivo
</td>
</tr>
<tr>
<td style="text-align:left;">
Ancillary studies in pleural, pericardial, and peritoneal effusion cytology.
</td>
<td style="text-align:left;">
Cancer Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma. Value of 67Ga scintigraphy compared to computerized tomography].
</td>
<td style="text-align:left;">
Rofo
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural malignant mesothelioma following Wilms’ tumor.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Updates in Effusion Cytology.
</td>
<td style="text-align:left;">
Surg Pathol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression of Numb and Gli1 in malignant pleural mesothelioma and their clinical significance.
</td>
<td style="text-align:left;">
J Cancer Res Ther
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
</td>
<td style="text-align:left;">
Wien. Klin. Wochenschr.
</td>
</tr>
<tr>
<td style="text-align:left;">
Intensity-modulated radiotherapy is a safe and effective treatment for localized malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Thorac Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs.
</td>
<td style="text-align:left;">
Clin Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Four-miRNA Signature to Identify Asbestos-Related Lung Malignancies.
</td>
<td style="text-align:left;">
Cancer Epidemiol. Biomarkers Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
What’s new in mesothelioma.
</td>
<td style="text-align:left;">
Pathologica
</td>
</tr>
<tr>
<td style="text-align:left;">
Investigating unilateral pleural effusions: the role of cytology.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Tumor-specific genetic variants can be detected in circulating cell-free DNA of malignant pleural mesothelioma patients.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypes.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].
</td>
<td style="text-align:left;">
Rev Pneumol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Pleural Mesothelioma presenting with Cardiac Tamponade- A Rare Case report and Review of the literature.
</td>
<td style="text-align:left;">
Clin Case Rep Rev
</td>
</tr>
<tr>
<td style="text-align:left;">
Quantitative mass spectrometry to identify protein markers for diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Proteomics
</td>
</tr>
<tr>
<td style="text-align:left;">
Genomic Deletion of <i>BAP1</i> and <i>CDKN2A</i> Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures.
</td>
<td style="text-align:left;">
Int J Mol Sci
</td>
</tr>
<tr>
<td style="text-align:left;">
Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis.
</td>
<td style="text-align:left;">
Mol. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemical evaluation of nuclear 5-hydroxymethylcytosine (5-hmC) accurately distinguishes malignant pleural mesothelioma from benign mesothelial proliferations.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification.
</td>
<td style="text-align:left;">
J Transl Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma: The role of surgery].
</td>
<td style="text-align:left;">
Rev Pneumol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis of malignant pleural mesothelioma from pleural fluid by Fourier transform-infrared spectroscopy coupled with chemometrics.
</td>
<td style="text-align:left;">
J Biomed Opt
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelin as a target for cervical cancer therapy.
</td>
<td style="text-align:left;">
Arch. Gynecol. Obstet.
</td>
</tr>
<tr>
<td style="text-align:left;">
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
</td>
<td style="text-align:left;">
Ther Adv Respir Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis of malignant pleural mesothelioma from pleural fluid by Fourier transform-infrared spectroscopy coupled with chemometrics (Erratum).
</td>
<td style="text-align:left;">
J Biomed Opt
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical significance of serum DRAM1 mRNA, ARSA mRNA, hsa-miR-2053 and lncRNA-RP1-86D1.3 axis expression in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Cell. Biochem.
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracic aortic endografts used to resect the left subclavian artery infiltrated by malignant tumours.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma in Finland: regional and gender variation.
</td>
<td style="text-align:left;">
Acta Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Differential Survival Characteristics of Sarcomatoid Subtype in Biphasic Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
An unusual case of chylothorax.
</td>
<td style="text-align:left;">
Respir Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies.
</td>
<td style="text-align:left;">
Tumour Biol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary malignant pleural tumors (mesotheliomas) presenting as localized masses. Fine needle aspiration cytologic findings, clinical and radiologic features and review of the literature.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Establishment and characterization of CRISPR/Cas9-mediated NF2<sup>-/-</sup> human mesothelial cell line: Molecular insight into fibroblast growth factor receptor 2 in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Real-life treatment practice for malignant pleural mesothelioma in Belgium.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[The German Mesothelioma Register : Current pathological diagnostics and services].
</td>
<td style="text-align:left;">
Pathologe
</td>
</tr>
<tr>
<td style="text-align:left;">
Soluble AXL is ubiquitously present in malignant serous effusions.
</td>
<td style="text-align:left;">
Gynecol. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review.
</td>
<td style="text-align:left;">
Transl Lung Cancer Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant peritoneal mesothelioma: a review.
</td>
<td style="text-align:left;">
Transl Lung Cancer Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations.
</td>
<td style="text-align:left;">
Transl Lung Cancer Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Is there a role for prophylactic radiotherapy to intervention tract sites in patients with malignant pleural mesothelioma?
</td>
<td style="text-align:left;">
Transl Lung Cancer Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Oncologist
</td>
</tr>
<tr>
<td style="text-align:left;">
A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Photochem. Photobiol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Deciduoid type malignant pleural mesothelioma: a case report.
</td>
<td style="text-align:left;">
AME Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Management of database: European Society of Thoracic Surgeons mesothelioma database-difficulties in improving quality data for rare tumour.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma: rare and aggressive but with new therapeutic perspectives].
</td>
<td style="text-align:left;">
Rev Prat
</td>
</tr>
<tr>
<td style="text-align:left;">
Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
</td>
<td style="text-align:left;">
AJR Am J Roentgenol
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of BRCA1-associated protein 1 in the diagnosis of malignant mesothelioma in effusion and fine-needle aspiration cytology.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Simultaneous presence of lung adenocarcinoma and malignant pleural mesothelioma: A case report.
</td>
<td style="text-align:left;">
Respir Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Nodules and masses are associated with malignant pleural effusion in dogs and cats but many other intrathoracic CT features are poor predictors of the effusion type.
</td>
<td style="text-align:left;">
Vet Radiol Ultrasound
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the pleura.
</td>
<td style="text-align:left;">
Mayo Clin. Proc.
</td>
</tr>
<tr>
<td style="text-align:left;">
Case report: Steroid responsive mesothelioma-related pleural effusion.
</td>
<td style="text-align:left;">
Respir Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India.
</td>
<td style="text-align:left;">
Indian J Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review.
</td>
<td style="text-align:left;">
Front Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Heparanase inhibitors restrain mesothelioma.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic Accuracy of a Limited Immuno-panel of Calretinin and Ber-EP4 for Diagnosis of Malignant Effusions.
</td>
<td style="text-align:left;">
J Coll Physicians Surg Pak
</td>
</tr>
<tr>
<td style="text-align:left;">
Return to work after surgical treatment for malignant pleural mesothelioma: report of a case.
</td>
<td style="text-align:left;">
Gen Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Semin. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database.
</td>
<td style="text-align:left;">
Carcinogenesis
</td>
</tr>
<tr>
<td style="text-align:left;">
ADAM10 mediates malignant pleural mesothelioma invasiveness.
</td>
<td style="text-align:left;">
Oncogene
</td>
</tr>
<tr>
<td style="text-align:left;">
Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs.
</td>
<td style="text-align:left;">
Pract Radiat Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial.
</td>
<td style="text-align:left;">
Thorax
</td>
</tr>
<tr>
<td style="text-align:left;">
Useful Application of Immunostaining to Malignant Pleural Effusion among Lao People in Vientiane Capital, Lao PDR
</td>
<td style="text-align:left;">
Asian Pac. J. Cancer Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Managing malignant pleural mesothelioma: experience and perceptions of health care professionals caring for people with mesothelioma.
</td>
<td style="text-align:left;">
Support Care Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Histomorphological and Immunohistochemical Analysis of Pleural Neoplasms.
</td>
<td style="text-align:left;">
Iran J Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
First report of probe based confocal laser endomicroscopy during medical thoracoscopy.
</td>
<td style="text-align:left;">
Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized malignant pleural mesothelioma arising in the interlobar fissure: a unique surgical case masquerading clinicopathologically as primary lung adenocarcinoma.
</td>
<td style="text-align:left;">
SAGE Open Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
[Possibilities of cytological diagnosis of the nature of the exudate at the stage of emergency.]
</td>
<td style="text-align:left;">
Klin. Lab. Diagn.
</td>
</tr>
<tr>
<td style="text-align:left;">
Multiple sclerosis outcomes after cancer immunotherapy.
</td>
<td style="text-align:left;">
Clin Transl Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Revisiting localized malignant mesothelioma.
</td>
<td style="text-align:left;">
Ann Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
About the diagnostic value of BAP-1 antibody in malignant pleural mesothelioma: a meta-analysis.
</td>
<td style="text-align:left;">
J Immunoassay Immunochem
</td>
</tr>
<tr>
<td style="text-align:left;">
Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Front Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
A 75 year old male with recurrent unilateral pleural effusion and positive ANA.
</td>
<td style="text-align:left;">
Respir Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Cryobiopsy during flex-rigid pleuroscopy: an emerging alternative biopsy method in malignant pleural mesothelioma. A comparative study of pathology.
</td>
<td style="text-align:left;">
Jpn. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
The importance of FISH signal cut-off values for 9p21 deletion in malignant pleural mesothelioma: Is it underestimated?
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
Body composition and nutritional status in malignant pleural mesothelioma: implications for activity levels and quality of life.
</td>
<td style="text-align:left;">
Eur J Clin Nutr
</td>
</tr>
<tr>
<td style="text-align:left;">
In commemoration of the 2018 Mataro Nagayo Prize: A road to early diagnosis and monitoring of asbestos-related mesothelioma.
</td>
<td style="text-align:left;">
Cancer Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Chemosensitivity and resistance testing in malignant effusions with focus on primary malignant mesothelioma and metastatic adenocarcinoma.
</td>
<td style="text-align:left;">
Pleura Peritoneum
</td>
</tr>
<tr>
<td style="text-align:left;">
Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
</td>
<td style="text-align:left;">
Medicine (Baltimore)
</td>
</tr>
<tr>
<td style="text-align:left;">
The forensic significance of pseudomesotheliomatous adenocarcinoma of the lung.
</td>
<td style="text-align:left;">
Forensic Sci Med Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
New marker for mesothelioma: an immunoperoxidase study.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Bilateral diffuse pulmonary infiltrates secondary to malignant peritoneal mesothelioma - A rare clinical presentation.
</td>
<td style="text-align:left;">
Respir Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracic Hyper-IgG4-Related Disease Mimicking Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Lung
</td>
</tr>
<tr>
<td style="text-align:left;">
Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Int. J. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pseudomesotheliomatous Carcinoma with a High Pleural Hyaluronic Acid Concentration Arising from a Primary Esophageal Squamous Cell Carcinoma.
</td>
<td style="text-align:left;">
Am J Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
A survey of patient and caregiver experience with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Support Care Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysis.
</td>
<td style="text-align:left;">
Medicine (Baltimore)
</td>
</tr>
<tr>
<td style="text-align:left;">
Endobronchial ultrasound-guided transbronchial needle aspiration mediastinal lymph node staging in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Extra-pleural pneumonectomy in the era of image-guided intensity-modulated radiotherapy.
</td>
<td style="text-align:left;">
Radiol Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy.
</td>
<td style="text-align:left;">
Proc. Natl. Acad. Sci. U.S.A.
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary malignant mesothelioma of the diaphragm with liver invasion: A case report and review of literature.
</td>
<td style="text-align:left;">
Medicine (Baltimore)
</td>
</tr>
<tr>
<td style="text-align:left;">
Management of Malignant Pleural Mesothelioma in the Elderly Population.
</td>
<td style="text-align:left;">
Ann. Surg. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Role of Ancillary Techniques in Fluid Cytology.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
A Rare Case of Malignant Mesothelioma Presenting with Systemic Lupus Erythematosus Seropositivity: A Case Report and Review of Literature.
</td>
<td style="text-align:left;">
Cureus
</td>
</tr>
<tr>
<td style="text-align:left;">
Metastatic Clear Cell Renal Carcinoma Without Evidence of a Primary Renal Tumour Mimicking Advanced Stage of Malignant Lung Tumour.
</td>
<td style="text-align:left;">
Klin Onkol
</td>
</tr>
<tr>
<td style="text-align:left;">
50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience.
</td>
<td style="text-align:left;">
Ann. Surg. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Confocal Laser Endomicroscopy as a Guidance Tool for Pleural Biopsies in Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis and characterization of malignant effusions through pleural fluid cytological examination.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Advances in pulmonary and pleural malignant disorders.
</td>
<td style="text-align:left;">
Clin Med (Lond)
</td>
</tr>
<tr>
<td style="text-align:left;">
Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial.
</td>
<td style="text-align:left;">
BMJ Open
</td>
</tr>
<tr>
<td style="text-align:left;">
The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Signet ring cell mesothelioma; A diagnostic challenge.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
MicroRNA profiling in serous cavity specimens: Diagnostic challenges and new opportunities.
</td>
<td style="text-align:left;">
Cancer Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of BRCA1-associated protein-1, glucose transporter-1 and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusions.
</td>
<td style="text-align:left;">
Cytopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Advances in pathological diagnosis of mesothelioma: what pulmonologists should know.
</td>
<td style="text-align:left;">
Curr Opin Pulm Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Communication of a mesothelioma diagnosis: developing recommendations to improve the patient experience.
</td>
<td style="text-align:left;">
BMJ Open Respir Res
</td>
</tr>
<tr>
<td style="text-align:left;">
The Prevalence and Clinical Relevance of Nonexpandable Lung in Malignant Pleural Mesothelioma. A Prospective, Single-Center Cohort Study of 229 Patients.
</td>
<td style="text-align:left;">
Ann Am Thorac Soc
</td>
</tr>
<tr>
<td style="text-align:left;">
Evaluation of Matrix Metalloproteinase 9 Serum Concentration as a Biomarker in Malignant Mesothelioma.
</td>
<td style="text-align:left;">
Dis. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
Biomarkers for detecting malignant pleural mesothelioma: Protocol for a reanalysis of published data based on systematic reviews of diagnostic test accuracy.
</td>
<td style="text-align:left;">
Medicine (Baltimore)
</td>
</tr>
<tr>
<td style="text-align:left;">
Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting ‘Direct to LAT’ in selected groups.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Breath Analysis: A Systematic Review of Volatile Organic Compounds (VOCs) in Diagnostic and Therapeutic Management of Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Cancers (Basel)
</td>
</tr>
<tr>
<td style="text-align:left;">
Prospective Study of the Utility of Computed Tomography Triage of Pleural Biopsy Strategies in Patients With Pleural Diseases.
</td>
<td style="text-align:left;">
J Bronchology Interv Pulmonol
</td>
</tr>
<tr>
<td style="text-align:left;">
In Silico Transcriptomic Analysis of Wound-Healing-Associated Genes in Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Medicina (Kaunas)
</td>
</tr>
<tr>
<td style="text-align:left;">
An asbestos contaminated town in the vicinity of an asbestos-cement facility: The case study of Sibaté, Colombia.
</td>
<td style="text-align:left;">
Environ. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Pleural Mesothelioma: A Multi-Disciplinary Approach.
</td>
<td style="text-align:left;">
Gulf J Oncolog
</td>
</tr>
<tr>
<td style="text-align:left;">
Long term survival and perioperative propensity score matched outcomes of diaphragmatic resections compared to stripping in cytoreductive surgery + intra-peritoneal chemotherapy.
</td>
<td style="text-align:left;">
Am. J. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Lung
</td>
</tr>
<tr>
<td style="text-align:left;">
Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas.
</td>
<td style="text-align:left;">
Mod. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant deciduoid mesothelioma: a rare variant of epithelioid mesothelioma.
</td>
<td style="text-align:left;">
BMJ Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Metastatic Pleural Effusion: An Unusual Presentation of Urothelial Bladder Carcinoma.
</td>
<td style="text-align:left;">
Cureus
</td>
</tr>
<tr>
<td style="text-align:left;">
Prostate Carcinoma and Pleural Mesothelioma: An Extremely Rare Co-occurrence.
</td>
<td style="text-align:left;">
Cureus
</td>
</tr>
<tr>
<td style="text-align:left;">
Perioperative anesthetic management of patients with malignant pleural mesothelioma undergoing cytoreductive surgery and intraoperative chemotherapy.
</td>
<td style="text-align:left;">
Rev Esp Anestesiol Reanim
</td>
</tr>
<tr>
<td style="text-align:left;">
The Oncolytic Virus <i>dl</i>922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth.
</td>
<td style="text-align:left;">
Front Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Heterologous sarcomatoid pleural mesothelioma with osteosarcomatous differentiation: a report of autopsy case that accomplished trimodality therapy and review of the literature.
</td>
<td style="text-align:left;">
Gen Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma of the tunica vaginalis testis.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Differential Diagnosis of Epithelioid Malignant Mesothelioma With Lung and Breast Pleural Metastasis: A Systematic Review Compared With a Standardized Panel of Antibodies-A New Proposal That May Influence Pathologic Practice.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Bidirectional chemotherapy allowing surgery and HIPEC for malignant peritoneal mesothelioma.
</td>
<td style="text-align:left;">
Pleura Peritoneum
</td>
</tr>
<tr>
<td style="text-align:left;">
Multidisciplinary palliative treatment including isolated thoracic perfusion for progressive malignant pleural mesothelioma: a retrospective observational study.
</td>
<td style="text-align:left;">
J BUON
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Pleural Effusion and Its Current Management: A Review.
</td>
<td style="text-align:left;">
Medicina (Kaunas)
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleuroscopy or video-assisted thoracoscopic surgery for exudative pleural effusion: a comparative overview.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives.
</td>
<td style="text-align:left;">
Front Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions.
</td>
<td style="text-align:left;">
Dis. Markers
</td>
</tr>
<tr>
<td style="text-align:left;">
Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology Annual meeting, part 2: effusion cytology with focus on theranostics and diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
J Am Soc Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Monoclonal Caveolin 1 Expression in the Differential Diagnosis of Malignant Pleural Mesothelioma and Pulmonary Adenocarcinoma: Is it Useful?
</td>
<td style="text-align:left;">
Pathol. Oncol. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Molecular Testing on Pleural Fluid Samples.
</td>
<td style="text-align:left;">
Semin Respir Crit Care Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Mesothelioma: Has Anything Changed?
</td>
<td style="text-align:left;">
Semin Respir Crit Care Med
</td>
</tr>
<tr>
<td style="text-align:left;">
The Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion.
</td>
<td style="text-align:left;">
Iran J Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Anaplastic thyroid carcinoma mimicking a malignant pleural mesothelioma: Clues for diagnosis.
</td>
<td style="text-align:left;">
Thorac Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Modified Liquid-Based Cytology Technique for Immunocytochemistry in Effusion Specimen.
</td>
<td style="text-align:left;">
Asian Pac. J. Cancer Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience.
</td>
<td style="text-align:left;">
Clin Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma in construction workers: the Apulia regional mesothelioma register, Southern Italy.
</td>
<td style="text-align:left;">
BMC Res Notes
</td>
</tr>
<tr>
<td style="text-align:left;">
In-vivo imaging of methionine metabolism in patients with suspected malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Nucl Med Commun
</td>
</tr>
<tr>
<td style="text-align:left;">
Establishment and characterization of human malignant pleural mesothelioma cell line SMC-1.
</td>
<td style="text-align:left;">
Sci. Sin., Ser. B, Chem. Biol. Agric. Med. Earth Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Effects of the Storage Solution Type and Prolonged Storage on the Immunoreactivity of Cells.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Treatment of Malignant Peritoneal Mesothelioma.
</td>
<td style="text-align:left;">
Klin Onkol
</td>
</tr>
<tr>
<td style="text-align:left;">
Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy.
</td>
<td style="text-align:left;">
Front Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Mesothelioma - Report of Two Cases with Different Presentations.
</td>
<td style="text-align:left;">
Indian J Occup Environ Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study.
</td>
<td style="text-align:left;">
Ann. Surg. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Elevated Adenosine Dehydrogenase (ADH) and Positive Tuberculin Test Firstly Misdiagnosed as Tuberculous Pleural Effusion Finally Proved as Pleural Mesothelial Sarcoma by Thoracoscopic Biopsy Pathology: a Case Report and Literature Review.
</td>
<td style="text-align:left;">
Clin. Lab.
</td>
</tr>
<tr>
<td style="text-align:left;">
Posterior Intercostal Lymph Nodes Double Recurrence and Death Risk in Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Role of the contrast-enhanced spectral mammography for the diagnosis of breast metastases from extramammary neoplasms.
</td>
<td style="text-align:left;">
J BUON
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic Value of Computed Tomography Imaging Features in Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
Detection of Anaplastic Lymphoma Kinase-Rearranged Mesothelioma Cells in Ascites by Companion Diagnostics.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Multicystic peritoneal mesothelioma: a systematic review of the literature.
</td>
<td style="text-align:left;">
Pleura Peritoneum
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report.
</td>
<td style="text-align:left;">
Virchows Arch.
</td>
</tr>
<tr>
<td style="text-align:left;">
Current treatment strategies in malignant pleural mesothelioma with a treatment algorithm.
</td>
<td style="text-align:left;">
Adv Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[The occurrence of asbestos-related diseases among former employees of asbestos processing plants in Poland].
</td>
<td style="text-align:left;">
Med Pr
</td>
</tr>
<tr>
<td style="text-align:left;">
Intrapleural urokinase directly under medical thoracoscopy for the diagnosis of tuberculous pleurisy.
</td>
<td style="text-align:left;">
Respirol Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Fibrolipoma of the left ventricle: an uncommon incidental autopsy finding.
</td>
<td style="text-align:left;">
Forensic Sci Med Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With Mesothelioma.
</td>
<td style="text-align:left;">
J Thorac Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Long-term benefit from immune modulation and anti-inflammatory treatment in metastatic mesothelioma.
</td>
<td style="text-align:left;">
Respir Med Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
MiR-4766-5p Inhibits The Development And Progression Of Gastric Cancer By Targeting NKAP.
</td>
<td style="text-align:left;">
Onco Targets Ther
</td>
</tr>
<tr>
<td style="text-align:left;">
Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Impact of an asbestos cement factory on mesothelioma incidence in a community in Italy.
</td>
<td style="text-align:left;">
Environ. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma - Comparison with contrast-enhanced CT.
</td>
<td style="text-align:left;">
Oncotarget
</td>
</tr>
<tr>
<td style="text-align:left;">
[How I manage… Malignant pleural mesothelioma in 2019].
</td>
<td style="text-align:left;">
Rev Med Liege
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Diffuse Mesothelioma in Women: A Study of 354 Cases.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
A gene-expression-based test can outperform bap1 and <i>p16</i> analyses in the differential diagnosis of pleural mesothelial proliferations.
</td>
<td style="text-align:left;">
Oncol Lett
</td>
</tr>
<tr>
<td style="text-align:left;">
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice.
</td>
<td style="text-align:left;">
J Vis Exp
</td>
</tr>
<tr>
<td style="text-align:left;">
LOX family and ZFPM2 as novel diagnostic biomarkers for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Biomark Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Dosimetric Comparison of Lung-Sparing Radiation Therapy between Volumetric Arc Therapy and Helical Tomotherapy for Unresectable Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Biomed Res Int
</td>
</tr>
<tr>
<td style="text-align:left;">
Not everything is what it seems: malignant pleural mesothelioma mimicking lung cancer.
</td>
<td style="text-align:left;">
Adv Respir Med
</td>
</tr>
<tr>
<td style="text-align:left;">
99mTc-HDP Bone Scintigraphy, SPECT/CT, and 18F-FDG PET/CT Diagnosis Imaging of Incidental Pleural Mesothelioma in a Patient With Biochemical Recurrences of Prostate Cancer: Is it Really a Coincidence?
</td>
<td style="text-align:left;">
Clin Nucl Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Gen Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
18F-fluorodeoxyglucose positron emission tomography in malignant pleural mesothelioma: diagnostic and prognostic performance and its correlation to pathological results.
</td>
<td style="text-align:left;">
Interact Cardiovasc Thorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis of Mesothelioma.
</td>
<td style="text-align:left;">
Surg Pathol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
Differential Diagnosis of Malignant Pleural Mesothelioma on Cytology: A Gene Expression Panel versus BRCA1-Associated Protein 1 and p16 Tests.
</td>
<td style="text-align:left;">
J Mol Diagn
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytologic presentation of malignant mesothelioma in pleural effusions.
</td>
<td style="text-align:left;">
Exp. Cell Biol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Endoscopic ultrasound-guided pleural biopsy in the hands of the pulmonologist.
</td>
<td style="text-align:left;">
Respirol Case Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Effusion cytology of malignant mesothelioma enables earlier diagnosis and recognizes patients with better prognosis.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Exhaled Breath Analysis in Diagnosis of Malignant Pleural Mesothelioma: Systematic Review.
</td>
<td style="text-align:left;">
Int J Environ Res Public Health
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines.
</td>
<td style="text-align:left;">
Clin Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of serum biochemical markers in patients with mesothelioma and pleural plaques versus healthy individuals exposed to environmental asbestos.
</td>
<td style="text-align:left;">
Turk Gogus Kalp Damar Cerrahisi Derg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981-1985.
</td>
<td style="text-align:left;">
Klin. Wochenschr.
</td>
</tr>
<tr>
<td style="text-align:left;">
Routine surveillance for diagnosis of venous thromboembolism after pleurectomy for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
J. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma cells secrete natriuretic peptides: Data and diagnostic clinical implications.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
Evaluation of gene expression levels in the diagnosis of lung adenocarcinoma and malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Turk Gogus Kalp Damar Cerrahisi Derg
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma following repeated exposures to cosmetic talc: A case series of 75 patients.
</td>
<td style="text-align:left;">
Am. J. Ind. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Intramedullary Metastasis to the Cervical Spinal Cord from Malignant Pleural Mesothelioma: Review of the Literature and Case Reports.
</td>
<td style="text-align:left;">
Asian J Neurosurg
</td>
</tr>
<tr>
<td style="text-align:left;">
Utility of Claudin-4 versus BerEP4 and B72.3 in pleural fluids with metastatic lung adenocarcinoma.
</td>
<td style="text-align:left;">
J Am Soc Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Short and long term behaviour of pleural effusion cultures. (Report of 200 cases) (author’s transl)].
</td>
<td style="text-align:left;">
Pathol. Biol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Application of immunohistochemistry in diagnosis and management of malignant mesothelioma.
</td>
<td style="text-align:left;">
Transl Lung Cancer Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Not gene therapy, but genetic surgery-the right strategy to attack cancer.
</td>
<td style="text-align:left;">
Mol. Gen. Microbiol. Virol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibition.
</td>
<td style="text-align:left;">
Sci Rep
</td>
</tr>
<tr>
<td style="text-align:left;">
Differentiating Between Malignant Mesothelioma and Other Pleural Lesions Using Fourier Transform Infrared Spectroscopy.
</td>
<td style="text-align:left;">
Appl Spectrosc
</td>
</tr>
<tr>
<td style="text-align:left;">
Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation.
</td>
<td style="text-align:left;">
Front Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Modulation of microRNA expression levels after naturally occurring asbestiform fibers exposure as a diagnostic biomarker of mesothelial neoplastic transformation.
</td>
<td style="text-align:left;">
Ecotoxicol. Environ. Saf.
</td>
</tr>
<tr>
<td style="text-align:left;">
Extracellular vesicles as biomarkers in malignant pleural mesothelioma: A review.
</td>
<td style="text-align:left;">
Crit. Rev. Oncol. Hematol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy.
</td>
<td style="text-align:left;">
Eur. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic and clinicopathological utility of programmed death-ligand 1 in malignant pleural mesothelioma: A meta-analysis.
</td>
<td style="text-align:left;">
Int. Immunopharmacol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome.
</td>
<td style="text-align:left;">
Cancer Genomics Proteomics
</td>
</tr>
<tr>
<td style="text-align:left;">
Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas.
</td>
<td style="text-align:left;">
Pathobiology
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge.
</td>
<td style="text-align:left;">
Cancers (Basel)
</td>
</tr>
<tr>
<td style="text-align:left;">
Breath Analysis for Early Detection of Malignant Pleural Mesothelioma: Volatile Organic Compounds (VOCs) Determination and Possible Biochemical Pathways.
</td>
<td style="text-align:left;">
Cancers (Basel)
</td>
</tr>
<tr>
<td style="text-align:left;">
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Breast metastasis as the initial presentation of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Breast J
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant asbestos-related disease in a population exposed to asbestos.
</td>
<td style="text-align:left;">
Am. J. Ind. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Estimate of environmental and occupational components in the spatial distribution of malignant mesothelioma incidence in Lombardy (Italy).
</td>
<td style="text-align:left;">
Environ. Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic Value of Ki67 Percentage, WT-1 Expression and p16/CDKN2A Deletion in Diffuse Malignant Peritoneal Mesothelioma: A Single-Centre Cohort Study.
</td>
<td style="text-align:left;">
Diagnostics (Basel)
</td>
</tr>
<tr>
<td style="text-align:left;">
Addition of radiotherapy to surgery and chemotherapy improves survival in localized malignant pleural mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) study.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Genomic-based ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
RapidPlan for Knowledge-Based Planning of Malignant Pleural Mesothelioma.
</td>
<td style="text-align:left;">
Pract Radiat Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Predicting cancer using supervised machine learning: Mesothelioma.
</td>
<td style="text-align:left;">
Technol Health Care
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses.
</td>
<td style="text-align:left;">
Clin Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical long-term outcome of non-specific pleuritis (NSP) after surgical or medical thoracoscopy.
</td>
<td style="text-align:left;">
J Thorac Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison between closed pleural biopsy and medical thoracoscopy for the diagnosis of undiagnosed exudative pleural effusions: a systematic review and meta-analysis.
</td>
<td style="text-align:left;">
Transl Lung Cancer Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical significance of histologic subtyping of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Transl Lung Cancer Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Integrative approach to cytologic and molecular diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Transl Lung Cancer Res
</td>
</tr>
<tr>
<td style="text-align:left;">
Testing for BAP1 loss and CDKN2A/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology.
</td>
<td style="text-align:left;">
Cancer Cytopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma Biomarkers: A Review Highlighting Contributions from the Early Detection Research Network.
</td>
<td style="text-align:left;">
Cancer Epidemiol. Biomarkers Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Laser ablation inductively coupled plasma mass spectrometry as a Novel Clinical Imaging Tool to Detect Asbestos Fibres in Malignant Mesothelioma.
</td>
<td style="text-align:left;">
Rapid Commun. Mass Spectrom.
</td>
</tr>
<tr>
<td style="text-align:left;">
New vistas in malignant mesothelioma: MicroRNA architecture and NRF2/MAPK signal transduction.
</td>
<td style="text-align:left;">
Life Sci.
</td>
</tr>
<tr>
<td style="text-align:left;">
Normal Mesothelial Cell Lines Newly Derived from Human Pleural Biopsy Explants.
</td>
<td style="text-align:left;">
Am. J. Physiol. Lung Cell Mol. Physiol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Determinants of plasma calretinin in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
BMC Res Notes
</td>
</tr>
<tr>
<td style="text-align:left;">
Multiplex Soluble Biomarker Analysis from Pleural Effusion.
</td>
<td style="text-align:left;">
Biomolecules
</td>
</tr>
<tr>
<td style="text-align:left;">
Verification of a blood based targeted proteomics signature for malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer Epidemiol. Biomarkers Prev.
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytology, immunopathology and flow cytometry in the diagnosis of pleural and peritoneal effusions.
</td>
<td style="text-align:left;">
Lab. Invest.
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma of childhood.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Histologic aspects of pleural mesothelioma].
</td>
<td style="text-align:left;">
Arch Inst Pasteur Tunis
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades, 1965-1985.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Expression of epithelial membrane antigen on malignant mesothelioma cells. An immunocytochemical and immunoelectron microscopic study.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death.
</td>
<td style="text-align:left;">
Br J Ind Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Case-control study of diet and mesothelioma in Louisiana.
</td>
<td style="text-align:left;">
Cancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Freeze-fracture study of intercellular junctions in benign and malignant mesothelial cells in effusions and a comparison with those seen in pleural mesotheliomas (solid tumour).
</td>
<td style="text-align:left;">
J. Submicrosc. Cytol. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Surgical treatment of asbestos-related disease of the chest.
</td>
<td style="text-align:left;">
Surg. Clin. North Am.
</td>
</tr>
<tr>
<td style="text-align:left;">
Thrombocytosis in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Flow cytometric analysis of ploidy in immunohistochemically confirmed examples of malignant epithelial mesothelioma.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Computerized interactive morphometry as an aid in the diagnosis of pleural effusions.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Fine needle aspiration cytology of malignant mesothelioma.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos-related malignancy.
</td>
<td style="text-align:left;">
Crit. Rev. Oncol. Hematol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Serum hyaluronate in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Benign and malignant mesothelial lesions of the pleura: quantitative study.
</td>
<td style="text-align:left;">
Appl Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Accuracy of diagnostic procedures in the initial evaluation and follow-up of mesothelioma patients.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
The cytologic diagnosis of mesothelioma.
</td>
<td style="text-align:left;">
Semin Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant mesothelioma of the pleura–intrapleural treatment with doxorubicin.
</td>
<td style="text-align:left;">
Arch. Geschwulstforsch.
</td>
</tr>
<tr>
<td style="text-align:left;">
High incidence of malignant pleural mesothelioma in neighbouring villages of Northwestern Greece.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma with occupational and environmental asbestos exposure in an Illinois community hospital.
</td>
<td style="text-align:left;">
Arch. Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant diffuse peritoneal mesothelioma: clinical and therapeutic aspects. Apropos of a case with gelatinous ascites].
</td>
<td style="text-align:left;">
Rev Med Interne
</td>
</tr>
<tr>
<td style="text-align:left;">
Applications of computerized interactive morphometry in pathology. II. A model for computer generated diagnosis.
</td>
<td style="text-align:left;">
Lab. Invest.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
</td>
<td style="text-align:left;">
Am. J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma cells in sputum.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of ferritin analysis in pleural effusions.
</td>
<td style="text-align:left;">
Scand. J. Clin. Lab. Invest.
</td>
</tr>
<tr>
<td style="text-align:left;">
[pH measurement in the diagnosis of pleural exudates].
</td>
<td style="text-align:left;">
Minerva Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunodiagnosis of mesothelioma: use of antimesothelial cell serum in an indirect immunofluorescence assay.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Secretory component in pulmonary adenocarcinoma and mesothelioma.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytopathology of asbestos-associated pulmonary disease.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Benign and malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Clin. Chest Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignancies.
</td>
<td style="text-align:left;">
Eur J Cancer Clin Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
The use of vimentin antibodies in the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Virchows Arch A Pathol Anat Histopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.
</td>
<td style="text-align:left;">
Mayo Clin. Proc.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant diffuse pleural mesothelioma: a comparison between computed tomography and the conventional chest x-ray].
</td>
<td style="text-align:left;">
Digitale Bilddiagn
</td>
</tr>
<tr>
<td style="text-align:left;">
Glycosaminoglycans in malignant diffuse mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Modified nucleosides in asbestos workers at high risk of malignant disease: results of a preliminary study applying discriminant analysis.
</td>
<td style="text-align:left;">
Br J Ind Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Biochemical and cytological features of diffuse mesotheliomas of the pleura.
</td>
<td style="text-align:left;">
Arch. Geschwulstforsch.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Bromocriptine in Parkinson’s disease: pleuropulmonary toxicity].
</td>
<td style="text-align:left;">
Ann Med Interne (Paris)
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural and peritoneal cytology].
</td>
<td style="text-align:left;">
Cesk Patol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Differential diagnosis of pleural diseases].
</td>
<td style="text-align:left;">
Z Gesamte Inn Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Epidemiologic surveillance of mesothelioma in Canada.
</td>
<td style="text-align:left;">
Can Med Assoc J
</td>
</tr>
<tr>
<td style="text-align:left;">
Exfoliative cytology of diffuse mesothelioma.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diffuse malignant mesothelioma of the pleura and peritoneum].
</td>
<td style="text-align:left;">
Cesk Patol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Ultrastructural diagnostic problems of pleural tumors. A study of 125 cases (author’s transl)].
</td>
<td style="text-align:left;">
Rev Fr Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
[The computed tomography of the malignant thoracic space-occupying process under special consideration of radiotherapeutic points of view (author’s transl)].
</td>
<td style="text-align:left;">
Strahlentherapie
</td>
</tr>
<tr>
<td style="text-align:left;">
[Rare malignant tumors of the lungs (44 cases)].
</td>
<td style="text-align:left;">
Vopr Onkol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Asbestosis. Apropos of one case].
</td>
<td style="text-align:left;">
Poumon Coeur
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistological study of malignant diffuse mesotheliomas of the pleura.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas.
</td>
<td style="text-align:left;">
Am. J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma. Cytopathology of 75 cases seen in a New Jersey community hospital.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment.
</td>
<td style="text-align:left;">
Eur J Respir Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized fibrous mesothelioma: an immunohistochemical and electron microscopic study.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Scanning electron microscopy of alcohol-fixed cytopathology specimens.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Fiber counting and analysis in the diagnosis of asbestos-related disease.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: ultrastructural distinction from adenocarcinoma.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Conventional treatment and its effect on survival of malignant pleural mesothelioma in Western Australia.
</td>
<td style="text-align:left;">
Aust N Z J Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Detection of tissue CEA-like substance as an aid in the differential diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Pathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Pseudomesotheliomatous carcinoma of the lung with histochemical and immunohistochemical study.
</td>
<td style="text-align:left;">
Acta Pathol. Jpn.
</td>
</tr>
<tr>
<td style="text-align:left;">
Carcinoembryonic antigen in pleural effusions. Diagnostic value in malignant mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis of pleural malignant mesothelioma in life–a practical approach.
</td>
<td style="text-align:left;">
J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Thoracoscopic and computer tomographic findings in pleural mesotheliomas].
</td>
<td style="text-align:left;">
Rofo
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the pleura in Barrow-in-Furness.
</td>
<td style="text-align:left;">
Thorax
</td>
</tr>
<tr>
<td style="text-align:left;">
Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycin.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Thoracoscopy with pleural brushing. A new diagnostic method for pleural diseases].
</td>
<td style="text-align:left;">
Rev Pneumol Clin
</td>
</tr>
<tr>
<td style="text-align:left;">
[Radiologic diagnosis in malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Radiol Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant mesothelioma of pleura: diagnostic criteria based on an autopsy study.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos exposure. An update on pleuropulmonary hazards.
</td>
<td style="text-align:left;">
Postgrad Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma in Connecticut, 1955-1977. Occupational and geographic associations.
</td>
<td style="text-align:left;">
J Occup Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma in urban dogs.
</td>
<td style="text-align:left;">
Vet. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Scope of scanning electron microscopy, transmission electron microscopy and freeze fracture technique in diagnostic cytology of effusions.
</td>
<td style="text-align:left;">
Scan Electron Microsc
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma following radiation exposure.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: incidence, asbestos exposure, and reclassification of histopathology.
</td>
<td style="text-align:left;">
Br J Ind Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: the role of computed tomography.
</td>
<td style="text-align:left;">
J Comput Tomogr
</td>
</tr>
<tr>
<td style="text-align:left;">
[Mesothelioma as an index tumor of the occupational hazard of asbestos dust].
</td>
<td style="text-align:left;">
Dtsch. Med. Wochenschr.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma. A clinical review of 19 patients.
</td>
<td style="text-align:left;">
Scand J Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
The radiology of thoracic malignant mesothelioma.
</td>
<td style="text-align:left;">
Crit Rev Diagn Imaging
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnosis and prognosis in malignant pleural mesothelioma: a prospective study.
</td>
<td style="text-align:left;">
Eur J Respir Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
CT of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
AJR Am J Roentgenol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma in children: report of seven cases and review of the literature.
</td>
<td style="text-align:left;">
Med. Pediatr. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
DNA flow cytometry of pleural effusions. Comparison with pathology for the diagnosis of malignancy.
</td>
<td style="text-align:left;">
Anal Quant Cytol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Clinical aspects and course of 38 cases of malignant pleural mesothelioma observed in the Marseilles region].
</td>
<td style="text-align:left;">
Poumon Coeur
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant thymoma with diffuse extensive growth on the pleura].
</td>
<td style="text-align:left;">
Gan No Rinsho
</td>
</tr>
<tr>
<td style="text-align:left;">
Trephine drill biopsy in the diagnosis of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur J Respir Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Ultrastructural diagnosis of pleural tumors.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural effusions.
</td>
<td style="text-align:left;">
Br J Hosp Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma in man and experimental animals.
</td>
<td style="text-align:left;">
Environ. Health Perspect.
</td>
</tr>
<tr>
<td style="text-align:left;">
Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Chemotherapy for malignant mesothelioma; CAMEO.
</td>
<td style="text-align:left;">
Am. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunotherapy with BCG vaccine in 30 cases of mesothelioma.
</td>
<td style="text-align:left;">
S. Afr. Med. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Development of radiological and clinical evidence of parenchymal fibrosis in men with non-malignant asbestos-related pleural lesions.
</td>
<td style="text-align:left;">
Br J Ind Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Rib destruction: a neglected finding in malignant mesothelioma.
</td>
<td style="text-align:left;">
Clin Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Computed tomography in the assessment of malignant mesothelioma of the pleura.
</td>
<td style="text-align:left;">
Clin Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the pleura: review of 123 patients.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients.
</td>
<td style="text-align:left;">
Ann. Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Metastatic mesothelioma of the pericardium].
</td>
<td style="text-align:left;">
Z Kardiol
</td>
</tr>
<tr>
<td style="text-align:left;">
The outcome of patients with pleural effusion of indeterminate cause at thoracotomy.
</td>
<td style="text-align:left;">
Mayo Clin. Proc.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Claude Bernard-Horner’s syndrome due to malignant pleural mesothelioma (author’s transl)].
</td>
<td style="text-align:left;">
Rev Fr Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma. Retrospective study of 16 cases].
</td>
<td style="text-align:left;">
Schweiz Med Wochenschr
</td>
</tr>
<tr>
<td style="text-align:left;">
The influence of occupational and environmental asbestos exposure on the incidence of malignant mesothelioma in Connecticut.
</td>
<td style="text-align:left;">
IARC Sci. Publ.
</td>
</tr>
<tr>
<td style="text-align:left;">
The clinical and radiological aspects of 185 cases of malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
IARC Sci. Publ.
</td>
</tr>
<tr>
<td style="text-align:left;">
The use of electron microscopy in the diagnosis of diffuse mesotheliomas using human pleural effusions.
</td>
<td style="text-align:left;">
IARC Sci. Publ.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of total and differential leukocyte counts in pleural effusions.
</td>
<td style="text-align:left;">
Acta Med Scand
</td>
</tr>
<tr>
<td style="text-align:left;">
Learning from quantitation.
</td>
<td style="text-align:left;">
Anal Quant Cytol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Current indications for thoracoscopy].
</td>
<td style="text-align:left;">
Rev Fr Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant pleural mesothelioma in Glasgow.
</td>
<td style="text-align:left;">
Br J Dis Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma presenting as apparent recurrent pulmonary embolism.
</td>
<td style="text-align:left;">
Br J Dis Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracoscopy in the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Poumon Coeur
</td>
</tr>
<tr>
<td style="text-align:left;">
[Intrapleural talc in malignant pleural effusions (author’s transl)].
</td>
<td style="text-align:left;">
Poumon Coeur
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic thoracoscopy.
</td>
<td style="text-align:left;">
Eur J Respir Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: a metastasis to the face.
</td>
<td style="text-align:left;">
J Surg Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma with lung cancer complicating asbestosis.
</td>
<td style="text-align:left;">
Acta Pathol. Jpn.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse, mixed malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Ann. Thorac. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: a review of 35 cases with diagnosis and prognosis.
</td>
<td style="text-align:left;">
Pathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Multiple skeletal muscle metastases from malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Epidemiology of malignant pleural mesothelioma in the Nantes-Saint Nazaire region. Course in 1956-1992].
</td>
<td style="text-align:left;">
Rev Mal Respir
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic video-assisted thoracoscopic procedures.
</td>
<td style="text-align:left;">
Ann. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the pleura: interobserver variability.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pericardial malignant mesothelioma: case report and discussion of immunohistochemical and histochemical findings.
</td>
<td style="text-align:left;">
Pathol. Int.
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnostic value of thrombomodulin immunolocalization in serous effusions.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized malignant mesothelioma. A clinicopathologic and flow cytometric study.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytochemical typification of mesothelial cells in effusions: in vivo and in vitro models.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Desmin and neural marker expression in mesothelial cells and mesotheliomas.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[The clinical picture and therapy of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Strahlenther Onkol
</td>
</tr>
<tr>
<td style="text-align:left;">
Markers for metastatic adenocarcinoma in serous effusion specimens.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Molecular cloning of a cell-surface glycoprotein that can potentially discriminate mesothelium from epithelium: its identification as vascular cell adhesion molecule 1.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytochemical characterization of malignant mesothelioma and carcinoma metastatic to the pleura: IOB3–a new tumor marker.
</td>
<td style="text-align:left;">
Lung
</td>
</tr>
<tr>
<td style="text-align:left;">
Production of granulocyte colony-stimulating factor by malignant mesothelioma.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant peritoneal mesothelioma after Thorotrast exposure.
</td>
<td style="text-align:left;">
Am. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical features and current treatment of diffuse malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Lung Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation.
</td>
<td style="text-align:left;">
J Surg Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Epithelioid hemangioendothelioma of the lung: pleural effusion cytology, ultrastructure, and brief literature review.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of diffuse malignant mesothelioma diagnosed by thoracoscopic biopsy].
</td>
<td style="text-align:left;">
Nihon Kyobu Geka Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of localized fibrous tumor of the pleura with bloody pleural effusion].
</td>
<td style="text-align:left;">
Nihon Kyobu Geka Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Parathyroid hormone-related protein antigen localization distinguishes between mesothelioma and adenocarcinoma of the lung.
</td>
<td style="text-align:left;">
J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction.
</td>
<td style="text-align:left;">
Ann. Surg. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
[Imaging diagnosis of localized pleural mesothelioma].
</td>
<td style="text-align:left;">
Zhonghua Zhong Liu Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Glycosaminoglycans from two human malignant mesothelioma cell lines: determination, distribution, and effect of platelet-derived growth factor on their synthesis.
</td>
<td style="text-align:left;">
Biochem. Cell Biol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesotheliomas–an analysis of 18 cases and review of the literature.
</td>
<td style="text-align:left;">
Medicine (Baltimore)
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diagnostic value of tissue polypeptide antigen in pleural effusions with malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Nihon Kyobu Shikkan Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic significance of DNA aneuploidy in diffuse malignant mesothelioma.
</td>
<td style="text-align:left;">
Cytometry
</td>
</tr>
<tr>
<td style="text-align:left;">
The value of immunohistochemistry of pleural biopsy specimens in the differential diagnosis between malignant mesothelioma and metastatic carcinoma.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
[High-resolution magnetic resonance tomography (HR-MRT) of the pleura and thoracic wall: normal findings and pathological changes].
</td>
<td style="text-align:left;">
Rofo
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignancies in the lung and pleura mimicking benign processes.
</td>
<td style="text-align:left;">
Semin Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Cardiac tamponade disclosing neoplasm: apropos of 23 cases].
</td>
<td style="text-align:left;">
Arch Mal Coeur Vaiss
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma and radical multimodality therapy: who benefits?
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
CT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
J Comput Assist Tomogr
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the pericardium. An anatomo-clinical study of 10 cases].
</td>
<td style="text-align:left;">
Arch Mal Coeur Vaiss
</td>
</tr>
<tr>
<td style="text-align:left;">
[Fluoroscopically guided percutaneous fine-needle biopsy of the lung using the ROTEX needle: results in 890 patients with focal lung lesions].
</td>
<td style="text-align:left;">
Rofo
</td>
</tr>
<tr>
<td style="text-align:left;">
[Mesotheliomas].
</td>
<td style="text-align:left;">
Rozhl Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
Chromosome analysis in pleural effusions. Efficiency of this method in the differential diagnosis of pleural effusions.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic flexible fiberoptic pleuroscopy in suspected malignant pleural effusions.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma: attributable risk of asbestos exposure.
</td>
<td style="text-align:left;">
Occup Environ Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse pleural thickening: percutaneous CT-guided cutting needle biopsy.
</td>
<td style="text-align:left;">
Radiology
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma in families of asbestos workers].
</td>
<td style="text-align:left;">
Harefuah
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma following radiation therapy.
</td>
<td style="text-align:left;">
Am. J. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Spectrum of peritoneal mesothelioma in childhood: clinical and histopathologic features, including DNA cytometry.
</td>
<td style="text-align:left;">
Pediatr Hematol Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
The pathology of benign and malignant pleural disease.
</td>
<td style="text-align:left;">
Chest Surg. Clin. N. Am.
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracoscopy for the evaluation and treatment of pleural space disease.
</td>
<td style="text-align:left;">
Chest Surg. Clin. N. Am.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural and pericardial mesothelioma in a general teaching hospital during the last fourteen years.
</td>
<td style="text-align:left;">
Zhonghua Yi Xue Za Zhi (Taipei)
</td>
</tr>
<tr>
<td style="text-align:left;">
Metastatic epithelioid hemangioendothelioma in a pleural effusion: diagnosis by cytology.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of the localized fibrous mesothelioma which size decreased temporarily].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of lactoferrin analysis in pleural effusions.
</td>
<td style="text-align:left;">
Eur J Clin Chem Clin Biochem
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemical reactivity in mesothelioma and adenocarcinoma: a stepwise logistic regression analysis.
</td>
<td style="text-align:left;">
APMIS
</td>
</tr>
<tr>
<td style="text-align:left;">
[Localized pleural mesothelioma].
</td>
<td style="text-align:left;">
Helv Chir Acta
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of laparoscopy in the evaluation of ascites of unknown origin.
</td>
<td style="text-align:left;">
Gastrointest. Endosc.
</td>
</tr>
<tr>
<td style="text-align:left;">
The histopathological diagnosis of malignant mesothelioma v. pulmonary adenocarcinoma: reproducibility of the histopathological diagnosis.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural tumor in a child mimicking a mesothelioma.
</td>
<td style="text-align:left;">
Eur J Pediatr Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural mesothelioma: a clinicopathologic study of 42 cases].
</td>
<td style="text-align:left;">
Zhonghua Nei Ke Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of acute subdural hematoma due to dural metastasis from malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
No Shinkei Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma: study of prognostic factors in a series of 188 cases].
</td>
<td style="text-align:left;">
Arch. Anat. Cytol. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Immunohistochemistry of mesotheliomas. Technique and current diagnostic contribution of immunohistochemical markers. General review].
</td>
<td style="text-align:left;">
Arch. Anat. Cytol. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Mesothelial cell. Cytology. Cytochemistry. Immunocytochemistry. Contribution of immunolabelling to the cytodiagnosis of serous effusions with cells of mesothelial aspect].
</td>
<td style="text-align:left;">
Arch. Anat. Cytol. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Flow cytometry and malignant pleural mesotheliomas. Value in the histologic and cytologic diagnosis].
</td>
<td style="text-align:left;">
Arch. Anat. Cytol. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells.
</td>
<td style="text-align:left;">
Arch. Pathol. Lab. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Interferon alpha and doxorubicin in malignant mesothelioma: a phase II study.
</td>
<td style="text-align:left;">
Aust N Z J Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural malignant mesothelioma complicated with disseminated intravascular coagulation].
</td>
<td style="text-align:left;">
Hua Xi Yi Ke Da Xue Xue Bao
</td>
</tr>
<tr>
<td style="text-align:left;">
Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesothelioma presenting as an axillary lymph node metastasis with anemone cell appearance.
</td>
<td style="text-align:left;">
Ultrastruct Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Asbestos-related mesothelioma in Monfalcone, Italy.
</td>
<td style="text-align:left;">
Am. J. Ind. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Effect of smoking on pleural thickening in asbestos workers.
</td>
<td style="text-align:left;">
Br J Ind Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma. A diagnostic and therapeutic challenge].
</td>
<td style="text-align:left;">
An Med Interna
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic and therapeutic thoracoscopy: techniques and indications in pulmonary medicine.
</td>
<td style="text-align:left;">
Tuber. Lung Dis.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Survey for primary tumor site in patients with initial clinical presentation of bone metastasis].
</td>
<td style="text-align:left;">
Kaku Igaku
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pericardial mesothelioma. Evolution and update in the last decade].
</td>
<td style="text-align:left;">
Pathologica
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the pleura with an unusual course].
</td>
<td style="text-align:left;">
Ugeskr. Laeg.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Thoracoscopy in pleural mesothelioma].
</td>
<td style="text-align:left;">
Zhonghua Jie He He Hu Xi Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Pulmonary complications of asbestos exposure.
</td>
<td style="text-align:left;">
Am Fam Physician
</td>
</tr>
<tr>
<td style="text-align:left;">
Metastatic mesothelioma of the oral cavity. Report of two cases.
</td>
<td style="text-align:left;">
Oral Surg. Oral Med. Oral Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Carcinoembryonic antigen-like reactivity in malignant mesothelioma. A comparison between different commercially available antibodies.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival.
</td>
<td style="text-align:left;">
Virchows Arch A Pathol Anat Histopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Three unusual presentations of interscapular back pain.
</td>
<td style="text-align:left;">
Aust Fam Physician
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant peritoneal mesothelioma].
</td>
<td style="text-align:left;">
Harefuah
</td>
</tr>
<tr>
<td style="text-align:left;">
Ultrastructure of diffuse malignant mesothelioma of the pleura. An analysis of ten cases.
</td>
<td style="text-align:left;">
Patol Pol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pleural mesothelioma. Review of 3 cases and role of thoracoscopy].
</td>
<td style="text-align:left;">
Rev Med Suisse Romande
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma: a clinicopathological study.
</td>
<td style="text-align:left;">
J Surg Oncol
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma caused by environmental exposure to asbestos or erionite in rural Turkey: CT findings in 84 patients.
</td>
<td style="text-align:left;">
AJR Am J Roentgenol
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of ultrasound assisted thoracoscopy in the diagnosis of pleural disease. Clinical experience in 687 cases.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytopathology of malignant mesothelioma: a study of its patterns and histological bases.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical aspects of malignant mesothelioma in Australia.
</td>
<td style="text-align:left;">
Aust N Z J Med
</td>
</tr>
<tr>
<td style="text-align:left;">
Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clinical and pathological features of thoracic neoplasia in the horse.
</td>
<td style="text-align:left;">
Equine Vet. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of slowly-growing localized malignant mesothelioma].
</td>
<td style="text-align:left;">
Nihon Kyobu Shikkan Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant pleural mesothelioma: clinical characteristics, prognostic factors and treatment].
</td>
<td style="text-align:left;">
Arch. Bronconeumol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracoscopic management of malignant pleural effusions.
</td>
<td style="text-align:left;">
Clin. Chest Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
FISH in the evaluation of pleural and ascitic fluids.
</td>
<td style="text-align:left;">
Cancer Genet. Cytogenet.
</td>
</tr>
<tr>
<td style="text-align:left;">
Parental cancer and genetic predisposition in malignant pleural mesothelioma: a case-control study.
</td>
<td style="text-align:left;">
Cancer Lett.
</td>
</tr>
<tr>
<td style="text-align:left;">
Post-irradiation malignant mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma, asbestos, and reported history of cancer in first-degree relatives.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Dysphagia as an unusual form of presentation of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Rev Esp Enferm Dig
</td>
</tr>
<tr>
<td style="text-align:left;">
Imaging of pleural diseases.
</td>
<td style="text-align:left;">
Monaldi Arch Chest Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Mesothelioma as a risk indicator of asbestos exposure: the role of the pathologist.
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
Stereological evaluation of malignant mesothelioma versus benign pleural hyperplasia.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant fibrous mesothelioma of the tunica vaginalis: a histologic and ultrastructural study.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Treatment and survival in diffuse malignant pleural mesothelioma; a study of 83 cases from the Massachusetts General Hospital.
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Acid glycosaminoglycans (mucopolysaccharides) in the differential diagnosis of pleural effusion.
</td>
<td style="text-align:left;">
Clin. Chim. Acta
</td>
</tr>
<tr>
<td style="text-align:left;">
Stimulatory effects of pleural fluids from mesothelioma patients on CD44 expression, hyaluronan production and cell proliferation in primary cultures of normal mesothelial and transformed cells.
</td>
<td style="text-align:left;">
Int. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diagnosis and treatment of pleural mesothelioma: a report of 40 cases].
</td>
<td style="text-align:left;">
Zhonghua Zhong Liu Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Peritoneal mesothelioma. Contribution of MRI. Apropos of a case].
</td>
<td style="text-align:left;">
J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Sarcomatous malignant mesothelioma diagnosed after death].
</td>
<td style="text-align:left;">
Nihon Kyobu Shikkan Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Adenomatoid tumors of the pleura.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Analysis of pleural effusions using flow cytometry.
</td>
<td style="text-align:left;">
Respiration
</td>
</tr>
<tr>
<td style="text-align:left;">
p53 gene product in pleural effusions. Practical use in distinguishing benign from malignant cells.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu-M1, Ber EP4, Tamm-Horsfall protein and thrombomodulin.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Endobronchial inflammatory pseudotumour in a patient with B-cell chronic lymphocytic leukemia and malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Acta Clin Belg
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the pleura].
</td>
<td style="text-align:left;">
Orv Hetil
</td>
</tr>
<tr>
<td style="text-align:left;">
Accuracy of death certification of pleural mesothelioma in Italy.
</td>
<td style="text-align:left;">
Eur. J. Epidemiol.
</td>
</tr>
<tr>
<td style="text-align:left;">
From the archives of the AFIP. Malignant pleural mesothelioma: radiologic-pathologic correlation.
</td>
<td style="text-align:left;">
Radiographics
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case report of surgical resection of renal cell carcinoma with intrathoracic metastasis].
</td>
<td style="text-align:left;">
Nihon Kyobu Geka Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases.
</td>
<td style="text-align:left;">
Am. J. Surg. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Imaging of peritoneal mesotheliomas].
</td>
<td style="text-align:left;">
J Radiol
</td>
</tr>
<tr>
<td style="text-align:left;">
Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates.
</td>
<td style="text-align:left;">
Hum. Gene Ther.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunopathology of malignant mesothelioma.
</td>
<td style="text-align:left;">
Pathology (Phila)
</td>
</tr>
<tr>
<td style="text-align:left;">
Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the pleura: correlations between thoracoscopy and radiology].
</td>
<td style="text-align:left;">
Radiol Med
</td>
</tr>
<tr>
<td style="text-align:left;">
[Pulmonary embolism in malignancy of the lung: a retrospective clinical evaluation and pathomorphologic personal material].
</td>
<td style="text-align:left;">
Pneumonol Alergol Pol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Evaluation of the usefulness of palpation and Daniel’s biopsy for detection of metastasis to supraclavicular and scalene lymph nodes in patients with lung neoplasms].
</td>
<td style="text-align:left;">
Pneumonol Alergol Pol
</td>
</tr>
<tr>
<td style="text-align:left;">
Differential diagnosis of malignant and reactive cells from serous effusions: image and texture analysis study.
</td>
<td style="text-align:left;">
Anal Cell Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Solitary fibrous tumor of the pleura. Clinical case].
</td>
<td style="text-align:left;">
Minerva Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
A case of malignant pleural mesothelioma with metastasis to the orbit.
</td>
<td style="text-align:left;">
Jpn. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Fibrous tumors localized in the pleura].
</td>
<td style="text-align:left;">
G Chir
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural mesotheliomas have an integrin profile distinct from visceral carcinomas.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME-1 expression.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
[A case of localized pleural mesothelioma].
</td>
<td style="text-align:left;">
Kyobu Geka
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the pleura following radiotherapy of Hodgkin disease].
</td>
<td style="text-align:left;">
Bull Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Response to chemotherapy of brain metastases from malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Tumori
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Videothoracoscopy in the diagnosis and treatment of malignant pleural mesothelioma with associated pleural effusions.
</td>
<td style="text-align:left;">
Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural effusion cytology of embryonal rhabdomyosarcoma.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Prevalence of pleural malignant mesothelioma in Poland in 1980-1993].
</td>
<td style="text-align:left;">
Przegl Epidemiol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Problems in diagnosis and therapy of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Med. Klin. (Munich)
</td>
</tr>
<tr>
<td style="text-align:left;">
High CD44 expression on human mesotheliomas mediates association with hyaluronan.
</td>
<td style="text-align:left;">
Cancer J Sci Am
</td>
</tr>
<tr>
<td style="text-align:left;">
[A mesenchymal malignant mesothelioma that changed from mixed type to purely sarcomatous type].
</td>
<td style="text-align:left;">
Nihon Kyobu Shikkan Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathology of malignant mesothelioma.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma metastatic to the skin, presenting as inflammatory carcinoma.
</td>
<td style="text-align:left;">
Am J Dermatopathol
</td>
</tr>
<tr>
<td style="text-align:left;">
bcl-2 expression in pleural and extrapleural solitary fibrous tumours.
</td>
<td style="text-align:left;">
J. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Diffuse malignant pleural mesotheslioma at CAMC: a retrospective study of 50 patients.
</td>
<td style="text-align:left;">
W V Med J
</td>
</tr>
<tr>
<td style="text-align:left;">
[Occupational neoplasms in Poland in the years 1971-1994].
</td>
<td style="text-align:left;">
Med Pr
</td>
</tr>
<tr>
<td style="text-align:left;">
[Thoracoscopy in malignant pleural effusions].
</td>
<td style="text-align:left;">
Zhonghua Zhong Liu Za Zhi
</td>
</tr>
<tr>
<td style="text-align:left;">
[Large-cell carcinoma presenting as diffuse thickening of the pleura and resembling malignant mesothelioma].
</td>
<td style="text-align:left;">
Nihon Kyobu Shikkan Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
[Thoracoscopic surgery for diagnosis and treatment of pleural and mediastinal disease].
</td>
<td style="text-align:left;">
Nihon Kyobu Shikkan Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
[Utility of thoracoscopy for diagnosis of pulmonary diseases in clinical pulmonary medicine].
</td>
<td style="text-align:left;">
Nihon Kyobu Shikkan Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma in south east England: clinicopathological experience of 272 cases.
</td>
<td style="text-align:left;">
Thorax
</td>
</tr>
<tr>
<td style="text-align:left;">
[Imaging of the pleura].
</td>
<td style="text-align:left;">
Rev Prat
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma. Diagnosis and treatment].
</td>
<td style="text-align:left;">
Rev Prat
</td>
</tr>
<tr>
<td style="text-align:left;">
Brain metastasis in malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma: incidence, survival and relative risks in selected municipalities 1943-1992].
</td>
<td style="text-align:left;">
Ugeskr. Laeg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Newly marketed tissue markers for malignant mesothelioma: immunoreactivity of rabbit AMAD-2 antiserum compared with monoclonal antibody HBME-1 and a review of the literature on so-called antimesothelioma antibodies.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Metastatic malignant mesothelioma presenting as colonic polyps.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Clear cell tumors of unknown nature and origin: a systematic approach to diagnosis.
</td>
<td style="text-align:left;">
Semin Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
[Tissue polypeptide antigen as a biological marker of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Nihon Kyobu Shikkan Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
[Photomicrographs of a pleural biopsy specimen, showing malignant mesothelioma and necrosis–malignant pleural mesothelioma in a patient with sarcoidosis].
</td>
<td style="text-align:left;">
Nihon Kyobu Shikkan Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
Pericardiectomy in dogs: 22 cases (1978-1994).
</td>
<td style="text-align:left;">
J. Am. Vet. Med. Assoc.
</td>
</tr>
<tr>
<td style="text-align:left;">
Brachytherapy for non-small cell lung cancer and selected neoplasms of the chest.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
[Soft tissue sarcomas as a rare cause of pleural effusion].
</td>
<td style="text-align:left;">
Pneumonol Alergol Pol
</td>
</tr>
<tr>
<td style="text-align:left;">
[A resected case of diffuse malignant pleural mesothelioma diagnosed by thoracoscopic biopsy].
</td>
<td style="text-align:left;">
Nihon Kyobu Geka Gakkai Zasshi
</td>
</tr>
<tr>
<td style="text-align:left;">
High-performance capillary electrophoretic analysis of hyaluronan in effusions from human malignant mesothelioma.
</td>
<td style="text-align:left;">
J. Chromatogr. B Biomed. Sci. Appl.
</td>
</tr>
<tr>
<td style="text-align:left;">
Pathology of diffuse malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Semin. Thorac. Cardiovasc. Surg.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma diagnosed after chest trauma.
</td>
<td style="text-align:left;">
Am Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
Silica-induced pleural disease: an unusual case mimicking malignant mesothelioma.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
</td>
<td style="text-align:left;">
Acta Cytol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma.
</td>
<td style="text-align:left;">
Jpn. J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Optimization of a battery using nine immunocytochemical variables for distinguishing between epithelial mesothelioma and adenocarcinoma.
</td>
<td style="text-align:left;">
APMIS
</td>
</tr>
<tr>
<td style="text-align:left;">
Pleural malignant mesothelioma and environmental asbestos exposure in Casale Monferrato, Piedmont. Preliminary analysis of a case-control study.
</td>
<td style="text-align:left;">
Med Lav
</td>
</tr>
<tr>
<td style="text-align:left;">
A case of malignant pleural mesothelioma following exposure to atomic radiation in Nagasaki.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
[GC12, marker of cells of mesodermal origin. Value and application to cytodiagnosis of serous effusions].
</td>
<td style="text-align:left;">
Arch. Anat. Cytol. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the pleura. Morphometric study].
</td>
<td style="text-align:left;">
Pathologica
</td>
</tr>
<tr>
<td style="text-align:left;">
Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective].
</td>
<td style="text-align:left;">
Anticancer Res.
</td>
</tr>
<tr>
<td style="text-align:left;">
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
</td>
<td style="text-align:left;">
J. Clin. Oncol.
</td>
</tr>
<tr>
<td style="text-align:left;">
The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura.
</td>
<td style="text-align:left;">
J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant mesothelioma of the pleura with etiological association to asbestos: report of 3 clinical cases].
</td>
<td style="text-align:left;">
Rev Assoc Med Bras (1992)
</td>
</tr>
<tr>
<td style="text-align:left;">
TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung.
</td>
<td style="text-align:left;">
Cancer Lett.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the pleura. The reproducibility of the immunohistological diagnosis.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Br. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor.
</td>
<td style="text-align:left;">
Int. J. Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracoscopy–state of the art.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Value of thoracoscopy and talc pleurodesis in diagnosis and palliative treatment of malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Praxis (Bern 1994)
</td>
</tr>
<tr>
<td style="text-align:left;">
Hyperplastic mesothelial cells in lymph nodes: report of six cases of a benign process that can stimulate metastatic involvement by mesothelioma or carcinoma.
</td>
<td style="text-align:left;">
Hum. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
E-cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Utility of the antibodies CA 19-9, HBME-1, and thrombomodulin in the diagnosis of malignant mesothelioma and adenocarcinoma in cytology.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
The usefulness of CYFRA 21-1 in diagnosing and monitoring malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Acta Med. Okayama
</td>
</tr>
<tr>
<td style="text-align:left;">
Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana.
</td>
<td style="text-align:left;">
J La State Med Soc
</td>
</tr>
<tr>
<td style="text-align:left;">
[Diffuse primary malignant mesothelioma in abdominal cavity].
</td>
<td style="text-align:left;">
Arq Gastroenterol
</td>
</tr>
<tr>
<td style="text-align:left;">
Two familial mesothelioma cases with high concentrations of soluble cytokeratin 19 fragment in pleural fluid.
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Immunoreactivity of pleural malignant mesotheliomas to glutathione S-transferases.
</td>
<td style="text-align:left;">
APMIS
</td>
</tr>
<tr>
<td style="text-align:left;">
A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours.
</td>
<td style="text-align:left;">
Histopathology
</td>
</tr>
<tr>
<td style="text-align:left;">
Static DNA cytometry as a diagnostic aid in effusion cytology: I. DNA aneuploidy for identification and differentiation of primary and secondary tumors of the serous membranes.
</td>
<td style="text-align:left;">
Anal. Quant. Cytol. Histol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Static DNA cytometry as a diagnostic aid in effusion cytology: II. DNA aneuploidy for identification of neoplastic cells in equivocal effusions.
</td>
<td style="text-align:left;">
Anal. Quant. Cytol. Histol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Computed tomographic findings of environmental asbestos-related malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
Thoracoscopy in undiagnosed pleural effusions.
</td>
<td style="text-align:left;">
S. Afr. Med. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
The role of immunohistochemistry in the diagnosis of malignant mesothelioma.
</td>
<td style="text-align:left;">
Monaldi Arch Chest Dis
</td>
</tr>
<tr>
<td style="text-align:left;">
Medical thoracoscopy in the diagnosis of unexplained pleural effusion.
</td>
<td style="text-align:left;">
Respirology
</td>
</tr>
<tr>
<td style="text-align:left;">
The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining.
</td>
<td style="text-align:left;">
Am. J. Clin. Pathol.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant mesothelioma of the pleura with a large tumor embolus in the left atrium: an autopsy case.
</td>
<td style="text-align:left;">
Intern. Med.
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized malignant mesothelioma: a case report.
</td>
<td style="text-align:left;">
Am Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
[Unusual metastasis of a malignant pleural mesothelioma].
</td>
<td style="text-align:left;">
Pneumologie
</td>
</tr>
<tr>
<td style="text-align:left;">
Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.
</td>
<td style="text-align:left;">
Chest
</td>
</tr>
<tr>
<td style="text-align:left;">
[Standards, Options, and Recommendations for the management of patients with malignant mesothelioma of the pleura. Fédération Nationale des Centres de Lutte Contre le Cancer].
</td>
<td style="text-align:left;">
Bull Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
[Benign fibrous mesothelioma: report of 8 cases].
</td>
<td style="text-align:left;">
Arch. Bronconeumol.
</td>
</tr>
<tr>
<td style="text-align:left;">
SV40 expression in human neoplastic and non-neoplastic tissues: perspectives on diagnosis, prognosis and therapy of human malignant mesothelioma.
</td>
<td style="text-align:left;">
Dev. Biol. Stand.
</td>
</tr>
<tr>
<td style="text-align:left;">
Malignant pleural mesothelioma.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Treatment results of 17 patients with diffuse pleural mesothelioma.
</td>
<td style="text-align:left;">
Ann Thorac Cardiovasc Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
The value of anti-calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology.
</td>
<td style="text-align:left;">
Pathol. Res. Pract.
</td>
</tr>
<tr>
<td style="text-align:left;">
[Malignant diffuse mesothelioma: contribution of 23 cases].
</td>
<td style="text-align:left;">
Rev Clin Esp
</td>
</tr>
<tr>
<td style="text-align:left;">
Adenocarcinoma simulating mesothelioma: a clinicopathologic and immunohistochemical study of 29 cases.
</td>
<td style="text-align:left;">
Ann Diagn Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
The treatment of malignant mesothelioma with a gene modified cancer cell line: a phase I study.
</td>
<td style="text-align:left;">
Hum. Gene Ther.
</td>
</tr>
<tr>
<td style="text-align:left;">
Localized fibrous tumours of the pleura: 15 new cases and review of the literature.
</td>
<td style="text-align:left;">
Eur J Cardiothorac Surg
</td>
</tr>
<tr>
<td style="text-align:left;">
[Modern approach to malignant pleural mesothelioma. 1) Pretherapeutic evaluation].
</td>
<td style="text-align:left;">
Srp Arh Celok Lek
</td>
</tr>
<tr>
<td style="text-align:left;">
Fibrous pleural tumour producing 171 litres of transudate.
</td>
<td style="text-align:left;">
Eur. Respir. J.
</td>
</tr>
<tr>
<td style="text-align:left;">
Basal lamina reduplication in malignant epithelioid pleural mesothelioma.
</td>
<td style="text-align:left;">
Ultrastruct Pathol
</td>
</tr>
<tr>
<td style="text-align:left;">
Primary pleural mesothelioma.
</td>
<td style="text-align:left;">
Cancer
</td>
</tr>
<tr>
<td style="text-align:left;">
Cytologic diagnosis of malignant mesothelioma, with particular emphasis on the epithelial noncohesive cell type.
</td>
<td style="text-align:left;">
Diagn. Cytopathol.
</td>
</tr>
</tbody>
</table>
<p><br></p>

          </div>

          



          
        </div>

        <div class="body-footer">
          
          

          
        </div>

      </article>

      <footer class="site-footer">
  
  <p class="powered-by">
    
      <a href="/mesothelioma/privacy/">Privacy Policy</a>
    
    
        &middot; 
      <a href="/mesothelioma/terms/">Terms</a>
    
    
        &middot; 
      <a href="/mesothelioma/supp/faq/">FAQ</a>
    
  </p>
  

  <p class="powered-by">
    BioHub - UFPE &middot; 

    Powered by the
    <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
    <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

    
  </p>
</footer>


    </main>
  </div>
</div>


      

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.js" integrity="sha256-yt2kYMy0w8AbtF89WXb2P1rfjcP/HTHLT7097U8Y5b8=" crossorigin="anonymous"></script>

      

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/highlight.min.js" integrity="sha256-eOgo0OtLL4cdq7RdwRUiGKLX9XsIJ7nGhWEKbohmVAQ=" crossorigin="anonymous"></script>
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.18.1/languages/r.min.js"></script>
        
      

    

    
    

    
    
    <script>const code_highlighting = true;</script>
    

    
    
    <script>const isSiteThemeDark = false;</script>
    

    
    
    
    
    
    
    <script>
      const search_config = {"indexURI":"/mesothelioma/index.json","minLength":1,"threshold":0.3};
      const i18n = {"no_results":"No results found","placeholder":"Search...","results":"results found"};
      const content_type = {
        'post': "Posts",
        'project': "Projects",
        'publication' : "Publications",
        'talk' : "Talks"
        };
    </script>
    

    
    
    <script src="https://cdnjs.cloudflare.com/ajax/libs/anchor-js/4.1.1/anchor.min.js" integrity="sha256-pB/deHc9CGfFpJRjC43imB29Rse8tak+5eXqntO94ck=" crossorigin="anonymous"></script>
    <script>
      anchors.add();
    </script>
    

    
    
    <script id="search-hit-fuse-template" type="text/x-template">
      <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
      </div>
    </script>
    

    
    
    <script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js" integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js" integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin="anonymous"></script>
    

    
    

    
    

    
    
    <script id="dsq-count-scr" src="https://procovid19.disqus.com/count.js" async></script>
    

    
    
    
    
    
    
    
    
    
      
    
    
    
    
    <script src="/mesothelioma/js/academic.min.37431be2d92d7fb0160054761ab79602.js"></script>

    






  
  

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

</body>
</html>
